Emerging out of the “blur”: exploration, evaluation 

and significance of 3D N-glycans’ structure through 





Emerging out of the “blur”: exploration, evaluation 
and significance of 3D N-glycans’ structure through 
molecular dynamic studies 
 
Aoife Harbison B.Sc. (Hons) 
A thesis submitted to Maynooth University in fulfilment of the requirement for the degree of 
 
Doctor of Philosophy 
By 
Aoife Harbison B. Sc. 




Research supervisor: Dr. Elisa Fadda 
Head of Department: Dr. Denise Rooney  
ii 
 
Table of Contents 
 
 
Acknowledgements .............................................................................................................. i 
Declaration...........................................................................................................................ii 
Abbreviations ...................................................................................................................... iii 
Abstract .............................................................................................................................. 1 
List of Publications .............................................................................................................. 1 
Chapter 1: Introduction ........................................................................................................ 4 
References......................................................................................................................12 
Chapter 2: Computational Method .......................................................................................17 
References......................................................................................................................26 
Chapter 3: Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: a 
molecular dynamics study ...................................................................................................29 
3.1 Introduction ..............................................................................................................29 
3.2 Computational Methods .............................................................................................31 
3.3 Results......................................................................................................................32 
3.4 Discussion ................................................................................................................43 
3.5 Conclusions ..............................................................................................................46 
References......................................................................................................................47 
Chapter 4: How and why plants and human N-glycans are different: Insight from molecular dynamics 
into the “glycoblocks” architecture ......................................................................................51 
4.1 Introduction ..............................................................................................................51 
4.2 Computational Methods .............................................................................................54 
4.3 Results......................................................................................................................55 
4.4 Discussion ................................................................................................................62 
4.5 Conclusions ..............................................................................................................65 
References......................................................................................................................66 
Chapter 5: An Atomistic Perspective on Antibody-dependent cellular cytotoxicity quenching by core-
fucosylation of IgG1 N-glycans from enhanced sampling molecular dynamics .......................69 
5.1 Introduction ..............................................................................................................69 
5.2 Computational Methods .............................................................................................71 
5.3 Results......................................................................................................................72 
5.4 Discussion ................................................................................................................79 




Chapter 6: All-Atom Molecular Dynamics Simulations of SARS-CoV-2 Spike Protein with glycan 
variation.............................................................................................................................84 
6.1 Introduction ..............................................................................................................85 
6.2 Computational Method ..............................................................................................89 
6.3 Results......................................................................................................................94 
6.4 Discussion .............................................................................................................. 106 
6.5 Conclusions ............................................................................................................ 108 
References.................................................................................................................... 109 











First, I would like to thank my supervisor Dr. Elisa Fadda for the immeasurable support you’ve given 
to me over the last few years through this PhD journey. I really appreciate the faith you had in me to 
succeed, even when I found some obstacles near impossible to overcome. I’ve truly enjoyed being your 
PhD student, and getting to know you as a person. 
I would also like to thank the other members of our research group, past and present. I would particularly 
like to thank Matthew and Carl, for indulging me in all the endless chatting, group Halloween costumes 
and tea breaks. It was great to be part of the team, and learn from each other. 
I would like to thank Maynooth University Graduate Studies office for their support of my research 
with the John Hume Scholarship, and the HEA and D/FHERIS for additional funding to finish my 
research.  
Many thanks to the members of staff from the Chemistry Department and the Hamilton Institute, who 
have helped me, gave me advice and had good discussions with me in the last four years. 
To all the postgrads of the Chemistry Department and Hamilton Institute, thanks for bringing fun and 
comradery to this experience. I’ll always remember the parties, board game nights, collective junk food 
binges, lunch time chats and general letting off of steam that made the harder parts of being a PhD 
student more bearable. 
I would like to thank my parents, Kevina and Tom, and my brother Eoin, for all the support they’ve 
provided for me. Thanks for standing by me through all my highs and lows, and for your unconditional 
love, I’m forever grateful. Thanks to all my friends who have rooted me on and kept me going and 
somewhat sane. Many thanks to Pauline for being a great listener and providing me with perspective. 
To Joe, thank you for not only putting up with the stress of your own PhD, but also putting up with the 
stress of me doing one concurrently. You’ve been the calm in the storm when I’ve needed it, a stalwart 
support, and a source of laughter and reason in equal measure. We’ve journeyed through this 3rd level 
experience together and I hope we can keep supporting each other and learning more (preferably in a 
less intense setting). 
Finally, I would like to thank Library Cat, for just being a cat. Maynooth University wouldn’t be the 








This thesis has not been submitted before, in whole or in part, to this or any other University for any 











ACE2  Angiotensin-Converting Enzyme 2 
ADCC  Antibody Dependant Cellular Cytotoxicity 
AMBER Assisted Model Building with Energy Refinement 
Asn  Asparagine 
CH Domain Chain (Heavy)  Domain 
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CoV  Coronavirus 
Cryo-EM Cryogenic Electron Microscopy 
DFT  Density Functional Theory 
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HPC  High Performance Computing 
ICHEC  Irish Centre for High End Computing 
IgG  Immunoglobulin G 
KDE  Kernel Density Estimation 
kJ/mol  kiloJoules per mole 
Lex  Lewis X 
sLex  Sialyl-Lewis X 
LeA  Lewis A 
sLeA  Sialyl-Lewis A 
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Man  Mannose 
MD  Molecular Dynamics 
MERS  Middle Eastern Respiratory Syndrome 
μs  microseconds 
MS  Mass Spectrometry 
NAMD  Nanoscale Molecular Dynamics 
NeuAc  N-Acetylneuraminic acid (also known as Sialic Acid) 
NMR  Nuclear Magnetic Resonance 
ns  nanoseconds 
NTD  N-Terminus Domain 
PCA  Principal Component Analysis 
PDB  Protein Data Bank 
PES  Potential Energy Surface 
ps  picosecond 
QM  Quantum Mechanics 
RBM  Receptor Binding Motif 
RBD  Receptor Binding Domain 
REMD  Replica Exchange Molecular Dynamics 
RESP  Restrained Electrostatic Potential   
RMSD  Root Mean Square Deviation 
SARS  Severe Acute Respiratory Syndrome 
Sia  Sialic Acid (see Neu5Ac) 
Ser  Serine 
Thr  Threonine 




Glycosylation is the most abundant and diverse post-translational modification of proteins, contributing 
to protein folding, trafficking, structural stability and dynamics, and function. Complex N-glycans are 
a class of glycans found in eukaryotes, sharing a common pentasaccharide core structure. The 
functionalization of the arms and the branching patterns are specific to different species, while the 
complexity of the cellular biosynthetic pathways contribute to the broad variety and to the heterogeneity 
of N-glycan sequences. By understanding at an atomistic level of detail the structural implications of 
glycan sequence, we can relate the glycan sequence to its function in a given glycoprotein environment.  
With this ultimate goal in mind I conducted, through conventional and enhanced molecular dynamics 
(MD) methods, a series of systematic studies of mammalian, plant and invertebrate glycosylation 
patterns, in order to characterize the intrinsic 3D architecture of different sets of commonly found and 
synthetic (non-natural) glycan structures. From these results, we were able to disentangle the 
complexity of N-glycans structure and dynamics through a new 3D representation, which describes N-
glycans not only in terms of the monosaccharides sequence, but that also includes anomeric 
configurations and linkage specificity. Within this framework, we defined N-glycans as structured by 
specific groups of monosaccharide units, named “glycoblocks”. This formulation incorporates 3D 
structural information and uniquely dictates the overall conformational landscape of any given N-
glycan.  
With this expanded viewpoint of sequence-to-structure dependencies in complex N-glycans, we applied 
this knowledge to glycoproteins, where variation of glycan composition affects its functional 
capabilities. In the two cases presented in this thesis, we determined how changes in the sequence of 
the N-glycans in the Fc region of IgG1 antibodies affect its effector function, and discovered for the 
first time a unique functional role of the glycan shield in the SARS-CoV-2 spike protein. In both cases, 
we observed that the conformational equilibria of complex N-glycans change to promote conformers 
that can accommodate interactions with the glycoprotein environment, but this adaption does not 
interfere with the intrinsic 3D glycan architecture, shifting a paradigm commonly assumed in structural 
biology, where the protein dictates the glycan conformation by actively morphing it.  
The work presented in this thesis shows an alternative atomistic perspective of N-glycans structure and 
dynamics, where glycans play a starring role rather than a cameo as a simple protein “decoration”, while 
the knowledge and insight gained could inform the ad-hoc design and modulation of sequence-to-
structure-to-function relationships of complex N-glycans, with applications in glycoengineering and 
therapeutic and diagnostic strategies.  
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Chapter 1: Introduction 
 
Complex carbohydrates, also known as glycans, are the most abundant biomolecules in nature, and 
highly diverse, given to the variety of possible sequences, branching patterns and 3D structures. This 
high degree of polymorphism allows glycans to facilitate and regulate a wide range of biological 
functions in the myriad of cellular pathways they are involved in. Monosaccharides are the basic units 
of a glycan structure. These are defined by the general formula, (CH2O)n and can be classified as 
polyhydroxyl aldehydes or ketones, see Figure 1.1. A monosaccharide’s configuration is defined by 
the orientation of the furthest carbon centre from the carbonyl C1, also known as the anomeric carbon, 
and is denoted as D- or L-, see Figure 1.1.  
 
Figure 1.1. D- and L- configurations of glucose in both, its acyclic form, shown as a Fischer projection above, and in its cyclic 
form, in the chair conformation, Image adapted from Bertozzi et al.1. 
In solution, monosaccharides are found in their more stable cyclic forms counting five or six membered 
rings, see Figure 1.1. The most stable ring conformation is known as “chair”, which can usually 
interconvert between two accessible forms, namely 4C1 to 
1C4, through a mechanism known as ring 
puckering. Puckering determines the change of the orientation of the hydroxy groups in the plane of the 
ring, i.e. from equatorial to axial, or vice versa. Cyclization produces an additional asymmetric 
stereocentre at the C1 anomeric carbon, which can be (α-) or (β-) with reference to the orientation of 
the hydroxyl group on the stereocentre that determines the sugar’s absolute configuration. More 
specifically, if in a Fisher projection the two hydroxy groups are on the same side, then the configuration 
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is (α-), if not it is (β-). Monosaccharides can differ based on the stereochemistry at any one of its chiral 
carbon atoms in the chain, with structures differing by one chiral centre referred to as epimers, or by 
the functionalization of one or more hydroxy groups2.  
Glycosidic bonds, which link monosaccharides together, are formed by a condensation reaction 
involving the hydroxy group at the C1 of one monosaccharide and any one of the hydroxy groups of 
another monosaccharide. Contrary to proteins or nucleic acids, where the combination of two amino 
acids or of two nucleotides has only two possible outcomes, taking into account the two anomeric 
configurations, the combination of two different hexoses, e.g. glucose and galactose, determines a 
theoretical 16 possible disaccharides. The progressive increase of the number of monosaccharides in a 
oligo- or polysaccharide, determines an combinatorial explosion of possible regio- and stereoisomers, 
to reach an enormous number of distinct glycans3. However, fortunately, glycan sequences are not found 
to be random in biological systems, suggesting that sequence and branching play a specific role in 
glycans’ functions in biology. This thesis summarizes my four year-long research effort in studying the 
molecular basis for sequence-to-structure-to-function relationships in complex carbohydrates, more 
specifically in N-glycans, by means of high-performance computing (HPC)-based molecular 
simulations.    
 
Figure 1.2. Three types of N-glycans, with the common core of Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1–4GlcNAcβ1 linked 
to Asn from the sequon NX(S/T). The three sub-categories are named based on the glycosylation sequence of their additional 
antennae. Adapted from Higel et al.4 
 
The types of glycosylation found in biological systems vastly differ between eukaryotes and bacteria 5, 
with eukaryotic glycans classified based on their core glycan sequence and on the amino acid in a 
glycoprotein that they are covalently linked to. In an N-glycan, the carbohydrate part (or glycone) is 
covalently linked through a glycosidic bond to the amide nitrogen of an Asn side chain (aglycone), 
typically within the sequon N-X-(S/T), where X is any amino acid but Pro. The “common core” 
sequence of an N-glycan consists of the pentasaccharide Manα1-3(Manα1-6)Manβ1-4GlcNAcβ1–
4GlcNAcβ1–Asn, shown in Figure 1.2. N-glycans can be further diversified in function of their 
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terminal, branching residues, and classified into three types, namely oligomannose (or high mannose), 
complex and hybrid, based on the residue types added to the core and to the “arms”, see Figure 1.2. 
Unlike proteins, glycans’ synthesis is not template driven but it depends on the nature, existence and 
expression levels of over 600 enzymes, between transferases and hydrolases, in mammalian cells6. This 
feature confers glycans the ability to retain a remarkable evolutionary plasticity, that allows them to 
modulate glycoproteins’ activity, reflecting the physiological state of the cell7. Glycosylation of proteins 
is a post-translational modification, involving sequential concerted steps, shown in Figure 1.3, in the 
endoplasmic reticulum (ER) and the Golgi apparatus of the cell, resulting in the glycosylation of over 





Figure 1.3. Biosynthetic pathways of N-glycans in the cell. Addition of glycan to the protein glycosylation site, and 
following processing and maturation as it is transported through the ER and Golgi apparatus. Adapted from Essentials of 
Glycobiology10. 
 
When a nascent protein is translocated into the ER, a 14 residues glycan (Glc3Man9GlcNAc2) assembled 
on the lipid carrier Dol-P (Dolichol phosphate) is transferred by the oligosaccharyltransferase (OST) to 
Asn residues that are part of N-X-S/T sequons11. The glycan is sequentially trimmed by ER α-
glucosidases and α-mannosidases, and specific features of the trimmed glycan are recognised by ER 
chaperones to regulate protein folding12. Further trimming is performed in the cis Golgi, see Figure 1.3, 
where high mannose glycans, namely Man9 to Man7 can be trimmed down to a Man5 (Man5GlcNAc2). 
Some oligomannose N-glycans avoid further modifications, while others undergo maturation in the 
medial and trans Golgi13. This step is initiated by the transfer of N-acetylglucosylamine (GlcNAc) to 
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both antennae by the GlcNAc-T1 enzyme, with consequent removal of terminal mannose residues from 
the Man5. Notably, hybrid-type N-glycans, see Figure 1.3,  are exposed to the activity of GlcNAc-T1, 
but only on one arm, so the other arm retains its mannose residues14. Levels of core-fucosylation, further 
branching, galactosylation and terminal sialylation are dependent on the activity of the relevant 
transferases, and it is also dependent by the physical accessibility of the N-glycosylation site15.The latter 
is uniquely determined by the surrounding protein’s landscape, which has reached folding maturation 
in the later Golgi16. Notably, the size of the glycoprotein and the location of N-glycan sites near β-turns 
is major factor in determining site-specific accessibility15. The products of this complex biosynthetic 
process is heterogeneous on a macro and micro scale, as glycosylation in the same site can vastly 
differ17,18. In order to understand the functional role of site-specific N-glycans in glycoproteins, one 
must first accurately identify the highest populated N-glycan sequences and the degree of heterogeneity 
at a given N-glycosylation site. 
Despite the great advances in experimental techniques to determine glycans’ sequences in biological 
systems19, there are still serious technological limitations hindering the rapid advancement of 
glycomics. The most commonly used technique for glycan characterisation is mass spectrometry (MS) 
with fluorescent labelling, usually preceded by separation chromatography20. Glycans must first be 
selectively cleaved from the protein surface with endoglycosidases21–23, producing intact N-glycans, 
which are further degraded by exoglycosidase digestion, taking advantage of enzymatic selectivity to 
identify specific anomericity, linkage type, and monosaccharide type in sequence24. It is important to 
note that enzymatic digestion is susceptible to changes in the 3D structure of the glycans, which can 
arise from modification of the structure upon addition of synthetic labels necessary for analysis25. 
Additionally, these methods are can indicate the type of N-glycan, but are unable to provide any 
information on its 3D structure and cannot distinguish between positional isomers. 
Similarly, because of their high flexibility and dynamic nature, the structural characterization of glycans 
is rarely straightforward if at all possible. Indeed, the rotation about the glycosidic torsion angle, namely 
phi (φ), psi (ψ), and in 1-6 linkages, omega (ω), can generate a large set of distinct 3D conformations 
that are relatively free to interconvert at room temperature, giving rise to complex conformational 
ensembles. Thus, from a structural biology point of view, glycans appear to be “unstructured” or 
“intrinsically disordered”. Because of all these difficulties inherent with glycoanalytics and with 
glycans’ structure characterization, the field of glycomics has and is lagging considerably behind the 
fields of proteomics and genomics26.The two major tools for structural characterization of complex 
carbohydrates at the atomistic level of detail are NMR spectroscopy27,28 and X-ray crystallography29.  
NMR takes advantage of naturally abundant isotopes (1H and 13C), and signals are usually enhanced by 
isotopic enrichment30. However, this enrichment technique is laborious and not atom-specific, making 
it difficult to identify local structural features of the populated conformers26. Crystallographic studies 
can provide a great deal of structural information on glycans, such as bond lengths, bond angles and the 
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3D occupancy of the glycan in space. Yet only small and relatively rigid carbohydrate species can be 
crystallized with ions in solution31. For the systems we are interested in, namely highly glycosylated 
glycoproteins, crystallization is often not feasible as larger glycans retain a high degree of flexibility 
even in cryogenic environments relative to the folded protein they are linked to. If any electron density 
corresponding to the glycan is obtained, and the glycan sequence at that site is known, a glycan structure 
can be reconstructed by fitting to the electron density map.  Yet, because of the broad features of these 
maps and the number of accessible degrees of freedom, it is a common occurrence to find in the PDB 
incorrect glycan structures due to overfitting of interpretive errors32.  
Thanks to the rapid development of high performance computing (HPC) in the last two decades, large 
scale computational studies of biomolecular systems have become more feasible and accessible to a 
wider cohort of researchers33,34, supporting experimental analysis and as an independent method of 
investigation in its own right. Molecular simulations allow us to observe the dynamics and interactions 
of a system at the appropriate timescales and at an atomistic level of detail. Furthermore, in a virtual 
setting, we can overcome some of the limitations of experimental synthesis or design system 
modifications experimentally difficult to achieve, with little difference in computational cost.  In the 
context of glycoscience, molecular simulations allow us to study the conformational propensity of 
specific glycan sequences and understand the intrinsic dynamics and architecture that dictates their 
overall structure and subsequent function when applied to larger biomolecules. However, much like the 
wider field of glycomics, progress in computational glycoscience has been slow to develop, with the 
majority of glycan-specific force fields created after 1990, and have been improved upon in the last 
twenty years35. The development of force fields to represent glycan dynamics has the added difficulty 
of capturing the flexibility of these biomolecules, and the branched nature of the carbohydrate 
structures, relative to proteins and other biomolecules. In the beginning, computational studies were 
limited to monosaccharide and disaccharide simulations at very low timescales36,37, but this has 
expanded with the advancement and widened accessibility to HPC, allowing for microseconds of large 
glycoprotein simulation. An in-depth discussion of the theory and details on the set-up of molecular 
simulation by molecular dynamics is presented in Chapter 2. 
Previous computational research into isolated glycan dynamics and conformational analysis has been 
conducted on a wide range of small disaccharides and trisaccharides38–44, and some select N-glycan 
sequences45–48. While these studies have investigated the conformational propensity of the simulated 
glycans, none have systematically broken down how the presence of each monosaccharide in the 
sequence affects the overall conformational propensity, with Nishima et al46 to be the only other group 
commenting on the change in populated conformers with monosaccharide alteration, using MD 
simulation. My work has further explored this concept, with exhaustive sampling of isolated N-glycans 
with a systematic approach of adding onto the glycan sequence, in order to ascertain the definitive effect 
of each alteration in monosaccharide addition and branching. Throughout my PhD I have studied the 
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sequence-to-structure relationships in complex N-glycans, an indissoluble connection widely accepted 
for proteins, but not for other biomolecules and in particular not for carbohydrates.  Starting with 
isolated N-glycans in solution, we were able to identify the intrinsic interactions between 
monosaccharide residues, as well as the significant conformational changes dependent on specific 
monosaccharide additions, detailed in Chapter 3 for mammalian N-glycans and Chapter 4 for plant 
and for (some) invertebrates N-glycans. By expanding the concept of “sequence” from single 
monosaccharides to specific groups of monosaccharides, we are able to describe the 3D structural 
ensemble and preferred conformations of distinct motifs. This alternative description of glycans’ 
architecture with grouped glycan residues, or “glycoblocks”, can explain more clearly the glycotopes’ 
exposure and/or presentation, their activity within a complex glycoprotein and their recognition. This 
concept highlights the influence that the local spatial environment has on the conformational propensity 
of these highly flexible biomolecules.  
The new perspective gained from our investigation into isolated N-glycan dynamics and its sequence-
to-structure relationship was applied to glycoproteins of interest. The functional role of N-glycans 
within a glycoprotein environment has been studied more widely with simulation49–54, as the presence 
of N-glycans and their effect on protein interaction and structure is undeniable. My interests into 
glycoprotein simulation centred on how the glycan structures adapt and functionally complement 
glycoproteins environments, which I explored in Chapters 5 and 6. More specifically, we explored 
how the glycans in glycoproteins are fundamental, from the initial glycosylation in the ER that guides 
protein folding12,16, to their active roles in recognition and in the mediation of intrinsic and extrinsic 
biomolecular interactions55, and even to camouflage viral epitopes from the host’s immune system56,57. 
We also found evidence that the interaction with the protein and binding events can shift the glycans’ 
intrinsic conformational equilibria observed in isolated/unlinked glycans, yet not actively shape glycans 
into unobserved conformations. More specifically, in our studies the proteins are never found to alter 
the inherent conformation of the linked or bound glycans, which depends exclusively on their sequence 
and branching, but only shift their inherent conformational equilibrium58.  
In Chapter 5, we examined the role that different glycan sequences and structures play in the dynamics 
of the Fc region of IgG1 antibodies. Our results provided a greater perspective of the role that core-
fucosylation and sialylation (in the context of core-fucosylaytion) play in reducing antibody-dependent 
cell cytotoxicity (ADCC), by affecting Fc dynamics and carbohydrate interactions within the Fc region, 
as well as impeding access of the Fc γ receptors, potentially affecting the binding free energy between 
the receptors and the antibodies. Our understanding of the role of glycans in glycoproteins was further 
expanded when our group participated in the global effort to discover the mechanical function(s) of the 
SARS-CoV-2 spike protein, a large (180 kDa) type I fusion glycoprotein. As we discuss in detail in 
Chapter 6, through multi-microsecond molecular dynamics simulations, we were able to identify key 
glycosylation sites that play a functional role in the infection mechanism, unique to SARS-CoV, 
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mediating and supporting the opening mechanism of the spike’s receptor-binding domain (RBD). By 
variation of the type of glycosylation and the extent of processing at these specific sites, we see a 
modulation of the structural support that the different glycoforms can provide, potentially weakening 
or strengthening the binding affinity of the spike’s RBD to the ACE2 primary host cell receptor.  
Based on the results and discussion presented from Chapters 3 to 6, I will conclude with some 
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Chapter 2: Computational Method 
 
This chapter details the different molecular simulation techniques I used in my work, starting 
by the description of the fundamental concepts and principles underlying classical mechanics-
based models and molecular dynamic (MD) simulations. Following from this, I will present 
the set-up of an MD simulation and explain some of the factors that can affect it and the 
parameters involved. I will also discuss the cases in which enhanced sampling methods within 
a MD framework are useful, focusing on replica exchange molecular dynamics (REMD), an 
approach I used to study the structure and dynamics of glycosylated IgG1s, see Chapter 5. 
 
Molecular Mechanics and Empirical Force Fields 
According to the fundamental principles of quantum mechanics (QM), all molecular properties 
of a system can be uniquely defined by the electronic wave function of the system, or by its 
electron density in density functional theory (DFT)1,2. The exact information needed from these 
calculations cannot be obtained exactly because of the mathematical formulation of these 
theories, whereby approximations are needed to find solutions. Different levels of theory can 
be applied to the molecular system in order to increase the accuracy. However, this comes at 
the cost of computational time and resources, as most of the ab-initio QM or DFT-based 
approaches do not scale linearly with the number of atoms (N) in the system. The most efficient 
scaling achieved with DFT schemes is N3, which allow us to handle routinely systems up to a 
few hundred atoms2. Nevertheless, when working with biomolecular systems, such as 
glycoproteins, this approach becomes unfeasible. Additionally, most QM and DFT calculat ions 
are run in the gas phase (in vacuo) or with implicit solvent, which does not accurately represent 
the properties of molecules at physiological temperatures or in the presence of heterogeneous 
solvents. By implementing the Born-Oppenheimer (BO) approximation, we can consider the 
nuclear motions of a molecular system separately from the electronic motions, due to the 
difference in mass between these subatomic particles. With this approximation, we can use 
molecular mechanics to represent our system with Newtonian laws of motion, which scale 
linearly with the number of atoms, thus modelling the properties of the full system in a 
reasonable amount of time.  
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Within a classical molecular mechanics framework, atoms are assumed to be a hard, 
impenetrable spheres, with the bonds between atoms represented as springs. This allows the 
model to incorporate both the stability of a chemical structure, while allowing for flexibility of 
the covalent bonds in their vibrational degrees of freedom. In order for these molecular models 
to be realistic, their structural and interaction properties are represented by parameters fitted to 
experimental data and QM data as part of what we call an empirical forcefield. Empirical force 
fields define molecular systems by internal and external potential energy (PE) terms that are 
used to calculate the specific potential energy of the system and the atomic motions, in function 
of the position of its atoms. The internal (bonding/covalent) PE terms represent the bond length 
and angles that are approximated by Hooke’s Law, while torsions that are treated as a sinusoida l 
function. External (non-bonding/non-covalent) terms are applied to atoms in a molecule more 
than four atoms apart, and include the Van der Waals attraction and repulsion interact ions 
between atoms, usually modelled with a Lennard-Jones potential, and the electrostatic 
interactions represented by a Coulomb potential, see Equation 2.1.   
 
 𝑉(𝑟


















[1 + cos(𝑛𝜔 − 𝛾)] 
 





















Force fields can be separated into additive and polarizable force fields, where the partial 
charges (q) of an atom is either centred on the representative atom, or the partial charge is 
variable in order to account for the 3D occupancy of the electron density surrounding an atom, 
respectively.  
Parameter sets are used in empirical force fields to minimise the number of unique parameters, 
making the calculation of these PE terms more efficient and manageable. This is achieved by 
assigning an “atom type” to atoms in similar chemical environments, which have a set of 
bonded and non-bonded parameters associated to them. This approach affects accuracy and 
determines the specificity of the force field to different biomolecules, i.e. carbohydrates, 
proteins, nucleic acids.  
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For proteins, there are many commonly used force fields developed within ‘families’, such as 
AMBER and CHARMM. Specific carbohydrate force fields have been developed so they can 
be used in conjunction with protein force fields in simulations, in order to give an accurate 
representation of the behaviour of glycoproteins. The most commonly used carbohydrate force 
fields are GLYCAM063 and CHARMM364. GLYCAM06 is the first complete and stand-alone 
all-atom force field for carbohydrates and glycoproteins5. The GLYCAM06 parameter set was 
independently developed but in a way that was consistent with AMBER parameters, allowing 
it to be used in combination with other protein force fields. AMBER does however include 
specialised atom types for the Asn and Thr/Ser residues linked to glycans in glycoprote in 
structures, thus making GLYCAM06 and AMBER protein force fields suitable to be paired for 
the simulation of glycoproteins. Another feature of GLYCAM06 is the absence of different 
atom types for α and β anomers, allowing the ring to “pucker”, i.e. to move through the different 
ring conformations accessible to different monosaccharides6. Note, puckering is an important 
feature to retain correctly as it is implicated in many oligosaccharide conformational changes7 –
10 and in enzymatic reactions11. The covalent PE terms for GLYCAM06 were derived from 
gas-phase QM calculations on appropriate molecular fragments, with torsional energy barriers 
fitted to minimize the error throughout the rotational PE curve, ensuring the force field could 
reproduce the flexibility of oligo- and polysaccharides3. Electrostatic point charges were 
obtained from QM restrained electrostatic potential (RESP) calculations 5. While 1-4 
electrostatic interactions are scaled in the AMBER family of protein force fields, in 
GLYCAM06 they are not, due to the unique structural flexibility of the 1-6 linkage. Lennard-
Jones potentials from the AMBER PARM94 were directly transferred to GLYCAM06 without 
modification. 
The CHARMM36 additive parameter set for carbohydrates and glycoconjugates4,12–14 was 
developed to be compatible with the CHARMM all-atom biomolecular force fields. Similar to 
GLYCAM06, parameters were derived for carbohydrate fragments and then applied to 
monosaccharides, with missing parameters developed and set adjusted to gas phase QM and 
condensed phase experimental data. These parameters were further refined with comparison to 
MD simulation of infinite crystals and of differently diluted solutions, aimed at reproducing 
crystal geometries of monosaccharides12,13 and disaccharides4. Notably, CHARMM has the 
first polarizable carbohydrate force field based on the Drude oscillator model15, which adds a 




In addition to parameter sets that describe protein and carbohydrate atoms, the quality of a 
simulated system greatly depends on the choice of water force field, if the system is solvated. 
Ideally, the chosen water model should match the water model used in the parameteriza t ion 
and validation of the protein force field itself. TIP3P16, the three-point water model, was used 
in development of AMBER and GLYCAM, making it a clear candidate for simulation with 
AMBER and GLYCAM force fields. 
 
Molecular Dynamics 
Molecular Dynamics (MD) is based on a classical mechanics approach to describe the 
distribution of atoms in space and how their position, through Newtonian motion, evolves over 
time.  The work presented in this thesis was completed by using both conventional MD and an 
enhanced sampling technique, namely temperature replica exchange molecular dynamics 
(REMD)17. 
Before starting a simulation, an initial starting conformation has to be selected, ideally from 
experimental sources, such as NMR, x-ray crystallography or cryogenic electron microscopy 
(cryo-EM). In terms of glycans, this can be an issue, as experimental techniques do not always 
resolve atoms of high flexibility and dynamics, or as in x-ray crystallography the atoms 
coordinates are obtained through fitting to an electron density map, sometimes without a proper 
consideration of the correct glycan structure. To supply for the absence of glycan structural 
information there are glycan building tools available, developed by GLYCAM and CHARMM 
teams, such as glycam-web (https://dev.glycam.org/) and CHARMM-GUI18  
(http://www.charmm-gui.org/). For the simulations of biomolecules, the biomolecular system 
needs to be solvated by water molecules, filling a simulation box within which counterions can 
be added to the desired concentration. Following this, energy minimisation and equilibra t ion 
steps need to be run to bring the system to a thermodynamic equilibrated state where 
thermodynamics and structural properties can be sampled through the integration of the 
equation of motion as described below.   
Empirical force fields provide the PE terms of the system as a function of the position of all its 
atoms, denoted by V(r). The forces acting on the atoms are produced as described by  Equation 
2.2, which gives the gradient of the PES.  
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Accelerations are calculated using Newton’s second law of motion, shown in Equation 2.3, 
 𝐹 = 𝑚𝑎 
2.3 
where m is the atom mass. Newton’s equation of motion are integrated numerically in order to 
determine the time-evolution (or trajectory) of positions and velocities of the atoms. A classic 
integrator, like the Verlet algorithm shown in Equations 2.4 to 2.6, takes the positions and 
accelerations at time t, with the previous positions (at time t - t) and calculates the new 
positions at time t + t.  











 ∴ 𝑟(𝑡 +  𝛿𝑡) = 2𝑟(𝑡) − 𝑟(𝑡 − 𝛿𝑡) + 𝑎(𝑡)𝛿𝑡2 
2.6 
Another option is the leap frog integrator, that uses velocities calculated at t + 1/2t to then 
calculate the accelerations at time t, while the positions are calculated at r(t + t) using r(t) and 
v(t + 1/2t)  shown in Equations 2.7 to 2.8. 









𝛿𝑡) = 𝑣 (𝑡 −
1
2
𝛿𝑡) + 𝑎(𝑡)𝛿𝑡 
2.8 
This overlapping “leap frog” generation of velocities and positions gives this integrator method 
an advantage over the Verlet integrator, as the velocities are explicitly calculated.  Other 
integrators are available like the velocity Verlet method19 or the Runge-Kutta method20. In my 
work I used a stochastic leap frog integrator when working with AMBER (Chapters 3, 4 and 
6), and a sympletic Verlet integrator with NAMD (Chapter 5). Temperature and pressure are 
regulated with a thermostat and a barostat, respectively. Langevin dynamics with a collis ion 
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frequency of 2.0 ps-1 was used in all of my simulations for temperature control. Pressure was 
regulated with the Berendsen barostat21 in AMBER, and with a modified Nosé-Hoover 
method22,23 selected in NAMD. 
A very important aspect of the set-up of MD simulations is the time-step, t, as it determines 
how long the simulation will take to run depending on the computational resources availab le. 
The size of the time-step is defined by an order of magnitude shorter than the shortest vibration 
of the system; in most systems, this is usually the vibration of covalent hydrogen-carbon bonds, 
approximating to 10 fs, leading to a time step of 1 fs. However, most simulation software, there 
is an option to constrain the vibration of covalent hydrogen bonds allowing for a longer time 
step of 2 fs. Both NAMD and AMBER software packages implement the SHAKE algorithm2 4  
to constrain these bonds.  
 
Conformational sampling 
Once the molecular simulation is set-up to run, the commonly asked question (or one that we 
should ask) is “how long of a trajectory is long enough?”. Indeed, the simulation length 
determines the reproducibility, thus the validity of the simulations results. Although the latter 
hinges on the choice of force field and methodology implemented, exhaustive (or sufficient) 
conformational sampling is key, though knowing when convergence will be reached is not 
intuitive, and can be unique for each chosen starting structure. In the case of complex 
carbohydrates, due to their high degree of flexibility, especially when unbound and isolated, 
complete sampling requires considerable computational resources for relatively small systems. 
Indeed, looking at the free energy associated to different conformations of two common 





Figure 1.1. Conformational heat maps corresponding to a) α(1-4) linkage and b) α1-6) linkage obtained for a N-glycan through 
complete conformational mapping performed with a series of conventional MD simulations run in parallel. The red dots and 
black dashed lines represent a hypothetical walk in time space obtained by MD simulation. The numbers correspond to the 
minima identified during complete sampling8, with the darkest shade of blue corresponding to the most stable structure. Maps 
rendered with RStudio (https://rstudio.com/index2/).   
 
MD simulations with a conventional implementation explore the force-field defined PES 
through a continuous walk in time. For the β(1-4) linkage, simulation from one starting 
structure is adequate in estimating the flexibility and stability of the structure (from population 
frequency and standard deviation measurements). However, the α-(1-6) linkage has an extra 
torsion angle, providing the linkage with extra flexibility and therefore a vaster and more 
complicated conformational landscape. Starting from one structure (red point), the MD 
trajectory may identify some minima of the PES, but not all, with the inability to cross high 
energy barriers at 300 K and thus a longer simulation is needed for greater exploration. An 
alternative approach is to set up a sufficient number of uncorrelated MD runs from different 
starting structures, with shorter MD sampling time for each structure, but an estimation of 
convergence based on structural interconversion between separate trajectories. We 
implemented this approach in the work discussed in Chapters 3 and 4, successfully 
characterizing the conformational propensity and dynamics of free carbohydrates in solvated 
systems.  
As an alternative that does not always require a previous knowledge of the conformationa l 
space, there are conformational sampling techniques available, referred to as “enhanced 
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sampling” approaches, that overcome the shortcomings of conventional determinist ic 
sampling. Enhanced sampling schemes are especially useful in cases where conformationa l 
degrees of freedom are restrained and PES barriers may be too high to cross at room 
temperature. Indeed, in complex systems, such as glycosylated biomolecules, glycans can be 
restricted by interactions with residues on the protein’s surface and/or can be part of complex 
networks of carbohydrate-carbohydrate interactions that also confine their dynamics to a 
smaller subset of possible conformational occupancies25. The scenario is made even more 
complex when starting structures from experimental sources have glycans in low populated, 
unnaturally distorted or even in incorrect conformations26. Enhanced sampling methods in this 
case may provide a strategy to resolve these issues by providing the particular system with 
enough energy to escape particularly tricky energy wells and/or barriers. Stochastic methods 
such as metadynamics27 (MTD) and umbrella sampling28 apply biases to the PES, to lower the 
energy barriers, and thus allowing the system to traverse the PES more freely. Determinist ic 
methods like temperature REMD29 perform the simulation partially at higher temperatures 
within a defined temperature range, allowing easier traversal of the PES.  Our specific 
implementation of temperature REMD is outlined in Chapter 4 and the basic principles of the 
method are discussed below. 
The REMD algorithm developed by Sugita and Okamoto17 combines the parallel tempering 
method used in Monte Carlo simulations with an MD approach, and is widely used as an 






Figure 2.2. Overview of temperature REMD, showing exchanges being attempted after every m simulation steps.  Exchanges  
can only happen between adjacent temperatures30. 
 
Using temperature as an exchange variable, multiple isothermal (conventional) MD 
simulations run in parallel, with a set number of replicas (n) generated in given temperature 
range, and each assigned a simulation temperature in ascending order (T0, T1,…. Tn-1). After m 
number of steps, the system will try to swap adjacent replicas i and j, with an acceptance ratio 








𝑘 𝑇𝑗 } 
 2.9 
If the distribution of the differential temperatures is set, in the selected temperature range, this 
ensures a better exchange probability, as the acceptance ratio is the same between all pairs of 
replicas31,32. This can be achieved easily with tools developed for temperature REMD33, which 
gives a good indication of the viability of a simulation for temperature REMD based on the 
predicted exchange ratio. Hamiltonian REMD34 can also be performed, where arbitrary 
perturbations to the Hamiltonian of the system is used rather than temperature as an exchange 
variable, and allows for smaller number of replicas with larger differences between individua l 
replica Hamiltonians. The easy set up and implementation of REMD comparative to other 
enhanced sampling techniques is an advantage, but REMD is computationally very costly, 
given the large number of replicas needed, which is dependent on the size of the system, 
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N-glycosylation of the immunoglobulin G (IgG) fragment crystallizable (Fc) region is essential for its 
structural stability and function1-4. The sequence and branching of the Fc N-glycoforms, bound at the 
highly conserved Asn 297 in both CH2 domains of the Fc region, strongly affect the antibody-mediated 
effector function5-7 by modulating the binding to the immune cells’ Fc receptors, thus the antibody-
mediated immune response8, 9. In this context the effects of core-fucosylation, sialylation and of 
galactosylation are particularly interesting. Between 81% and 98.7% of the Fc N-glycans in human 
IgGs are core-fucosylated10. Even though it may appear like a very subtle change to the glycan sequence, 
especially relative to the size of the whole IgG, core fucosylation, where fucose is (1-6) linked to the 
chitobiose core of the complex N-glycan, greatly affects the IgGs antibody-dependent cell-mediated 
cytotoxicity (ADCC) function. More specifically, a strongly enhanced ADCC corresponds to non-
fucolylated Fc N-glycan species6, 11-17. This information has found wide interest and applications in 
cancer immunotherapy, especially in regards to engineering non-fucosylated antibodies with higher 
efficacy 7, 13, 17-20. The molecular basis for this phenotype is not entirely clear. It has been linked to the 
stronger binding between IgG and the Fc  receptor IIIa (FcRIIIa)7, 21, 22, determined by a more effective 
contact between the IgG and FcRIIIa glycans in the absence of core fucose21. No significant structural 
changes in the IgG structure have been detected in function of the presence or absence of fucose11. 
Sialylation of the Fc glycans is known to reverse the antibody inflammatory effect from pro to anti23. 
Only about 20% of core-fucosylated biantennary Fc N-glycans are sialylated10, meanwhile the majority 
of Fc N-glycans in human IgGs are galactosylated, with neutral glycans without galactose slightly 
below 40%, neutral glycans with one terminal galactose slightly above 40%, and neutral glycans with 
two terminal galactoses contributing to 20% of the neutral IgG glycome10. The abundance of 
galactosylated glycoforms has been directly linked to aging, with decreasing levels correlated with 
aging, and to immune activation10, 24-26. Notably, the risk of developing rheumatoid arthritis is correlated 




The phenotypes linked to different Fc N-glycan sequences are likely to be determined by the modulation 
of the interaction of the IgG with cell surface receptors, which is a difficult topic to address as a whole 
due to the complexity of the systems involved. NMR spin relaxation data provide evidence that despite 
the close contact with the protein, both arms of the N-glycans at the IgG Fc remain flexible and 
accessible30, suggesting that the intrinsic conformational propensity of the Fc N-glycan in function of 
its sequence may play a role in regulating the molecular interaction with the cell surface receptors. 
Therefore, to understand the implications on the N-glycans structural and dynamics of their size and 
sequence, we conducted a complete conformational study by extensive molecular dynamics (MD) 
simulations of progressively long complex biantennary Fc N-glycans most commonly expressed in 
human IgGs10, 31. All the glycoforms we have analysed in this work are shown in Figure 3.1.  
 
Figure 3.1. Schematic representations of all N-glycans, fucosylated and non-fucosylated in pairs, analysed in this study. Letters 
are used as shorthand notation for the identification of each sugar. Numbers are used to identify residues. The graphical 
representation follows the guidelines indicated in (Varki, A., Cummings, R.D., et al. 2015). 
 
Because of the complexity of the N-glycans dynamics and the high flexibility of (1/2-6) linkages, we 
chose a sampling method based on single (conventional) MD trajectories, ran in parallel, all started 
from different combinations of (1/2-6) conformers, namely 3 trajectories for one (1-6) linkage, 9 for 
two (1-6) linkages, 12 for one (1-6) and one (2-6) linkages, 24 for two (1-6) and one (2-6) 
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linkages, and finally 72 for two (1-6) and two (2-6) linkages, for a total cumulative sampling time 
in excess of 62 s. This approach allowed us to systematically and directly sample by construction 
regions of the potential energy surface corresponding to rare conformations of the different (1/2-6) 
linkages and to assess their relative stability. Our results show that a) the highest conformational 
flexibility concerns primarily the (1-6) arm, while the (1-3) arm remains mostly extended, b) core 
fucosylation and sialylation do not affect the conformational equilibrium of the (1-6) arm in the 
isolated glycan in solution, meanwhile c) galactosylation of the (1-6) arm alone greatly shifts the 
conformational propensity of the arm from outstretched, to folded over the chitobiose core. These 
findings provide important insight into the differences in the molecular recognition of biantennary 
complex N-glycans by enzymes and lectins in function of their sequence. Implications in the molecular 
recognition of the different glycoforms studied here when isolated (unbound), Fc-linked, or on glycan 
arrays are discussed in the sections below. 
 
3.2 Computational Methods 
 
All glycans were built with the carbohydrate builder tool on GLYCAM-WEB (http://www.glycam.org). 
All combinations of rotamers for the (1/2-6) linkages have been considered as starting structures for 
the MD simulations, namely 3 trajectories for one (1-6) linkage, 9 for two (1-6) linkages, 12 for one 
(1-6) and one (2-6) linkages, 24 for two (1-6) and one (2-6) linkages, and finally 72 for two (1-
6) and two (2-6) linkages. The GLYCAM-06h-12SB version of the GLYCAM06 force field32 was 
used to represent the carbohydrate atoms, TIP3P parameters33 were used to represent water, while 
amber99SB parameters34 were used for the counterions, added in a number sufficient to neutralize the 
charge in the case of sialylated species. All simulations were run with versions 12 and 16 of the AMBER 
molecular simulation package35. Dispersion interactions were cutoff at a distance of 13 Å. Electrostatics 
interactions were treated with Particle Mesh Ewald (PME). A constant pressure of 1 atm was maintained 
by isotropic position scaling with a relaxation time of 2 ps, while a constant temperature of 300 K was 
regulated by Langevin dynamics using a collision frequency of 1.0 ps-1. The SHAKE algorithm was 
used to restrain bonds with hydrogen atoms and an integration time step of 2 fs was used throughout. 
For each sugar, each starting structure was analysed for at least 250 ns, with exceptions of sugar D, 
which was analysed for 3 s, because of the complexity of its dynamics, which will be discussed in the 
sections below, and sugar E for 500 ns on single trajectories. Further details on the minimizat ion, 
equilibration and production phases are included in Appendix I. High performance computing (HPC) 




As an interesting note, because of the better scaling on our machines of v. 4.6.3 and 5.0.x of GROMACS 
(GMX) for the calculations on these relatively small systems, we ran some tests on the medium-sized 
sugar H, see Figure 3.1, and compared the results with the GLYCAM/AMBER set-up. The starting 
structure and parameter files obtained from the carbohydrate builder on GLYCAM-WEB were 
converted to GMX format with the AnteChamber PYthon Parser interfacE (acpype.py) tool36. It is 
important to note that in all GMX simulations the 1-4 scaling was re-set to “1” as required by the 
GLYCAM force field32, 37. Equal amount of sampling was done with both GMX and AMBER, preceded 
by a very similar set-up and equilibration protocols. Details of the GMX protocol are provided in 
Appendix I. The results indicate large differences in (1-6) torsions populations between GMX and 
GLYCAM/AMBER, shown in Tables S.1 and S.2 in Appendix I. The reason for this may be problems 
in the transfer of torsional parameters from a GLYCAM/AMBER format to the GMX format. More 
specifically we found that simulations of sugar H with GMX do not reproduce the correct conformer 
populations, or give energetically disfavoured conformers, such as the tg in the core fucose (1-6) 




The results below are presented function of the different N-glycan linkages for clarity. Notable effects 
on the conformational propensity of different linkages determined by the N-glycan size and sequence 
are indicated within. All torsion angles discussed throughout correspond to the following nomenclature, 
  (O5C1OxCx),  (C1OxCxCx+1), and  (O6C6C5C4)
38. The method we have chosen to number the 
monosaccharides and to name the different N-glycans is indicated in Figure 3.1. A summary of the 
results obtained as averages over all the simulations for all fucosylated and non-fucosylated species is 
shown in as 3.1 and 3.2, respectively. Results obtained for each system studied are shown in Tables 




Table 3.1 Conformational propensities of different linkages calculated for all core-fucosylated species shown in Figure 3.1. 
The torsion angle values are shown in degrees and calculated as averages over all N-glycans. Data were collected and analysed 
at 100 ps intervals. Errors are shown in parenthesis and are averages of standard deviations calculated for each N-glycan. 
Relative populations (%) are indicated in red. All torsion angles discussed throughout correspond to the following 
nomenclature,  (O5-C1-Ox-Cx),  (C1-Ox-Cx-Cx+1), and  (O6-C6-C5-C4). 
Linkage     
GlcNAc(2)-(1-4)-GlcNAc(1) -77.9 (11.3) 100 -127.5 (15.1) 100 - 
Fuc(12)-(1-6)-GlcNAc(1) -77.3 (15.9) 100 
-185.2 (19.5) 78/ 94.5 (19.4) 
19/ -97.3 (16.5) 2 
47.1 (12.3) 92/ -168.5 (16.5) 
7/ -54.8 (30.5) 1 
Man(3)-(1-4)-GlcNAc(2) 
-78.1 (18.2) 97/ -
159.3 (18.5) 3  
-125.5 (15.3) 96/ 72.1 (12.9) 4 - 
(1-3) branch: Man(4)-(1-3)-
Man(3) 
72.9 (12.2) 99/ 
123.7 (22.0) 1 





-80.9 (16.5) 100 





-75.1 (15.9) 100  





65.1 (11.0) 90/ -50.4 
(15.2) 10 
-182.6 (24.5) 85/ -99.3 (16.7) 
11/ 104.7 (17.9) 3 
-63.7 (15.6) 64/ -165.5 (15.0) 
31/ 58.2 (14.3) 5 
(1-6) branch: Man(5)-(1-6)-
Man(3) (F,H,J,R) 
73.7 (15.8) 100 
85.3 (17.2) 49/ -178.5 (18.7) 
50/ -93.0 (17.4) 2 
51.9 (10.7) 81/ -173.6 (16.5) 
15/ -77.5 (19.6) 4 
(1-6) branch: Man(5)-(1-6)-
Man(3) (L,N,P,T) 
76.3 (15.0) 100 
85.3 (15.8) 76/ -185.1 (22.1) 
23/ -99.3 (13.6) 0 
50.5 (9.8) 88/ -172.8 (14.9) 
11/ -80.2 (18.1) 2 
(1-6) branch: GlcNAc(7)-(1-
2)-Man(5) 
-81.4 (14.9) 100 





-74.8 (13.7) 100 -122.6 (15.7) 99/ 153.3 (9.1) 1 - 
(1-6) branch: Sia(11)-(2-6)-
Gal(9) 
64.9 (11.8) 88/ -52.3 
(19.1) 13 
-182.0 (25.2) 88/ -101.3 
(16.6) 9/ 90.3 (16.3) 4 
-64.9 (16.2) 56/ -163.5 (15.2) 





Table 3.2 Conformational propensities of different linkages calculated for all non-fucosylated species shown in Figure 3.1. 
The torsion angle values are shown in degrees and calculated as averages over all N-glycans. Data were collected and analysed 
at 100 ps intervals. Errors are shown in parenthesis and are averages of standard deviations calculated for each N-glycan. 
Relative populations (%) are indicated in red. All torsion angles discussed throughout correspond to the following 
nomenclature,  (O5-C1-Ox-Cx),  (C1-Ox-Cx-Cx+1), and  (O6-C6-C5-C4). 
Linkage     
GlcNAc(2)-(1-4)-
GlcNAc(1) 
-78.7 (11.1) 100 




-79.6 (20.6) 97/ -157.9 
(18.2) 1/ 56.7 (9.1) 1 





72.8 (12.1) 100 





-81.0 (16.3) 100 





-75.7 (17.3) 100  





65.1 (11.2) 89/ -50.0 
(14.7) 11 
-177.2 (22.9) 80/ -100.3 
(15.9) 18/ 105.9 (15.8) 3 
-63.2 (15.5) 66/ -164.3 
(14.8) 31/ 60.3 (13.1) 4 
(1-6) branch: Man(5)-(1-6)-
Man(3) (E,G,I,Q) 
73.2 (16.5) 100 
82.1 (18.4) 45/ -177.7 (18.6) 
54/ -95.6 (17.7) 2 
51.8 (11.0) 80/ -172.3 
(17.0) 15/ -75.7 (17.9) 5 
(1-6) branch: Man(5)-(1-6)-
Man(3) (K,M,O,S) 
75.1 (14.9) 100 
82.9 (17.3) 74/ -182.2 (21.9) 
26/ -101.8 (13.4) 1 




-79.8 (19.6) 100 





-76.2 (15.1) 100 





64.5 (11.2) 90/ -50.7 
(13.7) 10 
-181.0 (25.2) 88/ -98.6 
(17.9) 9/ 106.5 (16.0) 3 
-62.6 (15.6) 60/ -166.6 




GlcNAc(2)-(1-4)-GlcNAc(1) linkage  
As shown in see Tables 3.1 and 3.2, this linkage is conformationally rigid with only one rotamer 
populated in all the N-glycans analysed. The average   angle values are -78.7° and -77.9°, while the  
angle values are -130.8° and -127.5° for non-fucosylated and for fucosylated species, respectively. In 
the core-fucosylated species this conformation of the chitobiose favours the formation of a hydrogen 
bond between the O2 of the fucose and the NH of GlcNAc(2). No significant deviations from these 
torsion angle values have been observed, except in the case of the core-fucosylated tetrasaccharide sugar 
D, shown in Figure 3.1, where the GlcNAc(1) ring pucker has been observed to transition from the 
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more stable 4C1 to a 
1C4 chair, causing a change to a  angle value of -74.0° for 13% of the time over a 
3 s trajectory. Because this transition has been seen exclusively for sugar D and it is caused by the 
reorientation of the GlcNAc(1) C5-C6 bond following the 4C1 to 
1C4 re-puckering, from an equatorial 
to an axial position, sugar D has been excluded from the averaging. The conformational propensity of 
sugar D is discussed in detail in a dedicated subsection below. 
 
Fuc(12)-(1-6)-GlcNAc(1) linkage  
The flexibility of the (1-6) linkage between the fucose and the GlcNAc(1) is unsurprisingly higher 
relative to the other core monosaccharides. Notably, the conformational space sampled is independent 
of the length or the size of the N-glycan. Thehighest populated (1-6) conformer, i.e.   -77.3° (100%), 
 -185.2° (78%), and  47.1° (89%), with relative average populations indicated in brackets, 
corresponds to a structure where the fucose O2 forms a hydrogen bond with the NH of GlcNAc(2). An 
example of this conformation is shown in the case of the dodecasaccharide sugar T in Figure 3.2. As 
the size of the glycan increases the fucose is also able to extend the hydrogen bond network by forming 
interactions with the GlcNAc(7) O3 when the (1-6) arm is folded over the chitobiose core, as shown 
in Figure 3.2.  A deviation from this conformation with 19% of the total population, consistently for 
all N-glycans, has the same   and  torsions, but a  value of 94.5°. In this conformer the fucose is not 
hydrogen bonded. A unique case where the  torsion deviates from its gg stable configuration, i.e.  of 
47.1°, is found only in the case of the tetrasaccharide sugar D, where the reducing GlcNAc(1) 1C4 chair 
conformation has the C5 in an axial positions and the  torsion to adopt a -64.5° value. This  value 
corresponds to an energetically prohibited tg conformer when the GlcNAc(1) is in the standard 4C1 
chair. The gt  conformation, corresponding to an average value of -168.7°, has relative populations 
ranging between 3% (sugar T) and 15% (sugar F) in a pattern that doesn’t seem to be dependent on the 




Figure 3.2. Hydrogen bond between the Fuc(12) O2 and the amide N of GlcNAc(2) and GlcNAc(7) in the dodecasaccharide 
sugar T is highlighted with yellow dots. Aside from Fuc(12) and GlcNAc(2) all other monosaccharides are shown in light  
grey. Note: the conformation shown, the highest populated in sugar T, has the (1-6) arm folded over the chitobiose core. The 
image was generated with pymol. 
 
Man(3)-(1-4)-GlcNAc(2) linkage  
This linkage has one largely preferred conformation for both, fucosylated and non-fucosylated species, 
irrespectively of the length and sequence of the N-glycan. For non-fucosylated species   and  have 
average values of -79.6° (97%) and -125.4° (96%), respectively. The relative populations calculated 
over the entire simulation time are indicated in parentheses. For core-fucosylated species   and  have 
average values of -78.1° (97%) and -125.5° (96%), respectively. Conformational changes from this 
prevalent configuration amount to 3% to 4% of the whole cumulative simulation time and represent 
changes of   to values around -160° and of  to values around 60° for both, non- and core-fucosylated 
species, see Tables 3.1 and 3.2. These and excursions are not correlated to each other and confer a 
slight flexibility in terms of rotations of the plane containing the (1-3) and (1-6) branches around the 
chitobiose core. In the most stable conformation the planes containing the chitobiose and the trimannose 
core are parallel to each other.  
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 (1-3) branch: Man(4)-(1-3)-Man(3) linkage  
The conformational dynamics of the (1-3) branch at the trimannose level is not particularly complex 
and it is not affected by core fucosylation. The torsion is prevalently found in a single conformation, 
72.8° in 100% of all non-fucosylated species analysed and 72.9° in 99% of all core-fucosylated species 
analysed. The slight difference is due to the more complex dynamics of sugar P and sugar T, which 
both have sialylated (1-3) arms, and for which in 5% and 1% of the sampling time the torsion value 
is an average of 123.7°, see Table S.9 in Appendix I. The torsion defines two distinct basins, 
identical in case of both fucosylated and non-fucosylated species. In case of non-fucosylated N-glycans 
the highest populated value is 146.5° (61%) and the lowest is 102.3° (39%). In the case of fucosylated 
species the values are, 147.5° with a relative population of 60% and 102.2 with a population of 39%. 
The remaining 1% is contributed by the more complex dynamics of sugar P, where the third value 
corresponds to 182.0°. The two distinct conformations of this linkage confer a degree of flexibility to 
the (1-3) branch with a range of movement shown in Figure 3.3.  
 
Figure 3.3. The conformational dynamics of the (1-3) arm, shown here for sugar R as an example, is restricted to two basins 




 (1-3) branch: GlcNAc(6)-(1-2)-Man(4) linkage  
The conformation of this linkage is restricted to two conformations, identical for both fucosylated and 
non-fucosylated species. In case of the non-fucosylated glycans the average value is -81.0°, while the 
values are 161.8° (84%) and 105.4° (16%). In case of the fucosylated glycans the average value is 
-80.9°, while the values are 161.9° (84%) and 105.4° (16%).  
 
 (1-3) branch: Gal(8)-(1-4)-GlcNAc(6) linkage  
This linkage is the least flexible in the branch with one conformation accounting for over 95% of the 
population of both fucosylated and non-fucosylated N-glycans. In case of the non-fucosylated glycans 
the average value is -75.7°, while the value is -122.1° (95%). In case of the fucosylated glycans the 
average value is -75.1°, while the value is -122.3° (95%). The 5% difference corresponds to 
excursions to values around 75° for both fucosylated and non-fucosylated species, see Tables 3.1 and 
3.2. 
 
 (1-3) branch: Sia(10)-(2-6)-Gal(8) linkage  
The linkage to the terminal sialic acid is the most flexible of the (1-3) arm and all the conformations 
visited are independent of core-fucosylation, both in terms of torsion angle values and populations, see 
Tables 3.1 and 3.2. The most flexible torsion is the angle with values around -60° (65%) and -165° 
(30%). A small contribution of around 5% is given by a value of 60°. These two values define the 
conformations shown in Figure 3.4, with the highest populated corresponding to the completely out-




Figure 3.4. The two highest populated conformations accessible to the terminal sialic acid here shown for sugar T on the (1-
3) arm. Note, only the section of the (1-3) arm from Man(4) is shown for clarity. The conformations corresponding to  
torsion values of -60° (65%) and -165° (30%) are shown with C atoms in cyan and green, respectively. The image was 




 (1-6) branch: Man(5)-(1-6)-Man(3) linkage  
The conformational dynamics of the Man(5)-(1-6)-Man(3) linkage is the most interesting and the only 
one that has a clear dependence on sequence among the IgG Fc N-glycans analysed here. Unlike the 
(1-3) arm that has a relatively restricted dynamics, the (1-6) arm can adopt two very distinct 
conformations, one extended, or ‘outstretched’, corresponding to values around -180°, and one where 
the arm is folded over the chitobiose core, which we’ll refer to as ‘folded-over’, corresponding to 
values around 80°, see Tables 3.1, 3.2 and Figure 3.5. In sugar E (F), with an (1-6) arm terminating 
with Man, over 80% of the conformer have the arm in an outstretched conformation, see Tables S.16 
and S.17 in Appendix I. The addition of the GlcNAc in (1-2) shifts this equilibrium, so for sugars G 
(H), I (J), and Q (R), where the fucosylated species are indicated in parenthesis, the outstretched and 
the folded-over conformations are equally populated, namely 45% (49%) for the folded-over 
conformation, and 55% (51%) for the outstretched conformation. Interestingly, galactosylation of the 
(1-6) arm shifts this equilibrium further with a high majority of the galactosylated sugars, namely K 
(L), M (N), O (P) and S (T), in a folded-over conformation. The relative average populations are 74% 
and 76% in a folded-over conformation for non-fucosylated and core-fucosylated sugars, respectively, 
while 26% and 23% in an outstretched conformation for non-fucosylated and core-fucosylated sugars, 
respectively. This equilibrium is not affected either by the type of glycosylation in the (1-3) arm, nor 
by the sialylation of the (1-6) arm, and it does not depend on core-fucosylation either, despite the 
fucose in its most stable conformation interacts effectively through hydrogen bonding with the (1-6) 






Figure 3.5. Two main conformations accessible to the (1-6) arm represented for sugar P as an example. The ‘outstretched’ 
conformation is shown on panel a) and the ‘folded-over’ on panel b). The image was generated with LiteMol with the 3D-
SNFG rendering39. 
 
 (1-6) branch: GlcNAc(7)-(1-2)-Man(5) linkage  
As seen in the case of the (1-3) arm, the conformational dynamics of this linkage is largely restricted 
to andvalues of -80° and 162°, respectively, both in case of fucosylated and non-fucosylated 
species, see Tables 3.1 and 3.2. The only significant alternative conformer accounting for 10% total 
contribution is characterized by values of 106° for non-fucosylated species and 108° for fucosylated 
species. The same linkage on the (1-3) arm has an analogous conformational equilibrium of the 
torsion, with a 85:15 ratio. 
 
 (1-6) branch: Gal(9)-(1-4)-GlcNAc(7) linkage  
Similarly to the same linkage on the (1-3) arm, the Gal(9)-(1-4)-GlcNAc(7) torsional space is highly 
restricted to a single conformation with andvalues around -75° and -125°, respectively, both in the 





 (1-6) branch: Sia(11)-(2-6)-Gal(9) linkage  
The conformational dynamics of the terminal sialic acid on the (1-6) arm is virtually identical to the 
one observed for the terminal sialic acid on the (1-3) arm. The linkage is highly flexible with, the 
angle predominantly around 65° (90%), with a ~ 10% contribution of -52°. The angle has also a 
preferred conformation around -180° (88%). Small contributions of values around -100° (9%), and 
+100° (3-4%) have been also detected, both in case of fucosylated and of non-fucosylated species. The 
angle is quite flexible, with values of -65° as the preferred conformation (60%) and of -162° (33%). 




Sugar D: Man-(1-4)-GlcNAc-(1-4)-[(1-6)-Fuc]-GlcNAc 
The conformational dynamics of the tetrasaccharide Man-(1-4)-GlcNAc-(1-4)-[ (1-6)-Fuc]-
GlcNAc, named here sugar D for short, see Figure 3.1, is quite complex showing occasional transitions 
of the reducing GlcNAc ring from the stable 4C1 chair conformation to a less stable 
1C4 chair. Similar 
conformational changes have been reported recently for Lewis X (Lex) and sialyl Lex (sLex)40, 41, where 
the linkage to the fucose is a less flexible (1-3). Although we observed the first 4C1 to
 1C4 chair 
transition within the first 100 ns of the simulation, we extended the trajectory to 3 s to evaluate more 
accurately the relative populations of the two different conformers. During the 3 s trajectory the 1C4 
chair conformation is visited 5 times and remains stable during intervals ranging from 30 ns up to 200 
ns. Based on these data, as shown in Figure 3.6, sugar D is found in the stable 4C1 chair for over 87% 
of the time. In terms of relative populations, the corresponding free energy for the 4C1 to
 1C4 chair 




Figure 3.6. Contour plot showing the conformational propensity of the reducing GlcNAc(1) of sugar D in function of two 
torsion angles O4C4C5C6 and O4C4C5O5 on the x and y axis, respectively. The structures corresponding to the highest  
populated 4C1 chair conformation (87%) and the lowest populated 
1C4 chair conformation (13%) over 3 s (30,000 data points) 
are also shown in line with the corresponding histograms on the y axis. Torsion angles are in degrees. 2D contour plots are 




The sequence of the N-glycans expressed at Asn 297 has been shown to have a significant effect in 
modulating the IgG effector function. In particular core-fucosylation, and galactosylation and 
sialylation of both (1-6) and (1-3) arms in Fc biantennary complex N-glycans have been identified 
as key players, with different roles in regulating the ADCC function5, 13, 16 and the onset of 
inflammation24, 26. In particular levels of galactosylation have been linked to aging31 and to the risk of 
developing conditions such as rheumatoid arthritis25, 27-29. The molecular basis underlying the link 
between the glycan sequence and these different phenotypes is very complex to understand, as it most 
likely depends on the dynamics and energetics of the interaction between the glycosylated antibody and 
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the receptors on the immune cells21. As a first step we wanted to determine if and how the 
monosaccharide sequence affects the N-glycan dynamics in the absence of the protein, so we analysed 
the intrinsic conformational propensity of the biantennary complex N-glycans most commonly 
expressed at Asn 297 on the IgG Fc5, 10. Although we do expect that contacts with residues on the IgG 
Fc surface are likely to affect the conformational equilibrium relative to the isolated glycan, it is has 
been shown that both (1-6) and (1-3) arms retain high degrees of flexibility in Fc-linked glycans30, 
therefore their intrinsic conformational propensity may play a role in their contact with the receptors. 
The results of our study based on extensive conformational sampling in excess of 62 s by MD 
simulations, show that while core-fucosylation and sialylation do not affect the conformational 
dynamics of the N-glycan as a whole, the effect of galactosylation of the (1-6) arm is remarkable, as 
it clearly regulates its conformation. Indeed, we have found that regardless of the sequence of the (1-
3) arm, of core-fucosylation, or of sialylation of the (1-6) arm, the presence of galactose (1-4) linked 
to GlcNAc shifts the conformational propensity of the whole (1-6) arm from an ‘outstretched’ 
conformation to a ‘folded-over’ conformation where the (1-6) arm is stacked against the chitobiose 
core, see Figure 3.5. The shift in the conformational equilibrium we observe for galactosylated (1-6) 
arms is likely due to a more effective interaction in terms of both hydrogen bonding and of stacking 
with the chitobiose core, regardless of the presence of the core-fucose. This is surprising as fucose does 
contribute to the hydrogen bonding network by bridging the GlcNAc(2) of the chitobiose to the 
GlcNAc(7) of the folded-over (1-6) arm, as shown in Figure 3.2. Conversely, the dynamics of the 
(1-3) arm is more restricted due to the intrinsic rigidity of the Man-(1-3)-Man relative to the Man-
(1-6)-Man. Nevertheless, it undergoes excursions between the two close rotamers, as shown in Figure 
3.3. The conformational dynamics of both arms is locally enhanced by the sialic acid due to the intrinsic 
flexibility of the (2-6) linkage.  
 
Although the existence of folded-over (and variation there-of) and of outstretched conformations of the 
(1-6) arm have been identified and discussed previously42, 43, our systematic study highlights the 
unique dependence of this conformational propensity on the galactosylation of the (1-6) arm. This 
behaviour can explain the recent evidence of differential recognition of positional isomers in glycan 
array screening44. As an example, the positional isomers sugar J and L have a galactose on either the 
(1-3) or the (1-6) arm, respectively, which confers a different conformational propensity of the (1-
6) arm. Indeed, in sugar J, shown in Figure 3.7.A, the folded-over and the outstretched conformations 
are equally populated during the MD simulations, i.e. 49% and 50%, respectively (note: the 1% 
corresponds to a  value of -99.3°), while in sugar L, shown in Figure 3.7.B, the folded-over (1-6) 
arm is the dominant conformation with a relative population of 81% over the simulation time. As a 
further implication of this behaviour, a different structural propensity shifted towards a folded-over (1-
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6) arm and an outstretched (1-3) arm is in agreement with the higher affinity of the sialyltransferase 
for the (1-3) galactose, more accessible in isolated glycans30. Interestingly, this selectivity is only 
moderately changed when the N-glycans are linked to the IgG Fc30.  
 
Figure 3.7. Contour plot showing the different conformational propensities of the (1-6) arm in sugar J (panel a) and L (panel 
b) in function of galactosylation. The ‘folded over’ conformation corresponds to a  value around 80°, while the outstretched 
conformation corresponds to a  value around -180°. Torsion angles are in degrees. 2D contour plots are done with seaborn 
(seaborn.pydata.org) with 2,500 data points. 
 
The systematic conformational analysis of progressively longer fucosylated and non-fucosylated N-
glycans has allowed us to highlight an additional and unique complexity in the dynamics of the 
tetrasaccharide sugar D, namely Man-(1-4)-GlcNAc-(1-4)-[(1-6)-Fuc]-GlcNAc. During a single 
(unbiased) MD trajectory extended to 3 s, we have observed the reducing GlcNAc ring transitioning 
from the most stable 4C1 chair to a 
1C4 chair a total of 5 times, where the 
1C4 chair remains stable for 
intervals between 30 to 200 ns. This relative ease of interconversion, corresponding to a free energy of 
4.7 kJ/mol, is somewhat in contrast with the results obtained for of Lex(a) and sLex(a) where opening 
events are much more rare and much more difficult to sample through conventional MD simulations4 0 , 
41. The greater accessibility of the open state in sugar D is most likely related to the higher flexibility of 
the (1-6) linkage to the fucose, relative to the (1-3) and (1-4) linkages in (s)Lex and (s)Lea, 
respectively. Indeed, in each of the 5 events sampled in this study and in agreement with previous 
work40, the 4C1 to 
1C4 transition involves high energy intermediate steps, where the reducing GlcNAc 
ring adopts boat and skewed-boat conformations, while the (1-4)-GlcNAc and the (1-6)-Fuc change 
from an equatorial to an axial configuration. It is reasonable that the energy cost involved in this latter 
equatorial-to-axial conversion is less for the more flexible sugar D, relative to the more rigid (s)Lex and 
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(s)Lea. The conformational propensity of the (1-6) linkage through the 3 s trajectory is shown in 




Here we have shown the results of extensive sampling obtained through unbiased MD simulations of 
the conformational space accessible to increasingly larger biantennary complex N-glycans, commonly 
expressed at the Asn 297 in the IgG Fc region. Our data indicate that while core-fucosylation and 
sialylation do not affect the overall conformation of the isolated N-glycan as a whole, but contribute to 
its local dynamics, galactosylation of the (1-6) arm shifts its conformational equilibrium towards a 
structure where the arm is ‘folded over’ the chitobiose core. This effect is determined by more effective 
hydrogen bonding and stacking interactions between the chitobiose and the ‘longer’ galactosylated (1-
6) arm and it is independent of the sequence of the (1-3) arm, of core-fucosylation, and of sialylation 
of the (1-6) arm. These results can explain the differential recognition of positional isomers44 and with 
the preference of sialyltransferases for the (1-3) arm in both, isolated and Fc-linked N-glycans30. 
Currently we are in the process of determining how the dynamics and the conformational equilibria we 
have discussed here for the isolated biantennary N-glycans are affected by the presence of the IgG Fc 
protein surface. As a note, a relatively long simulation of the tetrasaccharide Man-(1-4)-GlcNAc-(1-
4)-[(1-6)-Fuc]-GlcNAc, named here sugar D, has highlighted an equilibrium between a high populated 
‘closed’ form of the sugar, where GlcNAc(1) is in the stable 4C1 chair conformation, and an ‘open’ 
form, where GlcNAc(1) is in the 1C4 chair conformation. We find that the accessibility to the open state 
is significantly higher for sugar D, relative to (s)Lex(a), as reported in recent work40, 41. This is most likely 
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 4.1 Introduction 
 
Complex carbohydrates (or glycans) are an essential class of biomolecules, directly implicated in the 
cell’s interactions with its environment, facilitating communication and infection1, 2. These processes 
are often initiated by molecular recognition involving carbohydrate-binding proteins (lectins) or by 
glycan-glycan interactions1, 3-5, all events that hinge on specific structural and dynamic features of the 
glycans. This makes the 3D complementarity of the glycans architecture key towards the success of 
these processes and an essential piece of information for us to have in order to understand glycan 
recognition. Because of their chemical nature, glycans are intrinsically flexible and highly dynamic at 
room temperature, thus their characterization through experimental structural biology methods is hardly 
straightforward even in cryogenic environments 6. As an additive layer of difficulty, glycosylation is 
only indirectly dependent on the genome, which often results in a micro- (or macro-) heterogeneity of 
glycan sequences at specific sites7. These complexities are very difficult to resolve, requiring high levels 
of expertise and multi-layered orthogonal approaches7-10. Within this framework, the contribution of 
glycoinformatics tools and databases represents an essential resource to advance glycomics11-15, while 
molecular simulations fit in very well as complementary and orthogonal techniques to support and 
advance structural glycobiology research. Indeed, current high performance computing (HPC) 
technology allows us to study realistic model systems16, 17 and to reach experimental timescales18, so 
that computing can now contribute as one of the leading research methods in structural glycobiology.  
 
One of the most interesting and remarkably challenging areas in glycoscience research that HPC 
simulations can address is the study of the links between glycans sequence and 3D structure. This direct 
relationship is a well-recognized and broadly accepted concept in proteins’ structural biology, according 
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to which the amino acid sequence dictates the functional 3D fold and its stability.  However, the same 
notion is not generally invoked when discussing other biopolymers or complex carbohydrates. In the 
specific case of glycans, the structural complexity, in terms of the diversity of monosaccharides, the 
linkages’ stereochemistry and the branched scaffolds, makes the already difficult case even more 
intricate. Nevertheless, the fact that glycoforms follow recurrent sequence patterns, clearly suggests that 
the glycans 3D structure is also non-random and very likely sequence-determined. We use computer 
modelling to gain insight into these relationships and to define a framework to understand how subtle 
modifications to the glycans sequence can alter their 3D structure and conformational dynamics, 
ultimately regulating recognition19. In this work we use molecular dynamics (MD) simulations to 
analyse the effects of the inclusion of motifs typically found in plants and invertebrates N-glycans which 
are immunogenic in mammals20-23. More specifically, we investigate how core (1-3)-linked fucose 
(Fuc) and (1-2)-linked xylose (Xyl) affect the structure and dynamics of plants N-glycoforms23 and of 
hybrid constructs with mammalian N-glycoforms24.   
 
At first glance plants protein N-glycosylation23 is quite similar to the one of higher species25, carrying 
the distinctive trimannose core (Man3), which can be further functionalised with (1-2) linked GlcNAc 
residues on the arms. As a trademark feature, shown in Figure 4.1, plants N-glycans can also have a 
(1-2)-Xyl linked to the central mannose and core (1-3)-Fuc, instead of the (1-6)-Fuc commonly 
found in mammalian complex N-glycans. Additionally, the arms can be further functionalised with 
terminal galactose (Gal) in (1-3) instead of (1-4)23, commonly found in vertebrates, which forces the 
addition of fucose in the (1-4) position of the GlcNAc and results in the occurrence of Lewis A (LeA) 
instead of Lewis X (LeX) terminal motifs on the arms23, 26. In a previous study, we characterized through 
extensive sampling the structure and dynamics of complex biantennary N-glycans commonly found in 
the human IgGs Fc region24. The results of this study indicated a clear sequence-to-structure 
relationships, especially in the context of the dynamics of the (1-6) arm. More specifically, we found 
that the outstretched (open) conformation of the (1-6) arm gets progressively less populated as the 
functionalization of the arm grows, i.e. from 85% in Man3, to 52% in (F)A2, (F)A2[3]G1, and 
(F)A2[3]G1S1, where the (F) indicates the presence or absence of (1-6) core fucosylation, to 24% in 
all structures with (1-6) arm terminating with Gal-(1-4)-GlcNAc or Sia-(2-6)-Gal-(1-4)-GlcNAc, 
irrespective of the functionalization of the (1-3) arm24. As a practical implication of these results, 
positional isomers, such as (F)A2[3]G1 and (F)A2[6]G1, have different conformational propensities, 
the latter with a much lower population of outstretched (1-6) arm and therefore quite different 3D 
average structures, which ultimately explains their differential recognition in glycan arrays27. 
                                                 
  First shown in the  preliminary findings of Christian Anfinsen (Anfinsen, C. B. Principles 
that Govern the Folding of Protein Chains. Science (80-. ). 181, 223 LP – 230 (1973).) 
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Additionally, the different conformation of the arms explains the known difficulties in sialylating the 
(1-6) arm by ST6-Gal1, relatively to the (1-3) arm28. Also, the different 3D conformational propensity 
of the arms in function of sequence can have important implications in terms of the N-glycans 
biosynthesis and biodegradation29. As an additional interesting point, we found that the folding of the 
(1-6) arm over the chitobiose region is completely independent of core (1-6) fucosylation24, with the 
result that core-fucosylated and non-core fucosylated N-glycans with the same sequence in the (1-6) 
arm correspond to the same structural ensemble. 
 
In this work we discuss how core (1-3)-Fuc and (1-2)-Xyl regulate the conformational propensity of 
the (1-6) arm to push a predominantly outstretched (open) conformation when the arms are 
functionalized with terminal (1-3)-Gal. Within this framework, we explored the possibility of 
integrating these motifs in the context of mammalian sequences as an exploratory strategy towards the 
design of N-glycans with the desired 3D structure. For simplicity in the presentation and discussion of 
the results, we refer to N-glycans as either “plant” or “hybrid” separately. Nevertheless, it is important  
to underline that some of these motifs, such as (1-2) xylosylation and difucosylated core are also found 
in invertebrate N-glycosylation30. Finally, we discuss these findings within a framework where the 
different N-glycoforms can be represented as a combination of spatial self-contained units, named 
“glycoblocks”, rather than in terms of monosaccharides and linkages. We find that this approach helps 
our understanding of N-glycans architecture in terms of equilibrium structures and relative populations 





Figure 4.1. Representative structures of the plant N-glycans studied in this work with corresponding nomenclature. The letters 
f, x, and g indicate the presence of Fuc, Xyl and (1-3) Gal, respectively, and ng the absence of (1-3) Gal. LeA stands for 
Lewis A antigen. The N-glycans structures are shown with the (1-3) and (1-6) arms on the left and on the right, respectively.  
The monosaccharides colouring follows the SFNG nomenclature. The plants N-glycan characteristic linkages are indicated in 
the legend. Rendering was done with VMD (https://www.ks.uiuc.edu/Research/vmd/).  
 
4.2 Computational Methods 
 
All starting structures were generated with the GLYCAM Carbohydrate Builder 
(http://www.glycam.org). For each sequence we selected the complete set of torsion angle values 
obtained by variation of the 1-6 dihedrals, namely the three gg, gt and tg conformations for each 1-6 
torsion. The topology file for each structure was obtained using tleap31, with parameters from the 
GLYCAM06-j132 for the carbohydrate atoms and with TIP3P for water molecules33. All calculations 
were run with the AMBER18 software package31 on NVIDIA Tesla V100 16GB PCIe (Volta 
architecture) GPUs installed on the HPC infrastructure kay at the Irish Centre for High-End Computing 
(ICHEC). Separate production steps of 500 ns each were run for each rotamer (starting system) and 
convergence was assessed based on conformational and clustering analysis, see Appendix II for all 
relevant tables. Simulations were extended, if the sampling was not deemed sufficient, i.e. in case 
standard deviation values measured were significantly larger than 15° for each cluster in each trajectory. 
All trajectories were processed using cpptraj31 and visually analysed with the Visual Molecular 
Dynamics (VMD) software package34. Backbone Root Mean Square Deviation (RMSD) and torsion 
angles values were measured using VMD. A density-based clustering method was used to calculate the 
populations of occupied conformations for each torsion angle in a trajectory and heat maps for each 
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dihedral were generated with a kernel density estimate (KDE) function. Statistical and clustering 
analysis was done with the R package and data were plotted with RStudio (www.rstudio.com). Further 




Core  (1-3) fucose in plant N-glycans .  
One distinctive feature of plants N-glycans is the occurrence of core fucosylation in(1-3), rather 
than(1-6)-Fuc, normally found in mammalian N-glycans23, 24. To understand the effects on the 3D 
structure of this modification, we have considered two biantennary systems, one terminating with (1-
2)-GlcNAc on both arms (ngf) and the other with terminal (1-3)-Gal on both arms (gf), shown in 
Figure 4.1. In both glycoforms core(1-3)-Fuc occupies a stable position, with one single conformer 
populated (100%), see Tables S.1 and S.2 in Appendix II. This conformation is supported by a 
stacking interaction between the core(1-3)-Fuc and (1-4) GlcNAc of the chitobiose in a “closed” 
conformation, which resembles the stable conformation of LeX35. This spatial arrangement imposes a 
20° rotation of the GlcNAc-(1-4)-GlcNAc linkage, see Tables S.1 and S.2 in Appendix II, relative to 
the (1-6) core fucosylated or non-fucosylated chitobiose24, where the average psi value is -127.8° 
(14.8)24, but doesn’t affect the structure of the linkage to the central mannose. As shown by the low 
standard deviation values and by the lack of multiple minima (clusters), the N-glycan core remains 
relatively rigid throughout the trajectories. The slight torsion of the GlcNAc-(1-4)-GlcNAc linkage 
imposed by the (1-3)-Fuc has a dramatic effect on the conformational dynamics of the (1-6) arm, 
which is found predominantly in an outstretched (66%, cluster 1) conformation, rather than folded over 
(34%, clusters 1 and 2), see Table S.1 in Appendix II. The addition of a terminal (1-3)-Gal in the gf  
N-glycan pushes the equilibrium towards an outstretched (1-6) arm even further, with the open 
conformation populated at 72%, see Table S.2 in Appendix II. Interestingly, in the case of (1-6) core 
fucosylated N-glycans, and with double fucosylation as discussed later on, the equilibrium of the (1-6) 
arm was the exact opposite, with a predominance of the folded conformation, especially in the presence 
of terminal (1-4) Gal24. To note, the folded (1-6) arm conformation can be either a ‘front fold’, see 
Figure 4.2 panel A, where the torsion around the (1-6) linkage brings the arm towards the reader, or 
a ‘back fold’ where the (1-6) arm interacts with the(1-3)-Fuc, away from the reader. As shown in 




Figure 4.2. A representative structure of the non-galactosylated N-glycan with (1-3)-linked core fucose (ngf) is shown in 
panel a), with on the right-hand side the corresponding heat map showing the conformations accessible to the (1-6) arm in 
terms of the phi/psi torsion angles. A representative structure of the non-galactosylated N-glycan with (1-2)-linked xylose 
(ngx) is shown in panel b), with on the right-hand side a heat map showing the conformations accessible to the (1-6) arm in 
terms of the phi/psi torsion angles. The N-glycans structures are shown with the (1-3) and (1-6) arms on the left and on the 
right, respectively. The monosaccharides colouring follows the SFNG nomenclature. The structure rendering was done with 





Figure 4.3. -D-xylose ring pucker analysis over 3 s of cumulative MD sampling of the ngx N-glycan. The two snapshots 
on the right-hand side are representative ngx conformations corresponding to the two different ring puckers. The Xyl1 and 
Xyl2 axis labels refer to the torsion angles C1C2C3C4 and C2C3C4C5, respectively. The N-glycans structures are shown with 
the (1-3) and (1-6) arms on the left and on the right, respectively. The monosaccharides colouring follows the SFNG 
nomenclature. The structure rendering was done with VMD (https://www.ks.uiuc.edu/Research/vmd/) and the graphical 
statistical analysis with RStudio (www.rstudio.com).  
 
(1-2) xylose in plant N-glycans . 
 Because the (1-2)-Xyl sits in front of the two arms, it greatly affects their dynamics. Because of steric 
hindrance, the (1-3) arm is much more rigid relative to non-xylosylated species, see Table S.3 in 
Appendix II, losing its “two conformer” dynamics characteristic of the biantennary mammalian N-
glycans24, also retained in the plant N-glycans with only (1-3)-Fuc discussed above, see also Tables 
S.1 and S.2 in Appendix II. In regards to the (1-6) arm, as shown in Figure 4.2 panel B, the presence 
of (1-2)-Xyl has a very similar effect as the (1-3)-Fuc, pushing the equilibrium towards an open 
conformation. To note, in the presence (1-2)-Xyl, the (1-6) arm cannot fold over the chitobiose core 
in a ‘front fold’ either, because of steric hindrance. Also, similarly to the (1-3) fucosylated glycans, 
the stability of the open structure is slightly increased when the arm is further functionalized with 
terminal (1-3)-Gal, see Table S.4 in Appendix II. As an additional interesting feature, through the 
cumulative 3 s MD sampling, the xylose ring repeatedly inverts its conformation from the all 
equatorial 4C1 chair, to the 
1C4 chair, where all hydroxyl groups are axial, see Figure 4.3. This transition 
may be energetically facilitated by the hydrogen bonding interaction xylose is able to form when in a 
1C4 chair with the (1-6)-Man, which may compensate for the steric compression, making the 
1C4 chair 
the highest populated conformer at 76% within an N-glycan scaffold. Both experimental and ab-initio 
theoretical studies36-38 have shown that 1C4 chair is energetically accessible in isolated -D-Xyl at room 
temperature in different dielectric conditions. 
 
Core  (1-3) fucose and (1-2) xylose in plant N-glycans.  
The presence of both (1-3)-Fuc and (1-2)-Xyl brings in the characteristic features highlighted earlier 
in the analysis of the structures with either (1-3)-Fuc or (1-2)-Xyl. Indeed, we see here again the 20° 
rotation of the chitobiose GlcNAc-(1-4)-GlcNAc psi angle caused by the stacking of the (1-3)-Fuc 
to the chitobiose (1-4)-GlcNAc and the conformational restraints imposed by the (1-2)-Xyl on the 
(1-3) arm, see Table S.5 in Appendix II. We also observed that both (1-3)-Fuc and (1-2)-Xyl push 
the (1-6) arm equilibrium towards an open conformation, which is also the case when both are present 
in the ngfx N-glycan and to an even higher degree, i.e. 87%, in the gfx N-glycan, when both arms are 
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functionalized with terminal (1-3)-Gal, see Table S.6 in Appendix II. One feature specific to the ngfx 
N-glycan is the higher flexibility of the core Man-(1-4)-GlcNAc linkage, which allows for the rotation 
of the trimannose group relative to the chitobiose core. This conformation was accessible, but only 
populated around 2% when either (1-2)-Xyl or (1-3)-Fuc are present, see Tables S.1 to S.4 in 
Appendix II. When both fucose and xylose are present, the population of the rotated trimannose reaches 
above 20%, see Table S.5 in Appendix II, which can be considered a synergistic effect as this 
conformation is stabilized by a hydrogen bonding network involving the core fucose, the GlcNAc on 
the (1-6) arm and the xylose, as shown in Figure S.1 in Appendix II. Such folding event has been 
observed as a stable conformation in two independent simulations. To note, the functionalization of the 
arms to include terminal (1-3)-Gal reduces the occurrence of this event down to around 5%, see Table 







Figure 4.4. Comparison of the different conformational equilibria of the (1-6) arm in a core (1-3)-Fuc (1-2)-Xyl A2 N-
glycan with terminal LeA and LeX groups on the left- and right-hand side, respectively. Representative structures from 1.5 s 
MD sampling of each system are shown to illustrate the conformations corresponding to the different minima. The N-glycans 
structures are shown with the (1-3) and (1-6) arms on the left and on the right, respectively. The monosaccharides colouring 
follows the SFNG nomenclature. The structure rendering was done with VMD (https://www.ks.uiuc.edu/Research/vmd/) and 
the graphical statistical analysis with RStudio (www.rstudio.com).  
 
Terminal LeA and LeX motifs in plant N-glycans .  
To understand how an increased complexity on the arms would affect the dynamics of the (1-3) 
fucosylated and (1-2) xylosylated N-glycans, we considered the functionalization with terminal LeA 
antigens present in plants N-glycans26 and with LeX for comparison. As expected 35 the LeA and LeX 
structures are quite rigid, see Tables S.7 and S.15 in Appendix II, and remain in what is known as the 
“closed” conformation throughout the 1.5 s cumulative sampling time for each system. One interesting 
point is that the branching introduced by functionalizing the terminal GlcNAc residues with (1-4)-Fuc 
and (1-3)-Gal, i.e. LeA, promotes the interaction between the two arms, which is not observed when 
the arms are linear, neither here for plants N-glycans, nor for mammalian IgG-type complex biantennary 
N-glycans24. The interaction between the arms is promoted by the ability to form complex hydrogen 
bonding networks, which in this specific case, may also involve the central xylose. As outcomes of the 
complex interaction the branched arms can establish, the equilibrium of the (1-6) arm is restrained in 
conformations previously not significantly populated, see Figure 4.4 and Table S.7 in Appendix II, 
and the GlcNAc-(1-2)-Man linkage in both arms is remarkably flexible, which is also not observed 
when the arms are not branched. Although not natural in plants, to check the corresponding symmetry, 
we built a core (1-3)-Fuc and (1-2)-Xyl N-glycan with terminal LeX on both arms, a feature actually 
found in schistosome N-glycosylation30. Remarkably, as shown in Figure 4.4 and Table S.15 in 
Appendix II, within this framework the dynamics of the (1-6) arm is completely different. Contrary to 
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the N-glycan with terminal LeA groups, the two arms with LeX are not interacting and the (1-6) arm is 
predominantly (90%) in an extended (open) conformation, while the closed conformation, which 
accounts for the remaining 10% is achieved through a rotation around the core Man-(1-4)-GlcNAc. 
The lack of interaction between the arms is due to the inability to establish the same stable hydrogen 
bonding network due to the non-complementary position of the deoxy-C6 of the fucose in LeX relative 
to LeA. 
 
Hybrid N-glycans.  
To understand how characteristic plant N-glycan motifs can affect the structure of mammalian N-
glycoforms, we have designed and analysed the dynamics of a set of hybrid systems. In particular, we 
were interested in the effect of the addition of (1-2)-Xyl and (1-3)-Fuc to (F)A2G2 N-glycans 
scaffolds in terms of potential alteration of the (1-6) arm dynamics.  
 
Figure 4.5. Conformational analysis of the (1-6) arm in four hybrid N-glycoforms, (1-2)-xylosylated A2G2 (top-left), (1-
2)-xylosylated FA2G2 (bottom-left), (1-2)-xylosylated (1-3)-core fucosylated A2G2 (top-right) and (1-2)-xylosylated 
FA2 (bottom-right). The predominant conformations are indicated in the top - and bottom-left heat maps for simplicity. The 
simulation time relative to each system is indicated in the top right corner of each heat map. The N-glycans structures are 
shown with the (1-3) and (1-6) arms on the left and on the right, respectively. The monosaccharides colouring follows the 
SFNG nomenclature. The structure rendering was done with VMD (https://www.ks.uiuc.edu/Research/vmd/) and the graphical 





 Unlike the case of plants N-glycans, the presence of (1-2)-Xyl hinders but does not completely prevent 
the (1-6) arm from folding over when the terminal galactose is (1-4)-linked, as folding over the 
chitobiose can be stabilized by stacking, see Figure 4.5 and Table S.8 in Appendix II. The folded 
conformation with a median psi value of 103.5° (± 11.3) is 20° from the average value of 82.9° 
calculated for the non-xylosylated (mammalian) counterpart24, so slightly distorted, and its population 
reduced from 74% to 57%. Nevertheless, the closed conformation is still the predominant form, even 
with (1-2)-Xyl. The presence of (1-6)-linked core fucose to create a (1-2)-xylosylated FA2G2, 
which is actually a type of N-glycosylation found in schistosoma30, brings in yet another change. As 
shown in Figure 4.5 and Table S.9 in Appendix II, (1-6)-Fuc and (1-2)-Xyl are in an optimal 
conformation to support the closed (folded) (1-6) arm, by stacking of the terminal galactose by fucose 
and hydrogen bonding by xylose. Within this context the closed (1-6) arm is the highest populated 
conformer at 70.0% over 4.5 s of cumulative sampling of this system. To note that the conformation 
of the (1-6)-linked core fucose is the same as the one seen in mammalian N-glycans24, which on its 
own we have seen is not enough to affect the (1-6) arm equilibrium, see Table S.9 in Appendix II. The 
interaction of the (1-6)-Fuc with the terminal (1-4)-Gal is essential to promote the closed 
conformation of the (1-6) arm as demonstrated by the results obtained for the xylosylated FA2 systems, 
which recovers a conformational propensity similar to the non-fucosylated, xylosylated A2G2, see 
Figure 4.5 and Tables S.8 and S.10 in Appendix II. 
 
 (1-3)-fucosylated mammalian N-glycans . Because of its orientation tucked “behind” the chitobiose 
core defined in the context of plants N-glycans earlier, the effect of core (1-3)-Fuc on the (1-6) arm 
equilibrium within an A2G2-xylosylated scaffold is not as significant as (1-6)-Fuc. As shown in 
Figure 4.5 and Table S.11 in Appendix II, this lack of direct effect is demonstrated by the recovery of 
the same equilibrium as the non-fucosylated A2G2-xylosylated system. The dynamics of the chitobiose 
core is very similar to the one determined for the corresponding plant N-glycan. To analyse the effect 
of core (1-3) fucosylation without (1-2)-Xyl, we have looked at two A2G2 hybrid systems, one with 
only (1-3)-linked fucose and one with both core (1-3)- and (1-6)-linked fucose, a characteristic 
“double-fucose” glycosylation found in worm and fly cells30. As shown in Table S.12 in Appendix II 
unlike in plants N-glycans, the (1-3)-Fuc alone does not affect the A2G2 (1-6) arm equilibrium24, as 
the folding of the (1-6) arm with terminal (1-4)-Gal is not obstructed by the rotation of the chitobiose 
core imposed by the (1-3)-Fuc position. When both (1-3)- and (1-6)-linked fucoses are present the 
(1-6) arm with terminal (1-4)-Gal is predominantly folded (closed) at 85%, see Figure 4.6 and Table 
S.13 in Appendix II, which is higher than in the absence of (1-3)-Fuc24. Indeed, the latter can actively 
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contribute in stabilizing the interaction with the terminal (1-4)-Gal of the folded (1-6) arm. We also 
observed interesting events, one representing 10% of 2 s as indicated by the values of the GlcNAc-
(1-4)-GlcNAc torsion, where the GlcNAc is stacked in between the two fucose residues and another 
one, contributing to 18% of the simulation time, 14% when the system is also xylosylated, in which the 
GlcNAc ring transitions from 4C1 to 
1C4 allowing the two fucose to stack, see Tables S.13 and S.14 and 
Figure S.2 in Appendix II.  
 
 
Figure 4.6. Conformational equilibrium of the (1-6) arm in terms of phi/psi torsion angle values for the (1-3)-fucosylated 
FA2G2 N-glycoform. The structure with the folded (1-6) arm where the terminal (1-4)-Gal interacts with both fucose residues 
is shown on the left-hand side. The N-glycans structures are shown with the (1-3) and (1-6) arms on the left and on the right, 
respectively. The monosaccharides colouring follows the SFNG nomenclature. The structure rendering was done with VMD 




Differences and similarities in N-glycans sequences are highly cell-specific as well as important 
indicators of health and disease states1, 39. Exogenous N-glycans motifs can be quite subtle, yet trigger 
profound differences in terms of molecular recognition19, 27 and dangerous immunogenic responses20-22. 
In this work we have analysed the effects on the N-glycans structure and dynamics of two motifs in 
particular, namely (1-2)-Xyl and core (1-3)-Fuc, common in plants23 and invertebrates30, but 
completely absent in mammalian N-glycans. Within the context of plant-type N-glycans, which have a 
terminal (1-3)-Gal, rather than (1-4)-Gal, both (1-2)-Xyl and (1-3)-Fuc contribute independently 
in promoting an outstretched (open) conformation of the (1-6) arm because of steric hindrance of the 
xylose and of the rotation forced upon the chitobiose core by the (1-3)-Fuc. The latter is not an 
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obstruction for the folding of a (1-4)-Gal terminated (1-6) arm, as we have seen in the hybrid N-
glycans constructs. Therefore, in (1-2) xylosylated N-glycans terminating with (1-3)-Gal, both arms 
should be more available for recognition, binding and further functionalization30, unlike in mammalian 
N-glycans where the (1-4)-Gal determines a prevalently closed and inaccessible (1-6) arm24, 27. Also, 
the analysis of the structure and dynamics of the LeA terminating plant N-glycans showed that the 
specific branching and spatial orientation of the motif allowed for a stable interaction between the arms, 
which is not observed in complex N-glycans with a linear functionalization of the arms24. Notably, the 
same hydrogen bonding network between the arms cannot be established when the same N-glycan 
terminates with LeX, because of the non-complementary position of the (1-3)-Fuc deoxy-C6.  
 
The analysis of all these different complex N-glycoforms clearly shows that every modification, 
addition or removal of a specific motif, can greatly affect the 3D architecture of the N-glycan, thus its 
accessibility and complementarity to a receptor. However, these effects are rather complex to 
understand or to predict, if we think of the N-glycans 3D structure in terms of sequence of 
monosaccharides, a view that stems from the way we think about proteins. Our results show that the 
main effect of all functionalizations is actually local. For example, the core (1-3)-Fuc forces a rotation 
of the chitobiose, a degree of freedom very lowly populated otherwise; meanwhile, (1-2)-Xyl restricts 
the flexibility of the trimannose core and occupies its centre. Within this framework, the 3D structural 
and dynamics features of the N-glycoforms can be rationalized by discretizing their architecture in terms 
3D units, or “glycoblocks”, that group monosaccharides and their linkages within their immediate 
spatial vicinity, e.g. the core (1-3)-Fuc and the chitobiose which structure it has modified. A list of the 
glycoblocks that we have identified with the corresponding descriptors of their 3D features are listed in 
Figure 4.7. The whole N-glycan 3D architecture, in terms of the structures accessible and their 
conformational propensity, can be then described through the combination of these glycoblocks, 
together with the knowledge of their dynamic properties and flexibility. Also, consideration of these 
glycoblocks as spatial units can be useful to understand recognition by lectins and antibodies, which is 
often affected primarily by the targeted monosaccharide’s immediate vicinity and by its accessibility 
within a specific glycoform. For example, if we consider the 3D structure of the (1-2)-Xyl Man3 
glycoblock vs. the Man3 without Xyl, we can understand how the (1-2)-Xyl position within that unit 
negates binding to DC-SIGN lectins19, see Figure S.3 panels a and b in Appendix II. Additionally, 
we can see that the slight rotation on the chitobiose imposed by the core (1-3)-Fuc does not prevent 




Figure 4.7. List of 3D structural units of monosaccharides (glycoblocks) that regulate the 3D architecture and dynamics of 
complex biantennary N-glycans from plants and invertebrate sources and hybrid mammalian constructs. The SFNG 
representation of each glycoblock is indicated in the first column from the left, 3D structures from the highest populated 
conformers are shown in the second column, rendered with VMD (https://www.ks.uiuc.edu/Research/vmd/). A brief summary 
of the conformational features of each glycoblock and the characteristic linkage or its effect on the (1-6) arm conformation are 




4.5 Conclusions  
 
In this work we used extensive sampling through MD simulations to study the effects on the N-glycan 
architecture of subtle, yet highly consequential modifications, namely core (1-3)-Fuc and (1-2)-
Xyl19. These are part of standard N-glycoforms found in plants23 and invertebrates30, but immunogenic 
in humans21, 22, 26. Our results show that these modifications can greatly affect the 3D structure of the 
N-glycan and its structural dynamics, therefore its selective recognition by lectin receptors and 
antibodies. The atomistic-level of detail information that the MD simulations provide us with, highlights 
that the effects of different functionalizations, in terms of monosaccharide types and linkages, are 
primarily local, affecting the immediate spatial vicinity of the monosaccharide within the N-glycan 
structure. Within this framework, we propose an alternative approach that can help describe and predict 
the architecture of N-glycans based on the combination of structural 3D units, or glycoblocks. Unlike a 
description based on monosaccharide sequence and linkages as two separate features, the transition to 
well-defined and self-contained units, integrating information on both monosaccharides and linkages, 
can help us rationalize and deconvolute the glycans structural disorder and ultimately understand more 
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Chapter 5: An Atomistic Perspective on Antibody-dependent cellular 
cytotoxicity quenching by core-fucosylation of IgG1 N-glycans from 
enhanced sampling molecular dynamics 
 
Paper citation: Harbison, A. & Fadda, E. An atomistic perspective on antibody-
dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-glycans 




Immunoglobulins type G (IgGs) are the most abundant antibodies in human serum1. Their ability to 
trigger an effective immune response is dependent on their interaction with the fragment crystallizable 
(Fc)  receptors (FcRs) bound to the outer membrane of immune system effector cells2. The interaction 
between IgGs and FcRs type III (FcRIII or CD16) specifically triggers an antibody-dependent cell-
based cytotoxicity (ADCC) response3 that leads to the destruction of a targeted cell. Because ADCC is 
considered as the main antibody-based mechanism against tumour cells, strategies aimed at regulating 
ADCC are highly sought after, specifically within the framework of the antibody engineering of cancer 
therapeutics4. The IgGs/FcRs binding specificity and affinity depend not only on the specific amino 
acids in the IgG1 CH2 region in direct contact with the FcR5, but also on the type of glycosylation on 
both the IgG1 Fc and the FcR6-8. More specifically, both CH2 domains of human IgGs are glycosylated 
at Asn 297 with complex biantennary N-glycans, 96% of which are core-fucosylated and 60% 
terminating with one or two galactose residues9. Around 20% of the Fc N-glycans are sialylated9 with 
one terminal sialic acid preferentially on the (1-3) arm10, and di-sialylation only occurring 4% of the 
time11. Decreasing IgG1 Fc galactosylation levels have been linked to autoimmune conditions, such as 
rheumatoid arthritis12, and both galactosylation and especially sialylation are known to trigger an anti-
inflammatory response13. The mechanism(s) linking the Fc N-glycans sequence to IgG1 function are 
unclear. Nevertheless, it is very likely that the molecular basis for these effects resides in how the Fc 
N-glycoforms modulate the IgG/FcRs recognition and binding affinity.         
 
The crystal structures of the complex between an IgG1 and FcRIII give important insight into this 
matter, showing that the Fc and FcRIII N-glycans form an intricate network of interactions upon 
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binding14, 15. These carbohydrate-carbohydrate contacts are important in regulating the binding affinity 
of the complex6, 14-16. Indeed, the comparison between two crystal structures of the IgG1/FcRIII 
complex, one where the IgG1 N-glycan is core-fucosylated and the other where it is not14, shows that 
core-fucose hinders the carbohydrate-carbohydrate interaction, displacing the Fc N-glycans by 2.6 Å in 
comparison to the structure with the non-fucosylated Fc-linked N-glycan14, 15. Because of this steric 
hindrance, a less effective binding network can be formed between the two glycans, with a consequent 
reduction of the complex binding affinity. Although the effectiveness of the glycans interaction is most 
likely a contributing factor to the reduction of the ADCC by core-fucosylation, carbohydrate-
carbohydrate binding affinities are known to be very weak17, 18, thus a slight change in the enthalpic 
contribution due to looser N-glycans contacts is rather difficult to reconcile with  the 100-fold ADCC 
reduction observed in the presence of a core-fucosylated Fc N-glycan19-22. Furthermore, it does not 
explain how sialylation can decrease ADCC but only in the context of core-fucosylation21. Meanwhile, 
it is important to note that sialylation does not change the affinity of core-fucosylated Fc for CD16s and 
CD32s and only increases the affinity a-fucosylated Fc slightly32. Also, carbohydrate-carbohydrate 
interactions reach significant binding strengths only when large scale cooperativity is involved23.  
 
Therefore, to gain further insight in the role of the Fc N-glycans sequence, structure and dynamics in 
the IgGs function, here we present the results of a molecular dynamics simulation study of IgG1 Fc 
domains with specific N-glycans, shown in Figure 5.1, known to be significantly populated in human 
IgG1s9. Extensive sampling through temperature replica exchange molecular dynamics (REMD)24 was 
chosen as the method to explore exhaustively the potentially rugged conformational space. The N-
glycoforms were chosen specifically to address the three following points, 1) to investigate a potential 
link between the structure and dynamics of core-fucosylated N-glycans to the dramatic ADCC 
reduction, 2) to determine how the preferential conformation and dynamics of a sialylated (1-3) arm 
may affect ADCC in context of core-fucosylation21 and finally 3) to analyse the dynamics of the 




Figure 5.1. The two different types of biantennary complex N-glycans we have considered in this study are shown in panel 
a). For simplicity, we named the core-fucosylated N-glycan sugar p and the non-fucosylated N-glycan sugar o. A representative 
structure from one of the REMD simulations of the IgG1 Fc with the linked N-glycans is shown in panel b) with the protein 
represented as solvent accessible surface area and in panel c) with cartoon rendering, where the CH3 and CH2 domains are 
labelled, together with the CH2 C’E loop carrying the N297-linked N-glycan.    
The simulations results show that core-fucosylation affects dramatically the dynamics of the (1-3) arm 
of the opposed N-glycan and as a consequence of steric hindrance it significantly enhances the dynamics 
of the Fc domain. Also, structural alignment of our systems to available crystallographic data show that 
the core-fucose position within the Fc core obstructs the entry of N162 N-glycosylated FcRs. This 
suggests that binding a core-fucosylated IgG1 involves a more complex conformational displacement 
of the CH2 domain. Within the framework of this mechanism, not only the CH2 domain needs to “open” 
in order to accommodate the incoming FcγR, but also that the core fucosylated N-glycan has to undergo 
a more complex conformational change, to create the space for binding and to allow proper contact with 
the the FcγR N162 glycan. This argument is consistent with a higher energetic cost and a lower binding 
affinity. Furthermore, we find that at room temperature (300 K) the terminal galactose in the (1-6) 
arm is heavily restrained to the CH2 domain of the protein, which promotes an outstretched 
conformation as the only significantly populated conformer. In the following sections we will present 
and discuss these results in detail within the framework of the available experimental data and of the 
known evidence of the N-glycosylation dependence of IgG1 effector functions.       
 
5.2 Computational Methods  
 
Protein, counterions and carbohydrate atoms were represented with the ff14SB25 and GLYCAM06j-126 
forcefields, respectively, while the TIP3P model27 was used to represent the solvent. The total 
electrostatic charge of the system was neutralized by adding Cl- ions. All simulations were carried out 
using NAMD version 2.31b128. For the temperature Replica Exchange Molecular Dynamics (REMD)24, 
90 replicas were generated in the temperature range between 300 and 500 K, corresponding to an 
exchange probability of 0.13. The simulations were carried out on six IgG1 Fc models in total, one with 
two core-fucosylated N-glycans (pp), namely sugar p shown in Figure5.1, one with two non-
fucosylated N-glycans (op) and another with one core-fucosylated and one non-fucosylated N-glycan 
(op). Because the molecular crowding within the Fc core could limit the conformational space even 
within an enhanced sampling scheme, in order to explore the possibility of the folding (closing) of the 
galactosylated (1-6) arm we described in previous work for the corresponding unlinked glycans29, we 
built all starting structures with (1-6) arms both in open and closed conformations, see Figure S.1 in 
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Appendix III. The data analysis was done on ensembles collected from 13 and 11 ns simulations per 
replica. Further information on the simulation set-up and running protocol is included in Appendix III. 
 
5.3 Results  
 
The results are presented in separate sections for clarity. Unless stated otherwise, all results refer to 
simulations started with the N-glycans (1-6) arm in the open (outstretched) conformation. 
 
Protein and Fc-linked N-Glycans Dynamics .  
The IgG1 Fc domains flexibility and its overall dynamics has been evaluated in terms of backbone 
RMSD values, calculated from the simulations relative to the 1.9 Å resolution crystal structure (PDBid 
4DZ8) of a N-glycosylated and core-fucosylated IgG1 Fc30. The structural alignment was done on the 
two symmetric CH3 domains alone for all simulations as it is the most stable part of the IgG1 Fc. Results 
are shown in Figure 5.2 in terms of kernel density estimation (KDE) plots of the protein backbone 
RMSD values obtained from simulations of an IgG1 Fc linked to two core-fucosylated sugar p on both 
sides (pp), see Figure 5.2 panel A, an IgG1 Fc linked to two non-fucosylated sugar o on both sides 
(oo), see Figure 5.2 panel B, and to an IgG1 Fc with one sugar o and one sugar p on each side (op),  
see Figure 5.2 panels C and D. The average backbone RMSD values for all the systems studied are 
shown in Table S.1 in Appendix III. The results indicate that core-fucosylation significantly enhances 
the protein dynamics, with a maximum effect when both Fc N-glycans are fucosylated, see Figure 5.2 
panel A. As it will be discussed in detail further below, this enhanced dynamic is a consequence of the 
steric interaction between the core-fucose of one N-glycan and the (1-3) arm of the symmetrically 
opposed N-glycan. The KDE distributions also indicate that the protein dynamics is primarily 
determined by the CH2 domain, which is linked to the more rigid CH3 domain by an unstructured loop, 
see Figure 5.1 panel c. that allows for a flexible architecture. The stability of the CH3 domain is not 
affected by the presence of core-fucose, nor by the conformational dynamics of the arms. The results 
obtained for the op IgG1 Fc show that the presence of even one core-fucose increases the dynamics of 
the CH2 domain, even if to a lesser degree than two core-fucosylated N-glycans. The CH2 linked to the 
non-fucosylated sugar o, see Figure 5.2 panel C, appears slightly more dynamic, as a consequence of 




Figure 5.2. Kernel density estimation (KDE) plots are shown here to represent the probability density distribution of the 
protein backbone RMSD values. These are calculated throughout the simulations started from open conformations of the (1-
6) arms, in panel a) on an IgG1 Fc with two core-fucosylated sugars p, in panel b) with two non-fucosylated sugar o, and with 
one core-fucosylated sugar p and one non-fucosylated sugar o in panels c) and d), where the two CH3-CH2 domains are 
represented separately for the non-fucosylated and for the core fucosylated Fc-linked CH2 in panels c) and d), respectively. 
The probability density function (PDF) is on the y axis and the root mean square deviation (RMSD) values on the x axis. The 
plots are. Based on 6500 points for panel a), and 5500 points for panels b), c) and d). 
 
In regards to the dynamics (1-6) and (1-3) arms, the RMSD values distributions are shown in Figure 
5.3 for the pp, oo and op IgG1 Fcs. The distributions show that the presence of core-fucosylation 
enhances the dynamics of the whole N-glycans, but especially of the (1-3) arms. This enhanced 
flexibility is due to the steric hindrance between the core-fucose of one N-glycan and the extended 
sialylated (1-3) arm of the other. This clash pushes the (1-3) arm to interconvert between an extended 
conformation, which requires the opening of the CH2 domains in order to fit, and a bent conformation, 
where the sialic acid points towards the core of the Fc instead of towards the bulk water, see Figure 
5.4. The extended (1-3) arm is the preferential conformation seen during the simulation of the oo 
system and corresponds to the maxima in Figure 5.3 panel D, where none of the glycans are core-
fucosylated. As a note, the shift in the RMSD values observed for glycan 1 (g1) in Figure 5.3 panel D 
(red line) depends on the fact that the RMSD values are calculated relative to the starting conformation, 
which in this specific case was a low populated one where the (1-3) arm is slightly bent interacting 
with the opposite N-glycan’s chitobiose core. The results shown in Figure 5.3 panels E and F, obtained 
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for the mixed op IgG1 Fc system are quite interesting in that they show that the (1-3) arm of the non-
fucosylated glycan g2 is more dynamic than the (1-3) arm of the fucosylated g1, as it does interact 
with the g1 core-fucose. Also, the dynamics of (1-6) arm of the core-fucosylated glycan g1 is directly 
affected by this interaction. The corresponding average RMSD values calculated for the N-glycans 






Figure 5.3. Kernel density estimation (KDE) plots are shown here to represent of the RMSD values distributions calculated 
for the (1-6) and (1-3) arms (heavy atoms) during the simulations of the IgG1 Fc with two fucosylated N-glycans (pp) in 
panels a) and b), and with two non-fucosylated N-glycans (oo) in panels c) and d) and with one fucosylated and one non-
fucosylated N-glycans (op) in panels e) and f). The red and blue lines refer to the two different glycans g1 and g2, respectively. 
 
The folding backwards of the (1-3) arm towards the inside of the Fc core promoted by the core-fucose 
of the opposite glycan does not involve changes from the equilibrium torsion angle values we have 
determined for the unlinked (free) N-glycans in earlier work29. As shown in Table S.3 and Figure S.2 
in Appendix III the relative populations and values of the torsion angles for the (1-3) arm are quite 
similar to the ones we determined in solution29. The only significant difference is the increase of the 
population of the (1-3)  = 96° (15) torsion to 55%, corresponding to the value in solution  = 102° 




Figure 5.4. Different orientations of the sialylated (1-3) arm in the absence and presence of core-fucose on the opposite N-
glycan. In panel a) the snapshot from the oo IgG1 Fc simulation shows the (1-3) arm outstretched towards the solvent, 
meanwhile in panel b) the snapshot from the pp IgG1 Fc simulation shows the (1-3) arm folded over the Fc core obstructed 
by the core-fucose of the opposite N-glycan. The important residues of the N-glycans are highlighted according to the SNFG 
nomenclature, the protein is represented through a solvent accessible surface in grey. Rendering was done with pyMol. 
 
N-Glycans interactions within the Fc core. 
 In all simulation started from an open conformation, the (1-6) arm remains outstretched over the CH2 
 sheet and restrained to it through an extensive and organized architecture of interactions with both 
hydrophobic and hydrophilic residues. We did not observe any unbinding events at room temperature 
(300 K). As shown in Figure 5.5, residues Lys 240 can interact with the carbonyl oxygen of the (1-6) 
GlcNAc, while Glu 252, Asp 243 and Thr 254 are all engaging with the (1-6) terminal Gal. We have 
observed throughout all simulations that Lys 240 and Asp 243 intermittently engage in a salt-bridge 
interaction, partially releasing the (1-6) arm. Residues Phe 237, Val 256, Val 297 and Val 299 line-up 
to form and hydrophobic patch that supports by stacking the (1-6) arm movement across the CH2 
domain. This outstretched conformation is the only one populated in all simulations started from an 
open (1-6) arm conformation, as shown by the heat map in Figure 5.5. Because of the complexity of 
the system, as explained in the Computational Method section all simulations were also started from a 
closed (1-6) arm conformation, see Figure S.1 in Appendix III, where the (1-6) arm is folded over 
the chitobiose core as seen for the corresponding N-glycans in solution29. Because of the molecular 
crowding and the limited space available due to the partial collapse of the Fc core, in none of the 




Figure 5.5. On the left-hand side, a representative image of the highest populated conformer observed for the (1-6) arm in 
the simulations of both core-fucosylated (sugar p, represented here) and also of non-fucosylated sugar o. The (1-3) arm and 
the rest of the protein are not represented for clarity and the residues are coloured according to the SNFG nomenclature. On 
the right-hand side, the corresponding phi/psi Ramachandran plot of the (1-6) torsion calculated from the REMD simulation 
of the pp IgG1 Fc system, showing that only the extended conformer is populated at 300 K.  
 
The two N-glycans interact quite extensively with each other through transient and interchanging 
hydrogen bonds within a network that involves primarily the trimannose residues, while the arms are 
not involved. A representative structure from the simulation of the oo IgG1 Fc is shown in Figure S.3 
in Appendix III, where is also evident the narrow space between the (1-3) arm of one N-glycan and 
the CH2-linked GlcNAc of the other, which leaves very little room for the (1-6) fucose. 
 
Core-fucosylation hinders FcR access to the binding site. 
 To evaluate a potential direct effect of the core-fucose in the binding of the FcRs we performed 
different structural alignments of representative conformations obtained throughout our simulations to 
crystal structures of IgGs Fcs in complex with FcRs, one with N-glycosylated FcRIII at Asn 162 with 
PDBids 3SGJ and 3SGK14 and one where the FcRIII is non-glycosylated with PDBid 1E4K31. The 
structural alignments were done on the set of CH2 and CH3 domains on the left-hand side of the Figure 
5.6 panel A, with a corresponding backbone RMSD value of 1.9 Å based on 196 atoms. As shown in 
Figure 5.6 panel A, the alignment to the 3GSJ shows that the accommodation of the FcRIII requires 
a significant displacement of the opposite CH2 domain relative to the unbound IgG1 Fc conformation. 
This is regardless of the core-fucosylation state of the Fc N-glycan linked to that specific CH2 domain. 
The obstructing effect of the core-fucose is quite evident when we align the C’E loops, i.e. from residue 
293 to 300, to identify the relative position of the Fc N-glycan relative to the FcRIII residues and to 
the N-glycan at Asn 162 on the FcRIII when sufficient space has been created to accommodate the 
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FcRIII due to the CH2 displacement. As shown in Figure 5.6 panel B, the position of the core-fucose 
does indeed obstruct the access of the FcRIII due to a steric clash with the N-glycan at Asn 162. The 
higher energetic cost of moving the fucosylated N-glycan in addition to the CH2 domain displacement 
is consistent with a lower binding affinity of the complex. The alignment of our core-fucosylated pp 
IgG Fc to the structure of a complex with FcRIII (PDBid 1E4K)31 shows that in the absence of the N-
glycan at Asn 162 the fucose is not hindering the binding, see Figure S.4 in Appendix III. Nevertheless, 
a lower binding affinity may be expected because of the missing interactions of the IgG Fc with the 
FcRIII Asn 162 N-glycan6. 
 
Figure 5.6 Structural alignments of a representative structure from the REMD simulation of the pp IgG1 Fc (grey) with the 
IgG Fc in complex with the FcRIII PDBid 3SGJ (cyan). In panel a) the FcRIII is shown as a solvent accessible surface while 
the IgG Fc are represented with cartoon rendering. The N-glycans are omitted for clarity purposes. The CH2 domain shift is 
represented through a red arrow, while the brackets span the length of the CH2 domain. In panel b) the FcRIII backbone is 
represented in cyan as tube while the glycan as sticks. The structure from pp IgG1 Fc MD aligned through the C’E loop to the 
PDBid 3SGJ is represented in grey, with the Fc N-glycan also in sticks. The clash between the core fucose and the N162 N-







In this work we have determined the conformational propensities of two specific N-glycans, shown in 
Figure 5.1, linked to the IgG1 Fc at Asn 297 to identify how their sequence and structure modulates 
the dynamics of the system and in turn how it affects the FcRs molecular recognition and binding 
affinity. We designed the study specifically to address the still open question on how core-fucosylation 
of Fc-linked N-glycans reduces drastically the IgGs ADCC especially in the context of sialylation2 1 .  
The comparison between core-fucosylated and non-fucosylated systems shows that core-fucose affects 
the position of the sialylated (1-3) arm of the opposite N-glycan because of steric hindrance. As a 
consequence, the (1-3) arm becomes increasingly dynamic, switching between an outstretched and a 
bent conformation where the sialic acid is directed towards the Fc core. The (1-3) arm outstretched 
conformation is found to be the highest populated in non-fucosylated systems. Accommodating an 
outstretched (1-3) arm beside the core fucose translates into a widening of the Fc core, thus it has a 
significant effect in enhancing the dynamics of the Fc, in particular at the level of the CH2 domains, 
which are quite flexible due to the Fc architecture. The higher level of conformational disorder of the 
protein and the seclusion of the sialic acid from the interaction with the incoming FcRs could both be 
determinants in decreasing the levels of molecular recognition and ultimately in weakening the binding 
affinity. Furthermore, structural alignments of representative conformers from our simulations with 
different crystal structures of IgG1 Fcs in complex with FcgRIIIs14, 31 show that core-fucose obstructs 
the entry of a Asn 162 N-glycosylated FcgRIII, posing a further burden in terms of the energy required 
to displace it in addition to the displacement of the CH2 domain. This information derived from the 
structural alignments of N-glycosylated IgG1 Fcs is quite helpful in that it provides for the first time a 
view of how the correct structure and dynamics of the Fc-linked N-glycans work within the framework 
of the IgG1 Fc/FcgRIIIs complex. Indeed, because of their intrinsic dynamics, in most crystal structures 
the N-glycans are either invisible or fitted to very unusual (and debatable) conformations.  
In previous work29 we have determined the intrinsic dynamics and conformational propensities of all 
N-glycans significantly populated in IgG1s when unlinked from the IgG, i.e. free in solution. We found 
that the galactosylation of the (1-6) arm results in a dramatic change in the N-glycan preferential 
conformation, where the (1-6) arm is folded over the chitobiose core, instead of being outstretched29. 
Such compact structure is consistent with a more difficult recognition of the (1-6) in unbound N-
glycans from lectins34 and from sialyltransferases10, and it can also possibly explain the interdependence 
of the N-glycans arms functionalization process35. Notably, the (1-6) arm folding is independent of 
the presence of a terminal (2-6) sialic acid, of the sequence on the (1-3) arm and of core-
fucosylation29. In an Fc-linked N-glycan the terminal galactose on the (1-6) arm is firmly restrained 
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to the CH2 domain through a network of hydrogen bonds and hydrophobic interaction and we observed 
no (1-6) unbinding nor folding events at 300 K. This is somewhat is disagreement with NMR data that 
suggest that the Fc-linked (1-6) arm has a structural behaviour in between a restrained and a free 
(unlinked) N-glycan at 15 °C and at room temperatures36. Nevertheless, in agreement with the same 
NMR study above we observe that the free N-glycan behaviour mentioned in the study, which we 
assume to be the form unrestrained from the CH2 domain, does increase with temperature, see Figure 
S.5 in Appendix III. Indeed, as the temperature raises the (1-6) arm becomes progressively more 
dynamic and at the extreme of 500 K is completely unrestrained. Therefore, it is possible that the 
strength of the hydrogen bonding interactions delivered by the specific force field representation we 
have used is too high at 300 K relative to the experimental conditions. It is also to note that the 
experimental conditions, in terms of complexity of the solution and relative concentrations are quite 
different from the simulation conditions. Nevertheless, the strength of the non-bonded interactions gets 
progressively balanced as the temperature is increased through the replicas, providing the correct trend. 
Additionally, based on these data and analysis the reasons why the galactosylated α(1-6) arm is more 
difficult to functionalize both in free and in Fc-linked N 
glycans are actually different. In the former case a compact folded structure preclude access relative to 
the more accessible and outstretched α(1-3) arm, while in the case of an Fc-linked  
N-glycan the strong interaction of the terminal galactose with the CH2 domain segregates the α(1-6) 




In this work we used temperature REMD to assess the role of core-fucosylation of the Fc-linked N-
glycans in the IgG1 structure and interaction with FcRs. The results indicate a  
significant enhancement of the dynamics of the protein and of the N-glycans intrinsic structural 
disorder. Additionally, we suggest a mechanistic pathway for the binding of FcRs where core-fucose 
functions as a “door-stop” to the access of Asn 162 N-glycosylated FcRs. The atomistic level, dynamic 
information in this work provides for the first time to our knowledge a clear understanding of the effect 
of core fucose in the IgG1 structure and dynamics and a working framework for the rational design of 
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Chapter 6: All-Atom Molecular Dynamics Simulations of SARS-
CoV-2 Spike Protein with glycan variation 
 
Note: Part of the work from this chapter was published in the paper:  L. Casalino, Z. 
Gaieb, J. A. Goldsmith, C. K. Hjorth, A. C. Dommer, A. M. Harbison, C. A. Fogarty, 
E. P. Barros, B. C. Taylor, J. S. McLellan, E. Fadda, R. E. Amaro, Beyond Shielding: 
The Roles of Glycans in the SARS-CoV-2 Spike Protein. ACS Cent. Sci. 6, 1722–






Coronaviruses are a family of related RNA viruses that infect mammals and bird species, with four 
genera: -coronavirus, -coronavirus, -coronavirus and -coronavirus. There are varieties of 
coronaviruses that are attributed to mild “common cold” symptoms in humans1, while others pose a 
more severe threat. In the last two decades, -coronaviruses have been a cause of concern for human 
health, as there have been epidemics caused by Severe Acute Respiratory Syndrome (SARS-CoV) in 
20032, Middle Eastern Respiratory Syndrome (MERS) in 20123, and in 2020, an outbreak of SARS-
CoV-2, also referred to as COVID-19 or 2019-nCoV, has caused a global pandemic4.  
A characteristic feature of the coronavirus architecture is the “spike” (S) protein, anchored to the surface 
membrane of the virus, used primarily for recognition, binding to a primary receptor which leads to 
fusion to the host cell5. The S protein consists of a single chain precursor that forms a homotrimeric 
structure once folded6. Each S monomer can is organised into two subunits, namely S1 and S2 and in 





Figure 6.1. System overview. (A) Sequence of the full-length spike (S) protein contains the N-terminal domain  
(NTD, 16–291), receptor binding domain (RBD, 330–530), furin cleavage site (S1/S2), fusion peptide (FP, 788–
806), central helix (CH, 987–1034), connecting domain (CD, 1080–1135), heptad repeat 2 (HR2, 1163–1210) 
domain, transmembrane domain (TM, 1214–1234), and cytoplasmic tail (CT, 1235–1273). Representative icons 
for N-glycans (blue and green) and O-glycan (yellow) are also depicted according to their position in the sequence. 
(B) Assembly of the head, stalk, and CT domains into the full-length model of the S protein (Open system). (C) 
Fully glycosylated and palmitoylated model of the S protein in the (Open system). (D) Magnified view of S protein 
head glycosylation, where glycans are depicted using the Symbol Nomenclature for Glycans (SNFG). ( E) 
Magnified view of S protein stalk glycosylation. (F) Magnified view of S protein S-palmitoylation within CT. 
Image from Casalino et al7. 
 
Each topological domain can be further subdivided based on function, see Figure 6.1.B, with the 
majority of pre-fusion mechanistic tasks being performed by the protein head subdomain. The most 
important domains in terms of mechanistic roles in the S protein head are the receptor binding domain 
(RBD), shown in cyan in Figure 6.1.B , responsible for making initial contact with the host cell-bound 
receptor and the fusion peptide (FP), shown yellow in Figure 6.1.B , which penetrates and primes the 
host cell membrane for fusion8. The S protein is also heavily glycosylated, see Figure 6.1.C, with 22 
N-glycosylation sequons per chain9,10. Carrying a thick glycan shield is part of a common strategy used 
by viruses to evade the host immune system by means of “shielding” and “mimicry”11.  Glycan shielding 
by viral glycoproteins uses the coverage of densely glycosylated proteins to mask immunogenic 
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epitopes,  while also hijacking  host cell machinery to glycosylate their proteins, a strategy called glycan 
mimicry, that creates a “wolf in sheep’s clothing” effect11. Glycomics data analysis recently revealed 
that coronaviruses envelope proteins are less shielded than other viral glycoproteins, such as HIV-1 
Env, which results in a lower level of underprocessed oligomannose N-glycans and a higher level of 
complex N-glycans12. Moreover, our work has highlighted that uniquely to the SARS-CoV-2, specific 
N-glycans on the S protein mediate its mechanism of action, and therefore its method of infection7. As 
it will be explained further below in this section, the specific type of glycosylation at N234, N165 and 
N343 is crucial towards the RBD’s relative orientation and thus to the S protein activity.  
Conservation of the architecture of the S protein varies between members of the Coronavidae family 
and therefore a wide variety of host cell receptors are targeted. Although belonging to the same -genus 
as SARS-CoV-2, MERS has a different RBM structure, which recognises dipeptidyl peptidase 4 
(DPP4)13. SARS-CoV and SARS-CoV-2 however have a 76% sequence identity10, both targeting 
angiotensin-converting enzyme 2 (ACE2)14,15. Between SARS-CoV and SARS-CoV-2, 18 of 22 N-
glycosylation sites per chain are conserved, which suggests that the degree of shielding of the 
immunogenic epitopes is similar12. In terms of sequence mutations, which includes the addition/deletion 
of glycosylation sites, most of the changes are observed in and around the S1 subunit and especially in 
the RBD. To this end, the binding affinity of ACE2 by the RBD of SARS-CoV-2 has been reported to 
be 10- to 20- fold higher than that of the RBD of SARS-CoV16, which correlates to a higher rate of 
infectivity and transmissibility with SARS-CoV-217. In order to understand this higher binding affinity 
of the RBD of SARS-CoV-2, the role that both the surrounding protein and glycans play in the 
mechanics and interactions of the RBD needs to be considered.  
The S protein head undergoes a complex conformational change, from a “closed” (or “down”) state to 
an “open” (or “up”) state of the RBDs10, see Figure S.1 in Appendix IV. Only when the RBD is in as 
open conformation the receptor binding motif (RBM) can bind the ACE2 receptor in a one-to-one 
interaction achieved through protein-protein and protein-carbohydrate interactions18. The ACE2-RBD 
binding triggers the concerted actions of S2 rearrangement and S2’ site cleavage by host cell proteases19. 
Uniquely for its lineage, SARS-CoV-2 has a RRAR cleavage site between subunits S1 and S2 specific 
to furin20, which further promotes the dissociation of S1 and S2 domains, which precedes membrane 
fusion21. After membrane fusion, the virion is internalised through endocytosis and the viral mRNA 
genome is released into the cytoplasm. The host cell ribosome reads and translates the RNA into viral 
proteins, including the S protein, which is transported through the endoplasmic reticulum (ER) and the 
Golgi in order to be glycosylated, further assembled and incorporated into the budding virions 22. 
 
Obtaining atomistic structural data on the full “prefusion” S glycoprotein was achieved through 
mutations at residues 986 and 987 which stabilize S in its prefusion trimeric form23, named SARS-CoV-
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2 S-2P variant. This allowed for easier expression and for characterization of the native-like structure 
by cryogenic electron microscopy (cryo-EM)16. Structural studies have revealed both the open and 
closed conformations10,16 and glycosylation sites of the recombinant S protein bearing one or even two 
GlcNAc residues, which can help indicate the orientation of the whole N-glycans relative to the protein 
surface. This paired with glycomics data obtained on the HEK cells recombinant S-2P protein9has given 
us insight into the potential glycosylation pattern of a fully assembled prefusion trimer. Results from 
Wantanabe et al.9 are summarised in Table 6.1 in terms of relative oligomannose abundance. The same 
work indicates that an overall 22% of glycans are of the oligomannose-type, 5% of the hybrid-type and 
66% of the complex-type, with 1% of the sites unoccupied. Since the beginning of 2020, different 
glycosylation profiles have been published24–26 showing broader ranges of glycosylation types for each 
site. These differences have been attributed to whether the recombinant structure was analysed as an 
intact ectodomain or as separate S1 and S2 subunits, or based on a different interpretation of 
glycopeptide fragmentation software data following mass spectrometry (MS).  
Table 6.1. Percentage abundance of oligomannose-type N-glycans at each identified N-glycosylation site of the S protein. 









N17 4 N616 6 
N61 69 N657 0 
N74 4 N709 94 
N122 56 N717 74 
N149 8 N801 77 
N165 0 N1074 57 
N234 97 N1098 9 
N282 1 N1134 0 
N331 2 N1158 0 
N343 2 N1173 1 
N603 65 N1194 0 
 
In collaboration with Prof Rommie Amaro’s group at UCSD, we set out to explore the glycans coverage 
of the S protein surface and and the specific interactions between glycan and protein with both the open 
and closed conformations of the RBD, using all-atoms molecular dynamics (MD) simulations on both, 
a model of the whole S protein embedded in the viral membrane and on its ectodomain alone. In this 
work we explored the effect of different glycosylation patterns on multiple uncorrelated copies of the 
simulations run concurrently to explore a wider section of the conformational space. We also considered 
the effects of the use of different force fields, namely GLYCAM06j and CHARMM36 and of starting 
cyro-EM structures, namely PDBid 6VYB and 6VSB for the open conformation of the RBD. Our 
simulations reveal a greater role of specific S1 N-glycans in stabilization of the RBD, as well as 
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modulating the transition between open and closed states. Following these results, we focused our 
efforts in assessing the importance of the glycosylation type at N234 and in neighbouring sites on the 
dynamics of the open conformation of the RBD. 
 
6.2 Computational Method 
 
The next subsections detail the setup and running specifications for our MD simulations of the SARS-
CoV-2 S protein model, with our collaborative work with Prof. Amaro’s group described, followed by 
the details of our continued simulation of the ectodomain of the S protein, with specific glycan variation 
at N234. 
Initial Simulation Set 
The full-length S glycoprotein model, shown in Figure 6.1.B, was built in Prof Rommie Amaro’s lab 
under the guidance obtained from data we collected on preliminary simulations of the S ectodomain. 
The full model was built by homology in both, “open” (PDB 6VSB16) and “closed” (PDB 6VXX10) 
conformational states, see Figure S1 in Appendix IV and Section 1.1 of Appendix IV. The protein 
models were glycosylated at N-/O-glycosylation sites9,24 and the cysteines in the CT, see panel F in 
Figure.6.1, were palmitoylated27,28. Finally, the full length structures were embedded into a pre-
equilibrated all-atom membrane, in order to mimic the endoplasmic reticulum-Golgi intermediate 
compartment, see Table S4 in Appendix IV, where the spike is glycosylated and the virus buds. 
Following this, the system was solvated in an atmosphere of counterions. Six replicas of the open 
conformation models and three of the closed conformation models were run on the NSF Frontera 
computing system at the Texas Advanced Computing Center (TACC) with NAMD 2.14,34 achieving 
benchmarks of ~60 ns/day on 256 nodes for cumulative extensive sampling of ~4.2 and ~1.7 µs, 
respectively, see Figure S5, Movie S1 in Appendix IV. A greater number of replicas of the open 
conformation systems were run to understand the “meta-stable” state of the open RBD that was captured 
by the cryo-EM experiments 
 
In our group, we rebuilt the SARS-CoV-2 S protein ectodomain in the open conformation by homology 
modelling with SWISS MODEL29 using the cryo-EM structure with PDB ID 6VYB10 (3.2 Å resolution) 
and NCBI YP_009724390.1 as reference sequence. The missing loops in the 6VYB cryo-EM structure 
were built automatically by SWISS MODEL based on structural libraries of backbone fragments from 
the PDB with similar sequences. The resulting protein structure exhibits 18 N-glycosylation sites (or 
sequons) per protomer, for a total of 54 sites per trimer. Glycosylation on these sites was built by 
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sstructural alignment of conformationally equilibrated N-glycan structures from our GlycoShape library 
(under construction), more specifically fucosylated and non-fucosylated biantennary (FA2B/A2B) N-
glycans  and oligomannose type (Man5 and Man9)30 to the GlcNAc residues resolved in the cryo-EM 
structure. Selection of the type of glycan at each specific N-glycosylation site was decided based on the 
glycosylation profile in Wantanable et al.9, shown in Table 6.1, which was the only  data set available 
at the time we started the work (March 2020). The variation of glycosylation predicted at in some of 
the sites was broad. Based on our knowledge of glycan sequence-to-structure relationship and 
dynamics, we decided to include, whenever likely, more processed glycans, e.g. with galactosylation 
on the both arms and  core-fucosylation, to investigate possible interactions with the protein. 
Some of the glycosylation sites reside in disordered loops that needed to be reconstructed, therefore  the 
final 54-glycans model was built in two phases. In the first phase we built models with 46 glycosylation 
sites and run a 20 ns equilibration to obtain conformations of the rebuilt loops that allowed for the 
linking of our pre-equilibrated glycan structures. Appropriate loop conformations were then chosen to 
link the glycans on those sites to complete the glycosylation profile.  In this additional set of simulations 
of the SARS-CoV-2 S protein ectodomains, we considered three slightly different glycosylation 
profiles, shown in Table 6.2, to complement results obtained for the full S model. These three models 
differed specifically at position N234, occupied either by a Man9 (Man9-N234) or where N234 is 
mutated into Ala (N234A) leading to glycan deletion, or where the sequon at N234 is not mutated but 
not glycosylated. We ran two independent trajectories for the 46-glycans model (i.e., Man9-N234) and 
one for the related N234A mutant. Moreover, we performed one run each for the 54-glycans models, 
i.e., Man9-N234, the N234A mutant, and the 53-glycan model (non-glycosylated at N234) for a total 
of 6 independent MD runs, see Table 6.3. Notably, also the glycosylation we chose at N165 and N343 
differs from the one we selected for the full model of the spike to explore different profile. Also to note, 
the N165 and N234 sites in the ectodomain models are located in the NTD of chain C (NTD-C), while 




Table 6.2. Site specific glycosylation in the two 54-glycans models of SARS-CoV2 S head (~60,000 atoms), i.e. Man9-N234 
and N234A. The asterisk on position 234 chain C indicates the critical region where the glycans support the open RBD (chain 
B in 6VYB) by filling the empty space. We note that the third model is based on these 54-glycans models, but it was not 
glycosylated at position N234 within chain C. 
Chain Resid Glycan Chain Resid Glycan Chain Resid Glycan 
A 61 Man5 B 61 Man5 C 61 Man5 
A 74 FA2G B 74 FA2G C 74 FA2G 
A 122 Man5 B 122 Man5 C 122 Man5 
A 149 FA2G B 149 FA2G C 149 FA2G 
A 165 Man5 B 165 Man5 C 165 Man5 
A 234 Man9 B 234 Man9 C 234* Man9/ 
N234A 
A 282 FA2G B 282 FA2G C 282 FA2G 
A 331 FA2G B 331 FA2G C 331 Man5 
A 343 Man5 B 343 Man5 C 343 Man5 
A 603 Man5 B 603 Man5 C 603 Man5 
A 616 A2G B 616 A2G C 616 A2G 
A 657 Man5 B 657 Man5 C 657 FA2G 
A 709 Man5 B 709 Man5 C 709 Man5 
A 717 Man5 B 717 Man5 C 717 Man5 
A 801 Man5 B 801 Man5 C 801 Man5 
A 1074 Man5 B 1074 Man5 C 1074 Man5 
A 1098 A2G B 1098 A2G C 1098 A2G 
A 1134 FA2G B 1134 FA2G C 1134 FA2G 
 
In the simulations of the S ectodomain models based on PDB 6VYB, the protein and counterions (200 
mM) were represented by the AMBER ff14SB parameter set31, whereas the glycans by the 
GLYCAM06j-1 version of the GLYCAM06 force field32. Water molecules were represented by the 
TIP3P model33. All simulations were run with v18 of the AMBER software package34. The same system 
preparation and running protocol was used for all MD simulations.  
The energy of the S ectodomains models was minimized in two steps of 50,000 cycles of the steepest 
descent algorithm each. During the first minimization all the heavy atoms were kept harmonically 
restrained using a potential weight of 5 kcal mol−1Å2, while the solvent, counterions and hydrogen 
atoms were left unrestrained. During the second minimization step, only the protein heavy atoms were 
kept restrained, while the glycans, solvent, counterions and hydrogens were left unrestrained. After 
energy minimization the system was equilibrated in the NVT ensemble with the same restraints scheme, 
where heating was performed in two stages over a total time of 1 ns, from 0 to 100 K (stage 1) and then 
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100 to 300 K (stage 2). During equilibration the SHAKE algorithm was used to constrain all bonds to 
hydrogen atoms. The Van der Waals were truncated at 11 Å and Particle Mesh Ewald (PME) was used 
to treat long range electrostatics with B-spline interpolation of order 4. Langevin dynamics with 
collision frequency of 1.0 ps-1 was used to control temperature, which a pseudo-random variable seed 
to ensure there are no synchronization artefacts. Once the system was brought to 300 K an equilibration 
phase in the NPT ensemble of 1 ns was used to set the pressure to 1 atm. The pressure was held constant 
with isotropic pressure scaling and a pressure relaxation time of 2.0 ps. At this point all restraints on 
the protein heavy atoms were removed, allowing the system to evolve for 15 ns of conformational 
equilibration before production. The total simulation times, including equilibration, are shown in Table 
6.3.  
Table 6.3. MD production times (ns) used for the data analysis of the SARS-CoV2 S glycoprotein 
ectodomain (60,000 atoms). MD1 and MD2 refer to two independent MD trajectories started from 
different velocities. 
Systems 46 glycan MD1 46 glycan MD2 54 glycan 
Man9-N234 210 - 120 
N234A 240 240 390 
N234-nogly - - 420 
 
Construction of the second set of S protein ectodomain models  
The first set of simulations7highlighted the crucial role of the  N-glycan  at N234 in filling the void left 
vacant by the opening of the RBD, therefore as a second stage of the work we wanted to explore if any 
type of glycosylation would have been capable to fulfil this role.  An additional three models of the S 
ectodomain with 54-glycans. Since the completion of our first phase of simulation, more glycoanalytic 
studies were performed24–26, and we could make a more informed decision on our choice of 
glycosylation at each N-glycan site, as well as inclusion of O-glycans, based on Shajahan et al.24, with 
an O-glycan included at T323. In these models we changed the level of processing of the oligomannose 
glycan at N234 to understand what specific features of the oligomannose N-glycan is required (if any) 
to stabilize the RBD in the open conformation. Inclusion of paucimannose (Man3) as one of the 
variations has not been observed at N234 in any glycan profiling, but we chose to include iyt as it allows 
us to understand the basic function of an N-glycan at this glycosylation site and to rationalize the 
additive features of the antennae of the more elaborate oligomannose forms. The same glycosylation 
profile was used for each protomer, in order to directly compare behaviour of the N-glycans, with 
regards to the closed and open conformations of the RBD on each model. The change in glycosylation 





Table 6.4. Details of changes of glycosylation type at each available glycosylation site of the SARS-CoV-2 S protein head, 
applicable to all three chains of the trimer. The asterisk denotes the difference in glycosylation at site N234 for the previous 
models. The empty spaces indicate no change in glycosylation from the previous models. The dagger indicates the glycan type 
for N165 and N343 for Chains A and C in the previous models.  
PDB Previous Models Model 1 Model 2 Model 3 





165 Man5† FA2G2 FA2G2 FA2G2 
234 Man9* Man5 Man3 Man9 
282 FA2G2 
T323 unoccupied O-glycan O-glycan O-glycan 
331 FA2G2 
343 Man5† FA2G2 FA2G2 FA2G2 
603 Man5 
616 A2G2 








This second set of spike ectodomain models were set-up and studied by MD simulations following a 
same protocol  described earlier. The total simulation time for each replica produced to this day is shown 
in Table 6.5, including equilibration times. 
Table 6.5. MD simulations length (s) of the second set of SARS-CoV2 S protein ectodomain models.  
Systems Simulation Time (s) 
Model 1 Replica 1 (Man5 R1) 2.01 
Model 1 Replica 2 (Man5 R2) 2.01 
Model 2 Replica 1 (Man3 R1) 1.95 
Model 2 Replica 2 (Man3 R2) 1.89 






Initial MD Simulations of the SARS-CoV-2 S Protein Models in Open and Closed Conformations  
The overall structural stability of the full S protein models was monitored using root-mean-square-
deviation (RMSD) values relative to the starting structures, with convergence of the head and stalk 
domains reached within 400 ns, see Figure S2 and S3 in Appendix IV. The CT domain however 
fluctuates in RMSD values between replicas, see Figure S3 in Appendix IV, with large deviations due 
to the section that is exposed to the solvent and not anchored within the lipid bilayer. Root-mean-square-
fluctuation (RMSF) analysis performed on the glycans, see Figure S4 in Appendix IV, revealed the 
more branched, complex N-glycans had the most mobility on average, with the O-glycans at T323 and 
S325 showing the least flexibility, which may be accounted for due to their short size. The tetra-
antennary complex N-glycans located on the stalk domain had the highest fluctuations, suggesting its 
ability to shield the protein surface.  
Based on both variations of the SARS-CoV-2 ectodomain, conducted by the Fadda and Amaro groups, 
the N-glycans at N165 and N234 were identified as potentially crucial components in mediation of the 
RBD dynamics. The closed conformation replicate models reflect the results of glyoanalytic data9 that 
suggest that the N-glycan at N234 is solvent exposed, orientated away from the core of the S protein 
(Figure 6.3). In both variations of the open conformation models, Man9 at N234 is buried within the 
cleft left by the RBD in the open structure (Figure 6.3.B). Note, in the two different cryo-EM starting 
structures 6VSB and 6VYB, the open RBDs are named differently, i.e. RBD-A in the full S protein 
open structure, and RBD-B in the ectodomain open structure, respectively. Interestingly, because of the 
different orientation of the N-glycan fragments resolved by cryo-EM at N234, the positions of the whole 
N-glycans during the MD simulations are different (see Figure 6.2), as a result of the rigidity of the the 
chitobiose N-glycan core, although they converge to the same final orientation in the core of the trimer 




Figure 6.2. Alignment of 6VSB and 6VYB open chains. The glycan fragment at N234 from 6VYB (yellow) and from 6VSB 
(green) are close in Cartesian space, but the hydroxyl group (O4) of the GlcNAc monosaccharide (blue spheres) are pointed 
in different directions, which will orientate the superimposed Man9 residues in different starting positions. 
More specifically, the simulations of the full S protein models started with the Man9 at N234 inserted 
into the cleft, while the simulation of the S ectodomains had the Man9 exposed to the solvent in a similar 
position as the one found in the closed conformation. Interestingly, in the simulations of the ectodomain 
while the system equilibrated, we observed the Man9 progressively moving inwards to fill the void 
space left vacant by the RBD opening. This progressive “crawling” takes place through the Man9 
forming interactions with the opposing RBD-C residues, and then subsequently forming interactions 
with protein residues within the core of the spike structure (Movie S.2 in Appendix IV).  The N-glycan 
at N165 in the simulations of the open conformation is found interacting with the RBD-B either above 




Figure 6.3. N234A and N165A mutations show increased instability of RBD-A in the “up” state. (A-B) Top view of the 
S protein as in the closed (A) and open (B) systems. Protein is represented with cartoons, coloured in cyan, red, and grey for 
chains A, B and C, respectively. O-mannose N-glycans at position N234 are depicted with VdW spheres, where GlcNAc is 
colored in blue and Man in green. In closed (A), all the N-glycans at N234 are tangential to a hypothetical circle going through 
N234. In open (B), the N-glycan at N234 of chain B moves inward, filling in the vacancy under RBD-A in the “up” 
conformation. (C) Side view of the S protein (surface representation) in open, where the RBD of chain A (RBD-A, cyan) is 
stabilized by N-glycans at N165 and N234 in the “up” conformation. Same color scheme as panels A and B is applied. (D) 
PCA plot showing PC1 vs. PC2 of RBD-A (residues 330–530) in closed, open, and mutant in blue, teal, and magenta, 
respectively. The amount (%) of variance accounted by each PC is shown between parenthesis.  
 
In order to understand the significance of these two glycosylation sites with regards to the RBD 
dynamics, a set of “mutant” models was produced, by mutating N234A and N165A from the open 
conformation starting structure. Principal Component Analysis (PCA) was used to compare the 
conformational landscape of the open, closed and mutant models, with scatter plot projections generated 
from the first two eigenvectors, the motions with the two largest variances of 63% and 18% (see Panel 
D in Figure 6.D). This plot shows the mutant systems explore a greater conformational space than that 
of the open or closed conformational systems. This suggests a loss in stability from the absence of the 
N-glycans at N234 and N165, which suggests that these glycans play an essential role in the structural 
integrity of the open and closed conformations. The importance of the N-glycan at N234 can also be 
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observed in a much subtler single-point mutation N234A in the additional set of simulations of the S 
ectodomain (see section 2.2 of Appendix IV).  
The two most prevalent motions identified by PCA were furthered monitored using angle calculations 
(details of method in section 1.1 in Appendix IV). The first motion identified (PC1) was the in-plane 
motion of the RBD along the arc of a hypothetical circle centred on the central helices of the S protein, 
labelled the “lateral angle” (Figure 6.4.A). The second (PC2) was the RBD tilting motion away from 
or towards the central axis of the central helices, called the “axial angle” (Figure 6.4.B). 
 
Figure 6.4. RBD-A lateral and axial angle fluctuations. (A, B) RBD-A lateral angle (A) and axial angle (B), where chains  
A, B, and C of the spike are represented as ribbons coloured in cyan, red, and grey, respectively. Positive and negative 
variations with respect to the initial frame (0) are indicated with the “+” and “−” symbols, respectively. (C, D) Distributions 
of RBD-A lateral angle (C) and axial angle (D) fluctuations with respect to the initial frame in closed (blue), open (teal), and 
mutant (magenta). Angle variations were calculated with respect to their value at frame 0. Frequencies have been normalized 
within the respective data sets. 
 
The RBD lateral angle distributions of the open, closed and mutant systems are shown in panel 
C of Figure 6.4. The populations of both the open and mutant distributions agree with the PCA 
plot, suggesting that the inclusion of N234 and N165 glycans plays a role in stabilising the 
open conformation of the RBD. The axial-angle analysis (Figure 6.4.D) reveals a more 
negative trend in the mutant systems than in the open systems, indicating that the RBD without 
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the support of N165 or N234 tends to move closer to the centre of the spike, similar to the 
closed systems’ distribution. In order for the RBM to be accessible to the ACE2 receptor, the 
RBD must occupy a metastable state that is orientated away from the central axis and exposed 
to the solvent and our data suggest that the N-glycans at N165 and N234 do help facilitate. 
Hydrogen bonding analysis was performed to gain further insight on the interactions between 
the glycans at N234 and N165, and the protein residues. In the open conformation systems with 
a glycosylated N234 site, the Man9 glycan occupies a large volume in the void of the structure 
left vacant by the open RBD (Figure 6.5.D). Stable hydrogen bonds were observed between 
the glycan and H519 of the lower RBD, D198 of the NTD and R983, D985 and E988 of the 
central helix in the trimer, all of which were present in over 40% of the 4.2s simula t ion 
(Figure 6.5.A, Movie S.3 in Appendix IV). In particular, we observed that the interaction with 
H519 at the base of the RBD contributed to support the RBD in the “up” or open conformation. 
The glycan at N165 is more solvent exposed than the one at N234, yet it still interacts with the 
RBD and with the RBM, with a range of different hydrogen bonding interactions observed in 






Figure 6.5. Hydrogen bond interactions of N-glycans at N234 and N165. The main hydrogen bond interactions of N-
glycans at N234 (A) and N165 (B) within the Open system are shown as occupancy across all replicas (% frames). (C) A 
snapshot capturing Man9 glycan (licorice representation) at N234 establishing multiple hydrogen bonds with S protein residues 
(licorice representation) belonging to RBD-A (cyan surface), NTD-B (red surface), CH-B (red cartoons), and CH-C (grey 
cartoons). GlcNAc and Man carbons are colored in blue and green, respectively. (D) Molecular representation of Man5 glycan 
at N165 interacting with RBD-A. Multiple (1000) equally interspersed configurations (selected across all replicas) of the 
glycan at N165 are simultaneously shown. The glycan is represented as coloured liquorices (GlcNAc in blue, Man in green), 
whereas RBD-A and NTD-B are represented as cyan and red surfaces, respectively. 
 
Confirmation of the importance of N234 and N165 glycans by Biolayer Interferometry 
In conjunction with our computational work, Prof Jason McLellan’s lab (University of Texas at Austin) 
performed biolayer interferometry to measure the binding affinity of mutant S proteins to ACE2 
proposed based on our simulations, to quantify experimentally the role of the N-glycans at N234 and 
N165 play in mediating the open and closed states of the RBD. Prof McLellan and his team expressed 
two mutants, namely  N234A and  N165A. The binding responses obtained for N165A and N234A are 
shown in Figure 6.6. Results indicate that ACE2 binding is reduced in both cases relative to the native-
like S-2P variant, with N165A being 10% less effective, and N234A being 40% less effective (p=0.0051 
and p=0.0002 respectively, Student’s T-test). A negative control spike was engineered with mutations 
of S383C and D985C to “lock” all three RBDs into closed conformations. The negative control spike 
































































































Figure 6.6. N234A and N165A mutations reduce RBD binding to ACE2. (A) Biolayer interferometry sensorgrams showing 
binding of ACE2 to spike variants. (B) Binding responses for biolayer interferometry measurements of ACE2 binding to spike 
variants. Data are shown as mean ± S.D. from 3 independent experiments. Asterisks represent statistical significance (Student ’s 
t test; *0.01<p<0.05, **0.001>p>0.01, ***0.0001<p<0.001). 
 
Analysis of the glycan shield in the full-length SARS-CoV-2 S Protein 
The potential shielding of the protein by the selected glycoprofile was calculated from the S protein’s 
accessible surface area (ASA) in the open conformation, with probe radii ranging from 1.4 to 15Å, to 
understand the accessibility with regards to differential molecule size, corresponding to a water 
molecule to up to the approximate size of an antibody. In panel A of Figure 6.7, the 3D conformational 
space of each glycan is rendered using 300 superimposed snapshots from the MD trajectory, 
representing the dynamics each glycan undergoes within 1s of simulation and mimic the numbers of 
conformations a glycan could adopt during antibody/S protein binding. The ASA analysis indicates the 
head of the protein is less shielded than the stalk (Figure 6.7, panels B and C). The glycosylation of 
the stalk is highly efficient at shielding the protein for the larger values of the probe radius range, with 
coverage of 90% for antibody-sized molecules, but the shield becomes far less effective when the radius 
is decreased to the lower end of the scale (1.4-3Å).  In comparison, the head of the protein is equally as 
shielded to the stalk (20% to 26% respectively) from the smallest sized probe (water molecules), but is 
far more vulnerable, with only 62% of the surface camouflaged from the larger sized molecules. ASA 





Figure 6.7. Glycan shield of the SARS -CoV-2 S  protein. (A) Molecular representation of the Open system. Glycans at 
several frames (namely, 300 frames, one every 30 ns from one replica) are represented with blue lines, whereas the protein is  
shown with cartoons and highlighted with a cyan transparent surface. Color code used for lipid tails (licorice representation): 
POPC (pink), POPE (purple), POPI (orange), POPS (red), cholesterol (yellow). P atoms of the lipid heads are shown with 
green spheres. Cholesterol’s O3 atoms are shown with yellow spheres. (B, C) Accessible surface area of the head (B) and stalk 
(C) and the area shielded by glycans at multiple probe radii from 1.4 (water molecule) to 15 Å (antibody -sized molecule). The 
values have been calculated and averaged across all replicas of Open and are reported with standard deviation. The area 
shielded by the glycans is presented in blue (rounded % values are reported), whereas the grey line represents the accessible  
area of the protein in the absence of glycans. Highlighted in cyan is the area that remains accessible in the presence of glycans, 
which is also graphically depicted on the structure in the panels located above the plots. 
 
We explored more extensively the glycan coverage around the RBM (residues 400 to 508), in both open 
and closed systems, using varying probe radii with ASA analysis.  In the closed system simulations, the 
coverage of the RBM is moderate for molecules larger than 3Å; averaging 35% coverage across the 
range of probe radius sizes (Figure 6.8.A). In the open system however, the glycan coverage remains 
sparse, averaging to only 9% (Figure 6.8.D). Full data for this analysis can be viewed in Tables S8-
S10 in Appendix IV. For the smaller probe radii (1.4-3Å), the glycan shielding is equally ineffective 
in both systems. The section of the RBD not involved with ACE2 interaction is shielded in both systems 
(Figure S.7 in Appendix IV). This is due to the presence of the N-glycans of the RBD at N331 and 
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N343, and also owing to the N-glycans of the NTD N165 and N234, that we previously described 
interacting with the RBD (Figure S.8 in Appendix IV).   
 
 
Figure 6.8. Glycan shield of the RBD ACE2-interacting region. The accessible surface area of the RBM -A and the area 
shielded by neighboring glycans in the Closed (A) and Open (D) systems are plotted at multiple probe radii from 1.4 (water 
molecule) to 15 Å. The values have been averaged across replicas and are reported with standard deviation. In blue is the area 
of the RBM-A covered by the glycans (rounded % values are reported), whereas the gray line is the accessible area in the 
absence of glycans. Highlighted in cyan is the RBM -A area that remains accessible in the presence of glycans, which is also 
graphically depicted on the structure in the panels located below the plots. (B-F) Molecular representation of Closed and Open 
systems from top (B and E, respectively) and side (C and F, respectively) views. Glycans (blue lines) are represented at several 
frames equally interspersed along the trajectories (300 frames along 0.55 ns for Closed and 1.0 μs for Open), while the protein 
is shown with colored cartoons and transparent surface (cyan, red and gray for chains A, B and C, respectively). Importantly, 






Further simulation of SARS-CoV-2 ectodomain with varying glycosylation at N234 
To determine the impact of the type of glycosylation at N234 in the stability of the open conformation, 
we ran set of five uncorrelated conventional MD trajectories of the S ectodomain. Data from the 
simulations were collected after 300 ns of conformational equilibration. This rather long time interval 
was deemed necessary to allow the system to adjust to the presence of smaller glycans at N234, such 
as Man5 and Man3, which are not characteristic of the stable S-2P prefusion trimer. Conformational 
equilibration was estimated in terms of RMSD values of the protein backbone with the cryo-EM 
structure used as as reference. Lateral angle and axial angle calculations were performed using the same 
method reported above for the first set of simulations. The resultant distributions of the lateral and angle 
calculations over the equilibrated period of the simulations can be seen in Figure 6.9. In comparison to 
the open, closed and mutant systems of the initial set, the overall differences between distributions is 
subtler. The Man9 model used for comparison to the HEK trimer open system distributions (Figure 
6.4, panels C and D). The smaller range of motions measured can be attributed to an averaging over 
six replicas for the open system in the previous work7versus the single replica of the Man9 model used 
here. For the two replicas R1 and R2 of Man5 (panels A and B, Figure 6.9), their distributions have 
the same frequency and range of motion, with Man5 R2 deviating more dramatically from its starting 
conformation. This deviations suggests that a different conformational space was explored, even with 
the same glycosylation pattern, and this depends on the different interactions formed by the Man5 at 
N234, and by the N165 and N343 complex N-glycans. The two replicas, R1 and R2, of the Man3 models 
have slightly different distributions (panels C and D, Figure 6.9). The lateral and axial motions of R2 
of Man3 are more similar to the Man9 model than to the Man3 R1, which suggests a more stabilised 




Figure 6.9. RBD-B lateral and axial angle fluctuations. Panels A and B represent the lateral and angle calculations for 
replicas R1 (blue) and R2 (cyan) of the model with Man5 at N234. Panels C and D show the replicas R1 (red) and R2 
(orange) of the model with Man3 at N234. The distributions from the Man9 model are included in each graph (green), for 
reference, as it displays the most stabilised distributions amongst the five separate simulations. Positive and negative 
variations with respect to the initial frame (0) are indicated with the “+” and “−” symbols, respectively. 
We examined the interactions of N234 in each system through hydrogen bonding analysis to gain more 
insight on the difference in RBD motions between replicas. For the Man9 model, an intricate hydrogen 
bonding network is formed between the Man9 and the biantennary complex N-glycans at N165 and 
N343, which has a stabilising effect on the RBD (see panels A and B in Figure 6.10). A similar 
hydrogen bonding network is observed in Man3 R1, which explains the results obtained in the analysis 
of the lateral and axial angle distributions. While Man3 is substantially smaller than Man9 and so cannot 
occupy the void created by the open conformation of the RBD, our simulations show that it is indeed 
long enough to form a stable interaction with the RBD-C at residue N370. This interaction is present 
for 49% of the production length. Man3 is also found to interact with the glycan at N343. In summary, 
in both simulations of Man5 and Man3 at N234, a complex hydrogen bonding network involving the 
glycans at N343 and N234, coupled with the glycan at N165 interacting with either N234 and N343 
glycans and with the RBD residues produces a stabilising effect similar to what seen previously with 
Man9 at N234. Furthernore, the diversity of the RBD orientation sampled in presence of these glycans 
at N234 suggest a higher dynamics of the RBD that can occupy an ensemble of metastable states 
between the open and closed conformations identified with a very large oligomannose such as Man9, 
characteristic of the highly stable S-2P prefusion trimer. Relative populations of these states are 
modulated by carbohydrate-carbohydrate and carbohydrate-protein interactions and therefore depend 




Figure 6.10. Interactions of N165, N234 and N343 glycans. Representative snapshots of the N-glycans at N165 (yellow), 
N343 (orange) and N234 (green) interacting with the RBD-B (cyan), or the NTD-C and RBD-C (red), and/or each other. These 
snapshots capture the more stabilised h-bonding interactions of the terminal glycan of the antennae in each glycan.  
Indeed, in Man5 R1 and Man3 R2, there is no interaction between the three glycans at NN234, N165 
and N343. The Man3 N234 glycan in R1 explores a completely new region, inaccessible to the larger 
mannose structures, where it enters the cleft between the NTD-C and RBD-C, interacting with the top 
of the central helix. With the lack of any direct or indirect support of the RBD from Man3 in this 
trajectory, RBD-B appears to be less ‘anchored’, thus more dynamic. In Man5 R1, the Man9 at N234 
and the complex N-glycan at N165 resume supportive roles to the RBD, propping it up. Unlike Man9, 
Man5 is shorter and it is not able to reach the residues of the trimer’s core helices. Moreover, Man9 
because of its size also forms more stable hydrogen bonds with the NTD-C and with the lower hinge 
section of RBD-B, which helps to prop up the RBD, or somewhat restrict lateral motion in the direction 






Despite the differences in the systems sizes, setups, original cryo-EM structure (6VYB vs. 6VSB), force 
field parameter sets (AMBER vs. CHARMM), MD software packages (Amber vs. NAMD), in the 
running protocols and details in the models’ glycosylation, the two sets of initial simulations performed 
by the Fadda and Amaro group, respectively, converge in describing a very uniform picture of the role 
of the glycan shield in the activation of the SARS-CoV2 S protein. Through PCA, angle and hydrogen 
bonding analysis, and confirmed by the results of the biolayer interferometry experiments, we show 
that the absence of glycosylation at position N234 and at both positions N234 and N165 affects the 
conformational plasticity of the open RBD, allowing it to explore a larger conformational freedom, 
which indicates a degree of instability, supported by its lower degree of binding the ACE2 receptor. 
The equilibrium of the open and closed conformations of the RBD can be affected by relatively small 
modifications, like single point mutations within and around the RBD35, or also by varying pH 
conditions36. Similar to the RBD of the MERS S protein37, the SARS-CoV-2 open conformation is 
metastable within its conformational ensemble. We identified two glycosylation sites, N165 and N234, 
where the glycans can actively interact with the open RBD and “lock” it into an open position. While 
full conformational shift from the open to the closed conformation cannot be observed within this 
timescale, or possibly with conventional MD, we can still investigate the relative stability of the open 
conformation, based on its dependency on the surrounding glycosylation. This reveals a possible 
vulnerability of the SARS-CoV-2 S protein if the open conformation destabilised, thus decreasing its 
ability of binding to the ACE2 receptor. Through biolayer interferometry experiments on both N234A 
and N165A mutations of the S-2P protein, we have seen an agreement with the simulation dynamics, 
that both N-glycans play a role in stabilisation. The results suggest that the presence of N234 may have 
a greater effect on the RBD binding affinity, and therefore RBD stability than N165, which is more 
solvent exposed. The hydrogen bonding analysis however does support the role of the glycan at N165 
as a stalwart support, interacting with the open RBD steadily throughout the simulations.  
Our second set of simulations helped us to assess the importance of the N-glycan architecture at N234. 
With these simulations we were able to identify multiple uncorrelated structures that allow us to sample 
various degrees of stabilisation of the open conformation, determined by the accessible interactions of 
the oligomannose at N234, in combination with N165 and N343 glycosylated with complex N-glycans. 
In the original work7the glycan at N343 was not specifically investigated as a contributing factor in the 
stability of the RBD open conformation as in none of those trajectories it was found to interact with the 
open RBD or with the glycans at N234 and N165. Yet, in our original simulations of the S ectodomain, 
N165 and N343 were glycosylated with Man5 N-glycans, and thus their “reach”, in terms of the length 
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of their antennae/arms, was limited. In in our second set of simulations, we clearly see the role of N343 
is more crucial, as it appears to contribute to a more intricate hydrogen bonding network with N165 and 
N234, that stabilises the open RBD more effectively. In all replicas of this second set of S protein  
dynamics, N165 is always in contact with the RBD, reinforcing the idea that N165 is essential for the 
mediation of a stabilised open RBD. As for N234, the Man3 variants suggest that N-glycosylation of 
any kind at N234 is fundamental, as the difference in the mutant systems behaviour versus the Man3 
models is stark. While Man3 may not be able to stabilise the RBD as effectively as Man5 or Man9 can 
in this position, so long as it can form an interaction with the opposing RBD, bridging the opening of 
the void left by the open RBD, it can still form stabilising interactions, ssuggesting that any glycan at 
N234 is better than no glycan, provided that the positions at N165 and N343 are fully glycosylaeted. 
Interestingly, every oligomannose type substituted at N234 is capable of forming an interaction with 
N370 of the opposite RBD-C. An important mutation found in SARS-CoV-2 S relative to the SARS-
CoV S causes the loss of glycosylation at N370, part of a sequon in SARS-CoV, which suggests that a 
glycan at that location may interfere with the stabilisation abilities of the N234 glycan, potentially 
making SARS-CoV S protein less stable in the open conformation than SARS-CoV-2. Further 
investigation into the behaviour and possible function of the occupied N370 glycosylation site is 
currently ongoing in our group.  
 
The SARS-CoV-2 unique and extensive glycosylation pattern may be a strength and a weakness for the 
virus, as we propose that the glycan coverage not only can shield immunogenic epitopes, but plays a 
functional role in the mechanics of RBD opening and closing, which can be targeted and utilised for 
vaccine design27,38,39. Considering our analysis of the ASA of the S protein, the RBM and RBD are 
obvious candidates for targeting, as the RBM is concealed and well camouflaged in the closed 
conformation, but is exposed in the open conformation. This agrees with structural data that reports the 
open conformation of the RBD is a requirement40 for neutralization by host antibodies. Several 
antibodies targeting the S protein have been identified (see Table S11 in Appendix IV38,41–50). The 
RBD is the major target amongst these antibodies, with few selecting other antigenic regions in the 
NTD or CD (Figure S9 in Appendix IV). The S protein dynamics can be manipulated through 
introducing mutations to destabilise the open RBD conformation (N234A and N165A) or changes in 
glycosylation at N234, N165 or N343, reducing the binding affinity of the RBDs, but leaving the RBM 








Through this collaborative work with the Amaro group at UCSD and Mc Lellan group at UTexas based 
on extensive atomistic MD simulation of different models of the SARS-CoV-2 S protein supported by 
biolayer interferometry experiments, we were able to describe a new and unique role of the viral glycan 
shield. Indeed, we showed how the time-averaged glycan shield hides a vast amount of the S protein 
surface area from recognition by the immune system and how this shielding effects varies depending 
on the protein’s conformational state, i.e. between open and closed states.Additionally, the glycans 
around the RBD-, namely at positions N234, N165, and N343 interact directly (through glycan-protein 
interactions) or indirectly (through glycan-glycan interactions) with the open RBD, modulating its 
dynamics  and stability in the open conformation. The mutant variations (N234A and N165A) reveal 
the dependency the open conformation has on these glycans, demonstrated by and the markedly reduced 
binding affinity to ACE2 without them. With this knowledge, there is potential for taking advantage of 
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Chapter 7: Conclusions 
 
In my PhD research presented in this thesis, I explored the sequence-to-structure-to-function 
relationships in complex N-glycans, by means of HPC molecular simulations by molecular dynamics. 
Within this framework, all-atom simulations can be considered loosely as a form of computational 
microscopy, where we can observe the structural evolution of biomolecules at the molecular scale. 
Using conventional and enhanced sampling schemes, I provided the necessary atomistic level of detail 
to define how sequence and branching determines the 3D structural propensity of a given N-glycan. 
In Chapter 3, starting from the smallest disaccharide motif that occurs in every N-glycan, i.e. the core 
GlcNac-b4-GlcNAc chitobiose, I was able to build and analyse progressively larger complex N-glycans 
and to determine the role each specific monosaccharide-linkage addition has in affecting the overall 
structure. To achieve this goal, I performed virtually exhaustive sampling experiments, considering all 
possible rotamers for each unique glycan sequence in separately run simulations. This extensive 
sampling scheme revealed that N-glycans occupy distinct conformations of varying population at room 
temperature. This result debunks the idea that N-glycans are unstructured, and allows us to extract the 
most populated conformations from the “blur” of the conformational ensembles observed at 
experimental timescales, such as high microsecond to milliseconds for NMR and much higher for X-
ray crystallography data collection.  
The significance of the N-glycan sequence-to-structure relationship was further explored in Chapter 4, 
where I described the effects of modifications of the N-glycans’ sequence, found in plant and /or 
invertebrates and non-natural alterations to mammalian sequences, to the N-glycans’ structure and 
dynamics. We found that by changing the linkage, e.g. from α1-6 to α1-3 linked core-fucose, or by 
adding one monosaccharide, like β1-2 xylose, we can significantly alter the conformational space 
occupied by the adjacent monosaccharides, and thus influence the overall conformational landscape of 
the N-glycan. By quantifying the effect of each specific modification through conformational analysis, 
we were able to discretize the intrinsic 3D architecture of N-glycans in terms of specific groupings of 
monosaccharides, which we named “glycoblocks”. Contrary to the standard “monosaccharide 
sequence” viewpoint, this approach allows us to define more clearly 3D structure dependencies. As a 
step further in this direction, we are planning to build a structural database of glycoblock units for 
docking and molecular recognition studies, we named GlycoShape. 
The general validity of this glycoblock viewpoint to describe the intrinsic glycan 3D structure and 
dynamics, became quite useful when we studied different glycoproteins, as discussed in Chapters 5 
and 6, to understand the functional role of the N-glycans and of specific glycosylation patterns. For 
example, in Chapter 5 we have shown how and why the variation in N-glycosylation, more specifically 
sialylation and core-fucosylation, of the two N-glycans in the IgG1 Fc region modulates the relative 
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stability and dynamics of the Fc protein, and in turn how it may affect the binding affinity to the Fc γ 
receptor. Indeed, core-fucosylation of the Fc N-glycans is known to dramatically reduce ADCC, 
weakening the antibody effector function, thus its efficacy in biopharmaceutical applications.   
In Chapter 6 I described how glycosylation plays a crucial role in viral glycoproteins, and more 
specifically in the SARS-CoV-2 spike fusion protein. Through extensive sampling, we have shown how 
the extent and type of glycosylation in these heavily glycosylated proteins are imperative for the virus 
evasion of the host immune system, through shielding and mimicry. Moreover, as a unique feature of 
the SARS-CoV, within a collaborative effort we discovered an additional functional role of N-glycans 
at N234, N165 and N343, whereby the N-glycans at these sites structurally support the receptor binding 
domain (RDB) open conformation and mutations have shown strongly diminished binding affinity. The 
extent of the interaction and support provided by the N-glycans at these glycosylation sites is dependent 
on the N-glycan type and sequence. 
As a whole, my PhD work has contributed to the discovery of new structural dependencies of complex 
N-glycans from their sequence, bringing in a three-dimensional dynamics perspective to our 
understanding of glycans’ molecular recognition and more in general of their function. The 
discretization of the N-glycan architecture in terms of 3D glycoblocks has allowed us to understand 
how the addition or removal of single monosaccharides can radically alter the overall structural 
ensemble, an approach that can be used purposely to devise synthetic strategies to obtain complex 
glycosylation patterns, e.g. to achieve high or complex degrees of functionalization of the 1-6 arm. 
Within a glycoprotein context, we were able to explain at the atomistic level of detail for the first time 
how glycosylation impacts on antibody activity. This insight opens the door to further studies, where 
custom-designed (non-immunogenic) glycoforms can be tested for activity based on the profile obtained 
by computational models. Indeed, the effect imparted by specific glycoforms depends exclusively on 
their 3D structure and dynamics, inherent to their sequence/identity. Within this framework, another 
aspect that my studies have contributed to highlight is a paradigm shift of how glycan structure is 
viewed. We found in all our studies that the complex N-glycans’ structure is not actively changed by 
the protein landscape, but as an equal player, it adapts to it, depending on its allowed degrees of 
freedom. Because of this ability, different glycosylation types can modulate differently the function of 
a glycoprotein, and we have shown that this is particularly true in the SARS-CoV2 S proteins, where 
glycans play a functional role. Therefore, we (and others) see that targeting glycosylation is an 







1. Doores, K. J. The HIV glycan shield as a target for broadly neutralizing antibodies. FEBS J. 
282, 4679–4691 (2015). 
2. Williams, S. J. & Goddard-Borger, E. D. α-glucosidase inhibitors as host-directed antiviral 
agents with potential for the treatment of COVID-19. Biochem. Soc. Trans. 48, 1287–1295 
(2020). 
3. Watanabe, Y. et al. Vulnerabilities in coronavirus glycan shields despite extensive 
glycosylation. bioRxiv 2020.02.20.957472 (2020) doi:10.1101/2020.02.20.957472. 
4. Nascimento da Silva, L. C. et al. Exploring lectin–glycan interactions to combat COVID-19: 








Appendix I: Supplementary material from the paper: A.M. Harbison, L. P. Brosnan, K. Fenlon, E. 
Fadda, Sequence-to-structure dependence of isolated IgG Fc complex biantennary N-glycans: A 
molecular dynamics study, Glycobiology. 29, 94–103 (2019). 
 
Appendix II: Supplementary material from the paper: C. A. Fogarty*, A. M. Harbison*, A. R. Dugdale, 
E. Fadda, How and why plants and human N-glycans are different: Insight from molecular dynamics 
into the ‘glycoblocks’ architecture of complex carbohydrates, Beilstein J. Org. Chem. 16, 2046–2056 
(2020) 
 
Appendix III: Supplementary material from the paper: A.M. Harbison, E. Fadda, An atomistic 
perspective on antibody-dependent cellular cytotoxicity quenching by core-fucosylation of IgG1 Fc N-
glycans from enhanced sampling molecular dynamics, Glycobiology. 30, 407–414 (2020) 
 
Appendix IV: Supplementary material from paper: L. Casalino, Z. Gaieb, J. A. Goldsmith, C. K. 
Hjorth, A. C. Dommer, A. M. Harbison, C. A. Fogarty, E. P. Barros, B. C. Taylor, J. S. McLellan, E. 
Fadda, R. E. Amaro, Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein, ACS 






All glycans were built using the Glycam Carbohydrate Building tool (http://www.glycam.org). The 
appropriate rotamers of each glycan were chosen in order to generate a complete set of starting 
structures for the molecular dynamics simulations.  Once generated, the glycan pdb files were prepared 
using tleap (Salomon-Ferrer, R., Case, D.A., et al. 2013). For each starting structure topology and 
coordinate files were created with the GLYCAM06h-12SB forcefield(Kirschner, K.N., Yongye, A.B., 
et al. 2008) and TIP3P water model(Jorgensen, W.L. and Jenson, C. 1998) was included to represent 
the counterions for the sialylated structures. 
 
The energy minisations and MD  simulations were carried out using AMBER 12 and AMBER 
16(Salomon-Ferrer, R., Case, D.A., et al. 2013). Each system was initially minimized through 500,000 
cycles of steepest descent, with a restraint of  5 kcal/mol*Å on all heavy atoms. Following minimisation, 
the system was heated from 0 to 300 K over two stages, with restraints on heavy atoms in place. For 
the first stage, the system was heated from 0 to 100 K over 500 ps at constant volume. For the second 
stage the system was heated from 100 to 300 K over 500 ps. All degrees of freedom were equilibrated 
at 300 K and 1 atm of pressure for 5 ns. A production step followed, with a minimum of 250 ns run for 
each set of glycans. The overall length of the production run was set in function of the convergence of 
the system. The whole study entailed a cumulative simulation time in excess of 62 s.  Trajectory files 
were generated for each simulation, and were visualized using VMD(Humphrey, W., Dalke, A., et al. 
1996). Conformational analysis of the torsion angles was performed on each trajectory using VMD, 
Microsoft Excel and seaborn for the contour plots. 
trajectory. 2D contour plot were made with seaborn (seaborn.pydata.org) based on 30,000 data points. 
 
As an interesting note, because of the better scaling on our machines of v. 4.6.3 and 5.0.x of GROMACS 
(GMX) for the calculations on these relatively small systems, we ran some tests on the medium-sized 
sugar H, see Figure S1, and compared the results with the GLYCAM/AMBER set-up. The starting 
structure and parameter files obtained from the carbohydrate builder on GLYCAM-WEB were 
converted to GMX format with the AnteChamber PYthon Parser interfacE (acpype.py) tool(Sousa da 
Silva, A.W. and Vranken, W.F. 2012). It is important to note that in all GMX simulations the 1-4 scaling 
was re-set to “1” as required by the GLYCAM force field(Fadda, E. and Woods, R.J. 2010, Kirschner, 
K.N., Yongye, A.B., et al. 2008). Equal amount of sampling was done with both GMX and AMBER, 
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preceded by a very similar set-up and equilibration protocols. Details of the GMX protocol are provided 
as Supplementary Material. The results indicate large differences in α(1-6) torsions populations between 
GMX and GLYCAM/AMBER, shown in Tables S.1 and S.2. The reason for this may be problems in 
the transfer of torsional parameters from a GLYCAM/AMBER format to the GMX format. More 
specifically we found that simulations of sugar H with GMX do not reproduce the correct conformer 
populations, or give energetically disfavoured conformers, such as the tg in the core fucose α(1-6) 
linkage as the highest populated for sugar H2, see Table S.2. 
 
 
Figure S . 1 Conformational propensity of the Fuc(12)- (1-6)-GlcNAc(1) linkage during a conventional (unbiased) 3 s 
MD  
Table S . 1 Comparison of the average values of the torsion angles for all glycosidic linkages of sugar H1 calculated 
during 500 ns MD trajectory obtained with Amber 12 and with Gromacs v. 4.6.3. Averages, standard deviations, and 
population analysis are calculated over 5000 frames. 
Sugar H1 GlcNAc(1)-(1-4)-GlcNAc(2) 
   
Amber -77.1 (9.7) 100 -126.2 (14.5) 100 
GMX -77.4 (9.9) 100 -126.5 (15.0) 100 
 Fuc-(1-6)-GlcNAc(1) 
    
S4 
 
Amber -79.6 (17.7) 100 
-186.1 (19.6) 78/ 92.1 
(19.1) 20/ -98.6 (17.0) 
2 
44.8 (11.7) 96/ -169.5 
(13.9) 3/ -45.7 (30.4) 1 
GMX -78.6 (18.5) 100 
-184.4 (20.0) 80/ 91.3 
(19.3) 19 / -91.8 (19.0) 
1 
45.6 (12.3) 98/ -171.5 
(16.1) 1/ 54.8 (38.8) 1 
 Man(3)-(1-4)-GlcNAc(2) 
   
Amber -77.4 (18.8) 100 -123.6 (15.0) 100 
GMX -79.6 (22.2) 100 -126.2 (16.8) 100 
 Man(5)-(1-6)-Man(3) 
    
Amber 74.3 (15.0) 100 
-178.3 (19.3) 53/ 87.8 
(17.0) 46/ -100.4 (18.5) 
1 
52.0 (10.4) 92/ -172.6 
(16.0) 6/ -75.4 (14.9) 2 
GMX 73.2 (15.9) 100 
-177.9 (19.1) 54/ 80.6 
(18.4) 44/ -92.9 (18.1) 
2 
50.5 (10.5) 56/ -175.8 
(16.9) 40/ -77.0 (19.3) 5 
 GlcNAc(7)-(1-2)-Man(5) 
   
Amber -81.5 (15.8) 100 162.4 (13.1) 91/ 106.3 (12.4) 9 
GMX -81.2 (17.1) 100 161.5 (15.3) 87/ 107.5 (12.0) 13 
 Man(4)-(1-3)-Man(3) 
   
Amber 72.8 (12.2) 100 145.8 (12.6) 60/ 102.7 (14.4) 40 
GMX 73.1 (12.2) 100 145.8 (13.6) 59/ 101.7 (14.8) 41  
 GlcNAc(6)-(1-2)-Man(4) 
   
Amber -80.5 (16.1) 100 161.4 (14.1) 83/ 105.2 (12.9) 17 




Table S . 2 Comparison of the average values of the torsion angles for all glycosidic linkages of sugar H2 calculated 
during 500 ns MD trajectory obtained with Amber 12 and with Gromacs v. 4.6.3. Averages, standard deviations, and 
population analysis are calculated over 5000 frames. 
Sugar H2 GlcNAc(1)-(1-4)-GlcNAc(2) 
   
Amber -77.4 (9.8) 100 -126.4 (14.4) 100 
GMX   
 Fuc-(1-6)-GlcNAc(1) 
    
Amber -79.2 (18.1) 100 
-185.2 (19.1) 78/ 92.3 
(18.6) 21/ -102.6 (17.7) 
1 
44.9 (11.7) 95/ -173.7 
(13.3) 4/ -38.8 (26.9) 1 
GMX -73.4 (13.4) 100 
-183.6 (17.1) 91/ 94.6 
(19.9) 4/ -87.6 (18.0) 5 
-64.7 (12.1) 76/ 47.4 (12.0) 
14 / -166.7 (13.5) 10 
 Man(3)-(1-4)-GlcNAc(2) 
   
Amber -78.0 (19.6) 100 -124.8 (15.1) 100 
GMX -79.8 (24.9) 100 -125.6 (15.9) 100 
 Man(5)-(1-6)-Man(3) 
    
Amber 74.3 (15.0) 100 
-178.3 (19.3) 53/ 87.8 
(17.0) 46/ -100.4 (18.5) 
1 
51.4 (10.8) 84/ -177.2 
(16.4) 12/ -82.1 (20.5) 3 
GMX 72.8 (17.1) 100 
-179.5 (20.5) 58/ 85.5 
(19.0) 39/ -86.8 (18.4) 
4 
53.2 (10.8) 78/ -169.4 
(17.5) 16/ -77.0 (201.2) 6 
 GlcNAc(7)-(1-2)-Man(5) 
   
Amber -80.8 (15.1) 100 163.2 (16.3) 91/ 106.3 (12.8) 9 




   
Amber 73.0 (12.3) 100 146.1 (12.9) 60/ 101.9 (14.8) 40 
GMX 72.9 (11.9) 100 145.6 (12.4) 59/ 102.7 (14.0) 41 
 GlcNAc(6)-(1-2)-Man(4) 
   
Amber -81.0 (17.3) 100 161.5 (13.6) 84/ 104.6 (12.3) 16 




Table S .3 GlcNAc(2)- (1-4)-GlcNAc(1) linkage in non-fucosylated glycans 
 
phi stdev pop 
 
psi (1) stdev pop psi (2) stdev pop 
A -78.6 10.2 100 
 
-130.8 15.8 100 
  
0 
C -77.8 10.0 100 
 
-129.5 17.8 100 
  
0 
E -78.3 10.7 100 
 
-130.3 15.5 100 
  
0 
G -78.2 10.9 100 
 
-130.2 15.4 100 
  
0 
I -78.2 10.8 100 
 
-130.2 15.3 100 
  
0 
K -79.0 13.0 100 
 
-130.2 15.7 97 70.1 12.1 3 
M -79.3 12.0 100 
 
-131.5 15.7 100 
  
0 
O -80.3 11.0 100 
 
-133.3 15.0 94 68.3 12.4 4 
Q -78.4 11.3 100 
 
-130.5 15.8 99 70.4 13.6 1 
S -79.3 11.4 100 
 
-131.1 15.4 97 67.1 11.4 3 
AVERAGES -78.7 11.1 100 
 
-130.8 15.7 99 69.0 12.4 1 
 
Table S .4 GlcNAc(2)- (1-4)-GlcNAc(1) linkage in core-fucosylated glycans. Note: average values do not include sugar 
D as the dynamic of this linkage is affected by the equilibrium of the GlcNAc(1) ring pucker between 4C1 to 1C4 
conformations. 
 
phi stdev pop 
 
psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
B -77.3 9.7 100 
 
-127.2 15.0 100 
  
0   0 
D* -77.9 11.4 100 
 
-129.5 13.8 85 -82.8 11.5 12 69.6 11.8 3 
F -75.6 19.8 100 
 
-126.9 16.2 100 
  
0   0 
H -77.5 10.0 100 
 
-126.6 14.9 100 
  
0   0 
J -77.8 10.6 100 
 
-126.3 15.5 100 
  
0   0 
L -78.7 9.9 100 
 
-128.6 14.7 100 
  
0   0 
N -78.6 10.0 100 
 
-128.0 14.7 100 
  
0   0 
P -78.0 10.0 100 
 
-127.7 14.3 98 70.1 11.9 2   0 
R -77.9 10.7 100 
 
-126.9 14.6 100 
  
0   0 
T -79.0 9.7 100 
 
-129.9 14.0 100 
  
0   0 
AVE. -77.8 11.2 100 
 









Table S .5 Fuc(12)- (1-6)-GlcNAc(1) linkage. Note: average values do not include sugar D as the dynamic of this linkage 
is affected by the equilibrium of the GlcNAc(1) ring pucker between 4C1 to 1C4 conformations. 
 
phi stdev pop phi(2) stdev pop 
 
psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
B -74.2 12.3 97 -142.8 11.3 3 B -181.1 18.7 78 109.3 22.5 22 
  
0 
D* -75.9 15.7 100 
  
0 D -183.0 21.0 79 93.1 18.6 17 -87.8 15.2 4 
F -75 12.8 98 -142 10.3 2 F -183.1 21.7 75 92.7 18.9 20 -90.2 17 5 
H -78.6 15.8 100 
  
0 H -185.3 19.4 78 92.4 19.1 20 -99.2 16.3 2 
J -78.5 17.6 100 
  
0 J -185.5 19.4 79 92 19 19 -96.3 16.6 3 
L -78 16.7 100 
  
0 L -186.8 19.3 78 93.2 19.1 18 -97.5 16 4 
N -77.8 16.5 100 
  
0 N -187.5 19.1 81 93.5 19.3 16 -98.6 15.8 2 
P -78.7 17.6 100 
  
0 P -186.7 19.3 79 92.4 18.6 19 -97.6 17.2 2 
R -78.3 17.5 100 
  
0 R -184.2 19.6 79 92.5 19 19 -100.8 15.4 2 
T -78.3 16.9 100 
  
0 T -186.9 19.2 79 92.5 18.9 19 -98 17.5 2 
AV. -77.3 15.9 100 -142.4 10.8 1 
 
-185.2 19.5 78.4 94.5 19.4 19.1 -97.3 16.5 2.4 
 omega(1) stdev pop omega(2) stdev pop omega(3) stdev pop 





D* 46.7 12.0 77 -64.9 12.9 13 -172.2 14.0 11 
F 46.5 11.9 85 
  
0 -166.5 23.8 15 
H 45 11.8 93 -58.4 30.4 2 -169.4 19.1 6 
J 44.9 11.7 91 -67.3 28.3 2 -171.2 15.1 7 
L 43.8 12.6 85 -50.5 25.5 2 -172 14.5 13 
N 43.4 12.9 90 -43.5 29.8 2 -170.9 15 8 
P 44.4 12.3 93 -51.3 33.7 1 -156.9 14.7 6 
R 45.2 11.8 92 -63.5 30.7 1 -170 15.3 7 
T 44.5 12.3 96 -48.9 35.3 1 -170.8 14.8 4 





Table S .6 Man(3)- (1-4)-GlcNAc(2) linkage in non-fucosylated glycans 
 
phi stdev pop phi(2) stdev pop phi(3) stdev pop psi (1) stdev pop psi (2) stdev pop 
C -73.5 12.1 95 -156.4 25.5 5 
  
0 -124.8 17.3 82 70.7 13.7 18 
E -76.6 15.3 96 -165.9 16.2 4 
  
0 -125.8 16.2 93 73.1 12.1 7 




0 -124.6 15.5 100 
  
0 




0 -126 15.93 100 
  
0 




0 -126 15.2 100 
  
0 




0 -126.7 15.4 100 
  
0 
O -82.3 24.4 93 
  
0 56.7 9.1 7 -124.6 14.5 96 71 12.1 4 




0 -124.6 14.5 96 52.4 9.4 2 
S -79.13 15.07 92 -151.54 12.99 4 
  
0 -129.28 14.3 100 
  
0 





Table S .7 Man(3)- (1-4)-GlcNAc(2) linkage in core-fucosylated glycans 
 
phi stdev pop phi(2) stdev pop psi (1) stdev pop psi (2) stdev pop 
D -75.2 11.7 96 -163.1 26.1 4 -124.9 16.3 96 69.9 14.8 4 
F -76 12.6 95 -166.6 15.4 5 -125.5 15.4 91 70.6 11.3 9 
H -77.6 18.8 100 
  
0 -124.4 15 100 
  
0 
J -79.3 21.8 100 
  
0 -126 15.9 98 71.8 12 2 
L -84.6 27.3 100 
  
0 -125.7 15.1 94 68.3 12.5 6 
N -83 24.8 100 
  
0 -125.3 14.4 93 72 12.5 7 
P -71.5 13.8 87 -152 14.5 13 -126.2 14.5 100 
  
0 
R -78.1 19.6 100 
  
0 -125.6 15.8 96 71.7 12.3 4 
T -77.2 13.2 92 -152.2 16.6 8 -126.5 14.8 99 78.5 15.4 1 





Table S .8 Man(4)- (1-3)-Man(3) linkage in non-fucosylated glycans 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
E 72.7 12.4 100 143.8 13.6 72 102.4 12.2 28.0 
G 72.7 11.8 100 145.7 12.6 59 101.9 14.5 41.0 
I 73.0 12.1 100 146.0 13.2 58 102.4 14.3 42.0 
K 72.5 12.3 100 146.4 17.2 59 103.1 14.6 41.0 
M 73.1 12.5 100 146.1 12.7 61 102.1 14.7 39.0 
O 73.1 12.3 100 150.0 15.3 65 102.4 14.4 35.0 
Q 72.7 12.2 100 145.8 12.7 59 101.7 14.7 40.0 
S 72.6 11.3 97 147.9 14.1 58 102.2 14.1 42.0 





Table S .9 Man(4)- (1-3)-Man(3) linkage in core-fucosylated glycans 
 
phi stdev pop phi(2) stdev pop phi(3) stdev pop 

























P 72.4 10.1 93 124.9 21.7 5 164.6 17.9 2 





T 72.7 10.3 98 122.4 22.2 2 
  
0 
AVERAGES 72.9 12.2 99 123.7 22.0 1 164.6 17.9 0 
 psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop psi (4) stdev pop 
F 145.5 12.3 65 105.1 13.6 34   0   0 
H 145.8 12.6 60 102.3 14.5 40   0   0 















P 147.4 13.8 55 102.6 15 34 182 17.3 4 -47.4 16.4 2 















Table S .10 GlcNAc(6)- (1-2)-Man(4) linkage in non-fucosylated glycans 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
G -80.7 16.4 100 161.4 13.9 84 105.2 12.9 16 
I -80.9 15.8 100 161.7 16.1 84 105.2 12.4 16 
K -80.4 16 100 162.1 16.3 84 105.1 12.3 16 
M -80.8 16.4 100 162.3 17.1 85 105.4 12.1 15 
O -79.7 15.5 100 161.7 15.7 84 105.6 12.2 16 
Q -81.1 17.6 100 162.3 17.2 83 105.7 12.1 18 
S -83.43 16.21 94 161.09 14.81 86 105.92 12.18 14 
AVERAGES -81.0 16.3 99 161.8 15.9 84 105.4 12.3 16 
 
Table S .11 GlcNAc(6)- (1-2)-Man(4) linkage in core-fucosylated glycans 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
H -80.7 16.4 100 161.1 13.9 84 105.2 12.6 16 
J -80.9 16.3 100 162 15.9 84 105.1 12.5 16 
L -80.3 15.7 100 161.7 15.5 84 105.3 12.5 16 
N -81.2 17.1 100 162 16.2 84 105.3 12.4 16 
P -81 15.9 100 162.2 15.9 85 105.9 12.3 15 
R -80.3 17.1 100 162.1 15.6 85 105.7 12.2 15 
T -81.7 17 100 162.4 16.3 85 105.5 12.1 15 
AVERAGES -80.9 16.5 100 161.9 15.6 84 105.4 12.4 16 
 
Table S .12 Gal(8)- (1-4)-GlcNAc(6) linkage in non-fucosylated glycans 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
I -74.1 16.9 100 -120.3 15.7 97 71.8 15.3 3 
M -75 16.9 100 -120.3 15.9 100 
  
0 
O -76 18 100 -123.1 16.7 88 76.6 19.4 12 
Q -76.8 18.3 100 -123.7 17.2 98 
  
2 
S -76.4 16.18 100 -122.98 16.3 91 75 18 9 







Table S .13 Gal(8)- (1-4)-GlcNAc(6) linkage in core-fucosylated glycans 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
J -74.9 16 100 -120.3 15.3 98 73.9 20.4 2 
N -74.8 17 100 -120.5 16.2 97 71.7 17.8 3 
P -76.7 16.7 98 -123.9 16.6 96 79 20.4 4 
R -75.2 18.4 100 -122.9 16.9 89 84.4 19.5 11 
T -74.1 11.6 95 -124 17.3 94 84.5 27.3 6 
AVERAGES -75.1 15.9 99 -122.3 16.5 95 78.7 21.1 5 
 
Table S .14 Sia(10)- (2-6)-Gal(8) linkage in non-fucosylated glycans 
 
phi stdev pop phi(2) stdev pop psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
O 65.4 11.2 88 -50.3 15.4 12 -182.2 24.3 84 -99.4 16.4 11 105.1 16.6 5 
Q 65.2 11.2 88 -50.7 15.9 12 -172.2 21.3 74 -101.1 15.2 23 104.8 15.7 3 
S 65.0 11.2 90 -49.2 13.5 10 -182.2 24.5 85 -99.4 16.7 13 107.0 15.9 3 
AVE. 65.2 11.2 89 -50.1 14.9 11 -178.9 23.4 81 -100.0 16.1 16 105.6 16.1 4 
 omega stdev pop omega(2) stdev pop omega(3) stdev pop 
O -61.5 16.3 51 -166.7 14.2 32 59.4 14.2 14 
Q -62.6 15.3 65 -165.0 14.8 33 62.1 12.4 2 
S -63.8 15.7 67 -163.6 14.8 28 58.5 13.8 5 





Table S .15 Sia(10)- (2-6)-Gal(8) linkage in core-fucosylated glycans 
 
phi stdev pop phi(2) stdev pop psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
P 65.2 10.9 91 -50.1 14.1 9 -182.4 24.6 85 -99.7 16.5 11 107.3 16.8 3 
R 65.1 11.1 90 -50.4 16.5 11 -182.5 24.4 85 -98.2 16.8 11 106 16.7 4 
T 65.1 11.1 90 -50.7 15.1 10 -182.9 24.5 85 -100 16.7 12 100.7 20.1 3 
AVERAGES 65.1 11.0 90 -50.4 15.2 10 -182.6 24.5 85 -99.3 16.7 11 104.7 17.9 3 
 omega stdev pop omega(2) stdev pop omega(3) stdev pop 
P -62.7 15.5 65 -164.3 14.8 30 57.8 14.3 5 
R -65.9 15.7 63 -167.3 15.5 33 57 15.2 4 
T -62.5 15.7 64 -164.9 14.7 30 59.9 13.5 6 








Table S .16 Man(5)- (1-6)-Man(3) linkage in non-fucosylated glycans. 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
E 72.2 17.2 100 81.5 17.6 13 -175.3 17.3 84 -87.5 21.2 3 
G 72.8 15.5 100 80.9 18.9 44 -177.5 18.8 54 -97.3 17.4 2 
I 74.1 17.3 100 82.8 18.5 40 -178.8 18.5 58 -98.6 17.2 2 
Q 73.7 16.1 100 83.2 18.4 50 -179.2 19.6 49 -99.1 15.1 2 
AVE. 73.2 16.5 100 82.1 18.4 45 -177.7 18.6 54 -95.6 17.7 2 
K 74.9 14.2 100 83.2 17.6 68 -178.9 20.4 30 -94.1 18.2 2 
M 75.3 14.9 100 83.8 17.8 65 -181.2 20.8 34 -105 13.9 1 
O 74.9 15.4 100 80.7 16.6 77 -183 21.8 22 -99.2 13.8 1 
S 75.34 15.11 100 83.76 17.36 85 -185.84 24.73 17 -108.97 7.73 0 
AVE. 75.1 14.9 100 82.9 17.3 74 -182.2 21.9 26 -101.8 13.4 1 
 omega(1) stdev pop omega (2) stdev pop omega(3) stdev pop 
E 54.1 10.8 75 -171 16.7 20 -73.4 16.7 5 
G 51.3 11 81 -174.4 16.6 14 -78 19.4 4 
I 51.1 11.3 81 -174.8 16.9 15 -77.2 18 5 
Q 50.6 11 84 -168.9 17.8 11 -74 17.3 5 
AVE. 51.8 11.0 80 -172.3 17.0 15 -75.7 17.9 5 
K 49.8 10.4 85 -169.5 18 11 -78 18.5 4 
M 50.7 10.4 84 -172.4 17 11 -75 15.9 4 
O 50.1 10.4 74 -185.7 12.9 24 -82.4 17 2 
S 48.4 10.3 99 -173.5 18.5 1 -70.5 17.8 0 












Table S .17 Man(5)- (1-6)-Man(3) linkage in core-fucosylated glycans. 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
F 72 16.8 100 83.1 18.2 13 -175.3 16.7 85 -96.3 20.9 2 
H 74.3 15.2 100 84.4 17.2 53 -178.8 19.6 46 -75.8 17.4 1 
J 74.3 15.8 100 85.8 16.8 49 -179.9 19.3 50 -100.1 17.1 2 
R 74.2 15.5 100 87.8 16.4 45 -180.1 19.1 53 -99.8 14.2 2 
AVERAGES 73.7 15.8 100 85.3 17.2 49 -178.5 18.7 50 -93.0 17.4 2 
L 75.8 14.9 100 84.4 15.5 76 -184.4 21.4 24 
  
0 
N 76.3 15.7 100 84.4 16.6 76 -185.2 22.4 23 -98.3 14.8 1 
P 76.2 14.4 100 87 15.5 77 -185.8 22.4 22 -87.6 18.3 0 
T 76.7 14.9 100 85.2 15.5 76 -184.9 22.2 22 -112.1 7.8 0 
AVERAGES 76.3 15.0 100 85.3 15.8 76 -185.1 22.1 23 -99.3 13.6 0 
 omega(1) stdev pop omega (2) stdev pop psi (4) stdev pop 
F 54.1 11 73 -174 15.8 23 -77.7 19.3 4 
H 51.2 10.7 84 -176.1 16.5 13 -76.6 19.3 3 
J 51.3 10.6 84 -172.9 17.5 12 -79.3 19.7 4 
R 51 10.6 83 -171.2 16.3 12 -76.2 19.9 5 
AVERAGES 51.9 10.7 81 -173.6 16.5 15 -77.5 19.6 4 
L 50.6 9.8 83 -181.2 14.5 16 -74.7 19.5 1 
N 50.5 9.9 85 -175.2 15.2 13 -77 16.4 2 
P 50.5 9.5 94 -170.8 16.3 5 -82 18.8 1 
T 50.2 9.9 90 -163.9 13.6 8 -86.9 17.5 3 






Table S .18 GlcNAc(7)- (1-2)-Man(5) linkage in non-fucosylated glycans. 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
G -80.8 16.4 100 162 14.6 89 106 12.6 11 
I -78.9 22.7 100 160.2 14.6 85 100 15.4 15 
K -82.2 15.3 100 163.4 13.7 93 108.2 11.6 7 
M -75.9 31 100 162.8 13 92 107.6 11.9 8 
O -81.4 14.4 100 160.8 14.2 84 109.2 10.6 16 
Q -78.1 22.5 100 162.2 13 91 105.7 12.6 10 
S -81.39 14.58 100 163.33 11.79 97 109.03 11.76 3 
AVERAGES -79.8 19.6 100 162.1 13.6 90 106.5 12.4 10 
 
Table S .19 GlcNAc(7)- (1-2)-Man(5) linkage in core-fucosylated glycans. 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
H -81.2 15.7 100 162.7 14.2 90 106.4 12.2 10 
J -81.1 15.6 100 161.8 13.3 89 104.9 13 11 
L -83.4 14.2 100 160.7 13.4 89 109.5 11.3 11 
N -83.2 14.4 100 161.5 12.7 92 108.6 11.3 8 
P -76.9 14.6 100 161.9 11.9 96 108.8 11.4 4 
R -80.9 15.8 100 162.6 13.8 91 106 12.7 9 
T -83.2 13.9 100 162.8 12.7 94 110.3 10.4 7 
AVERAGES -81.4 14.9 100 162.0 13.1 92 107.8 11.8 9 
 
Table S .20 Gal(9)- (1-4)- GlcNAc(7) linkage in non-fucosylated glycans. 
 
phi stdev pop psi (1) stdev pop psi (2) stdev pop 
K -76.6 16 100 -123.3 15.6 88 120.3 7.2 12 
M -76 13.7 100 -126 13.8 100 
  
0 
O -74.5 15.6 100 -124.6 15.7 100 
  
0 
S -77.7 15 95 -128.79 16.35 100 
  
0 






Table S .21 Gal(9)- (1-4)- GlcNAc(7) linkage in core-fucosylated glycans. 
 
phi stdev pop phi(2) stdev pop psi (1) stdev pop psi (2) stdev pop 
L -75.6 15 100 
  
0 -122.9 15.6 99 152.1 10.6 1 
N -75 14.8 100 
  
0 -122.1 15.5 99 154.5 7.6 1 
P -74.7 14.3 100 
  
0 -122.3 15 100 
  
0 
T -73.9 10.8 100 -123.5 19.3 5 -123.2 16.8 96 
  
0 
AVERAGES -74.8 13.7 100 -123.5 19.3 1 -122.6 15.7 99 153.3 9.1 1 
 
Table S .22 Sia(11)- (2-6)- Gal(9) linkage in non-fucosylated glycans. 
 
phi stdev pop phi(2) stdev pop psi (1) stdev pop psi (2) stdev pop psi (3) stdev pop 
S 64.54 11.23 90 -50.67 13.68 10 -180.96 25.21 88 -98.61 17.87 9 106.45 15.97 3 
AVE. 64.5 11.2 90 -50.7 13.7 10 -181.0 25.2 88 -98.6 17.9 9 106.5 16.0 3 
 omega stdev pop omega(2) stdev pop omega(3) stdev pop 
S -62.56 15.61 60 -166.58 14.35 33 58.76 13.61 7 
AVE. -62.6 15.6 60 -166.6 14.4 33 58.8 13.6 7 
 


























T 64.9 11.8 88 -52.3 19.1 13 -182 25.2 88 -101.3 16.6 9 90.3 16.5 4 
AVE
. 



















      
T -64.9 16.2 56 -163.5 15.2 34 60.3 14.4 8       
AVE
. 
-64.9 16.2 56 -163.5 15.2 34 60.3 14.4 8       
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1. Computational Methods 
 
System preparation. All N-glycan starting structures for the MD simulations were generated 
with the GLYCAM Carbohydrate Builder (http://www.glycam.org). For each sequence we 
selected the complete set of rotamers obtained by variation of the 1-6 torsion angles, namely 
gg, gt and tg conformations for each 1-6 torsion. The topology file corresponding to each 
structure was obtained using tleap1, with parameters from the GLYCAM06-j12 for the 
carbohydrate atoms and with TIP3P for water molecules3. Each N-glycan was placed in the 
centre of a cubic simulation box of 16 Å sides with no counterions to be consistent with the 
simulations run in earlier work4. Long range electrostatic were treated by Particle Mesh Ewald 
(PME) with cut-off set at 11 Å and a B-spline interpolation for mapping particles to and from 
the mesh of order of 4. Van der Waals (vdW) interactions were cut-off at 11 Å. The MD 
trajectories were generated by Langevin dynamics with collision frequency of 1.0 ps-1. Pressure 
was kept constant by isotropic pressure scaling with a pressure relaxation time of 2.0 ps. All 
calculations were run with the AMBER18 software package1 on NVIDIA Tesla V100 16GB 
PCIe (Volta architecture) GPUs installed on the HPC infrastructure kay at the Irish Centre for 
High-End Computing (ICHEC).  
 
Simulation protocol. The energy of the hydrated systems was initially minimized through 
500,000 cycles of steepest descent, with all heavy atoms restrained with a harmonic potential 
with a force constant of 5 kcal mol-1Å-2. After minimization, the system was heated in two 
stages. During the first stage the temperature was raised from 0 to 100 K over 500 ps at constant 
volume and in the second stage from 100 K to 300 K over 500 ps at constant pressure. Through 
the heating process all heavy atoms were kept restrained. After heating phase all restraints were 
removed and the system was allowed to equilibrate for 5 ns at 300 K and at 1 atm of pressure. 
Separate production steps of 500 ns each were run for each rotamer (starting system) and 
convergence was assessed based on conformational and clustering analysis. Simulations were 
extended, if the sampling was not deemed as fully converged.  
 
Data analysis. All trajectories were processed using cpptraj1 and visually analysed with the 
Visual Molecular Dynamics (VMD) software package5. Backbone Root Mean Square 
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Deviation (RMSD) and torsion angles values were measured using VMD. A density-based 
clustering method was used to calculate the populations of occupied conformations for each 
torsion angle in a trajectory and heat maps for each dihedral were generated with a kernel 
density estimate (KDE) function. Statistical and clustering analysis was done with the R 
package and data were plotted with RStudio (www.rstudio.com).  
 
2. Supplementary Tables and Figures 
 
Table S .1. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-3) core fucosylated ngf glycan. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -71.1 (8.9) 141.1 (6.3) 100 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.1 (8.3) -107.1 (7.6) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -73.3 (12.3) -122.1 (14.9) 90.0 
Cluster 2 -166.4 (16.7) -145.6 (9.8) 8.3 
Cluster 3 -64.0 (10.0) 75.3 (9.3) 1.7 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 69.2 (10.2) -176.6 (17.5) 65.7 
Cluster 2 74.2 (9.4) 89.2 (10.8) 25.2 
Cluster 3 60.4 (6.4) 60.0 (5.8) 9.1 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -78.8 (14.3) 160.7 (20.6) 96.2 
Cluster 2 69.6 (9.3) 154.8 (10.3) 2.5 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 70.9 (8.5) 140.3 (13.5) 66.8 
Cluster 2 70.6 (8.7) 99.2 (9.5) 33.2 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -77.8 (13.7) 161.5 (13.5) 88.8 
Cluster 2 -78.5 (8.0) 109.2 (7.2) 9.7 
 
 
Table S .2. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-3) core fucosylated gf glycan. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
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Cluster 1 -72.5 (10.7) 125.2 (17.4) 100 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.9 (8.6) -105.7 (11.7) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -74.0 (12.3) -123.9 (15.7) 88.5 
Cluster 2 -165.7 (14.7) -145.7 (8.8) 11.5 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 69.3 (10.6) -177.6 (19.4) 72.5 
Cluster 2 71.5 (6.2) 79.2 (7.1) 16.2 
Cluster 3 60.7 (5.7) 60.4 (5.1) 1.1 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -76.7 (13.8) 162.5 (12.4) 88.4 
Cluster 2 -76.0 (6.2) 113.5 (6.6) 5.9 
Cluster 3 -147.6 (9.5) 97.9 (9.4) 1.9 
Gal (1-3) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -72.9 (11.2) 124.0 (18.2) 96.6 
Cluster 2 -82.1 (12.2) -64.0 (8.4) 3.0 
Cluster 3 -150.0 (11.3) -101.0 (7.3) 1.4 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 71.7 (8.9) 141.5 (14.5) 66.9 
Cluster 2 70.4 (8.6) 99.12 (9.5) 33.1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -77.9 (14.2) 160.9 (14.5) 83.3 
Cluster 2 67.2 (9.2) 152.4 (10.4) 8.6 
Cluster 3 -77.7 (7.7) 152.4 (6.2) 8.1 
Gal (1-3) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -72.4 (9.8) 125.0 (15.8) 100 
 
 
Table S .3. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 3 s MD sampling of the  (1-2) core xylylated ngx glycan. 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -78.1 (10.2) -129.6 (15.67) 96.3 
Cluster 2 -81.8 (9.8) 63.8 (8.11) 3.7 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.5 (12.6) -123.5 (14.6) 94.4 
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Cluster 2 -64.2 (6.8) 74.2 (9.7) 5.6 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -80.2 (12.0) 133.2 (17.0) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 69.7 (10.3) -174.4 (16.8) 77.2 
Cluster 2 73.5 (10.1) 106.1 (10.6) 22.8 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -80.9 (15.5) 161.7 (12.0) 90.1 
Cluster 2 -73.1 (7.9) 114.2 (7.8) 9.3 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 78.4 (7.3) 114.8 (14.8) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -77.4 (13.3) 161.5 (12.2) 88.2 
Cluster 2 -78.9 (6.4) 109.1 (7.18) 8.2 
Cluster 3 -66.9 (9.0) 149.1 (12.3) 3.6 
 
 
Table S .4. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-3) core xylylated gx glycan. 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -78.0 (10.1) -130.2(15.7) 97.5 
Cluster 2 -84.0 (5.4) -64.8 (5.6) 2.5 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.2 (13.5) -124.7 (15.0) 87.6 
Cluster 2 -67.9 (14.7) 72.9 (11.7) 11.3 
Cluster 3 -178.3 (6.9) -175.5 (7.3) 1.0 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -78.2 (9.3) 138.4 (15.4) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 70.5 (10.4) -173.6 (19.4) 70.0 
Cluster 2 71.8 (9.6) 103.8 (12.9) 25.7 
Cluster 3 161.6 (8.0) 132.5 (9.2) 2.3 
Cluster 4 79.0 (6.7) -80.2 (8.05) 1.59 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -82.1 (15.0) 161.3 (12.2) 88.2 
Cluster 2 -77.7 (7.47) 112.5 (7.0) 10.0 
Cluster 3 -147.3 (9.0) 98.9 (9.4) 1.9 
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Gal (1-3) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -72.1 (10.0) 126.1 (15.5) 80.8 
Cluster 2 -83.6 (11.4) -63.0 (7.57) 19.2 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 72.5 (10.7) 125.2 (17.4) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.5 (14.2) 162.4 (13.0) 91.2 
Cluster 2 -77.8 (7.4) 111.1 (7.0) 8.8 
Gal (1-3) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -71.1 (7.2) 125.5 (11.8) 100 
 
 
Table S .5. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-2) core xylylated and  (1-3) core 
fucosylated ngxf glycan. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -71.3 (9.0) 140.5 (6.0) 100 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -73.2 (11.0) -106.4 (21.0) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.9 (14.4) -124.2 (15.3) 75.4 
Cluster 2 -66.5 (11.3) 73.3 (10.8) 21.1 
Cluster 3 179.0 (7.6) -174.7 (8.2) 2.3 
Cluster 4 -151.9 (8.2) -146.5 (6.7) 1.2 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -78.8 (10.8) 135.9 (17.4) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 70.6 (9.0) 175.2 (17.6) 68.5 
Cluster 2 71.7 (10.0) 106.5 (12.3) 24.5 
Cluster 3 81.6 (8.0) -75.0 (10.0) 4.4 
Cluster 4 158.0 (8.9) 135.9 (10.4) 2.4 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -79.2 (14.4) 158.4 (24.9) 90.1 
Cluster 2 -80.0 (6.33) 113.0 (7.3) 9.3 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 69.1 (9.4) 113.8 (16.8) 1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
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Cluster 1 -77.4 (13.3) 161.5 (12.2) 88.2 
Cluster 2 -78.9 (6.4) 109.1 (7.18) 8.21 




Figure S .1. Conformational analysis of the (1-6) arm in terms of phi/psi torsion values. Representative structures 
selected from MD sampling are shown on the left- and right-hand side of the heat map. The GlcNAc-bound 
conformation is obtained through a torsion of the Man3 “glycoblock” relative to the ch itobiose and it is stabilized by 
hydrogen bonding interactions between the  (1-2)-Xyl and  (1-3)-Fuc. The monosaccharides colouring follows the 
SFNG nomenclature. The structure rendering was done with VMD and the graphical statistical analysis with RStudio 
(www.rstudio.com).  
Table S .6 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-2) xylylated and  (1-3) core 
fucosylated gxf glycan. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -71.1 (9.8) 140.5 (7.1) 88.9 
Cluster 2 -156.8 (5.6) 90.7 (6.7) 11.1 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.2 (8.5) -107.0 (8.0) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -76.7 (15.1) -124.5 (17.0) 85.2 
Cluster 2 -179.5 (8.5) -174.7 (9.5) 8.3 
Cluster 3 -63.0 (9.9) -75.6 (10.3) 5.5 
Cluster 4 -153.1 (6.2) -147.4 (5.31) 1 
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Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -78.2 (9.9) 135.9 (17.4) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 70.73 (10.3) -174.2 (19.0) 87.2 
Cluster 2 70.8 (8.1) 101.5 (10.7) 9.3 
Cluster 3 161.6 (8.5) 131.9 (10.6) 3.5 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -78.1 (14.3) 161.9 (12.9) 84.7 
Cluster 2 -76.1 (7.6) 111.6 (7.2) 10.5 
Cluster 3 -147.1 (10.9) 99.5 (10.1) 3.2 
Cluster 4 67.4 (7.4) 152.4 (8.4) 1.6 
Gal (1-3) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -70.7 (10.4) 125.0 (16.8) 96.7 
Cluster 2 -81.6 (7.07) -64.6 (6.4) 3.3 
Cluster 3 -81.6 (7.07) -64.6 (6.4) 1.3 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.7 (9.1) 114.1 (16.6) 1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.2 (14.7) 162.0 (13.0) 90.1 
Cluster 2 -78.1 (7.2) 112.1 (6.8) 9.9 
Gal (1-3) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -71.9 (6.9) 126.0 (11.9) 100 
 
Table S .7. Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-3) core fucosylated LeA glycan. 
Fuc(1-3) GlcNAc sPhi Psi Pop(% ) 
Cluster 1 -71.7 (9.8) 141.8 (6.6) 82.8 
Cluster 2 -156.3 (7.02) 88.8 (17.6) 17.2 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.6 (8.7) -107.4 (7.4) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.2 (12.0) -124.5 (14.0) 97.1 
Cluster 2 179.7 (6.1) -178.2 (6.6) 2.9 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 -75.5 (7.4) 148.1 (7.4) 53.6 
Cluster 2 -70.1 (5.8) -177.0 (11.2) 28.2 
Cluster 3 -73.2 (6.7) -101.9 (6.0) 9.4 
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Cluster 4 -148.0 (6.3) -165.3 (5.8) 8.8 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -83.9 (10.5) 132.8 (14.0) 100 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -150.0 (9.3) 98.5 (7.9) 40.9 
Cluster 2 -91.5 (8.5) 151.6 (8.6) 29.9 
Cluster 3 -62.7 (8.5) 161.4 (9.9) 29.2 
Gal (1-3) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -70.1 (7.6) 131.5 (7.6) 100 
Fuc(1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -67.8 (7.5) -101.26 (7.3) 100 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 61.5 (8.5) 111.0 (15.1) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -77.9 (16.9) 162.3 (12.3) 57.8 
Cluster 2 -79.9 (11.4) 105.1 (12.4) 27.9 
Cluster 3 66.1 (10.1) 153.8 (10.8) 14.26 
Gal (1-3) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -70.6 (7.5) 134.5 (6.8) 100 
Fuc (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -68.6 (8.9) -100.9 (6.7) 98.4 
Cluster 2 -148.9 (8.0) -150.7 (3.8) 1.6 
 
 
Table S .8 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-2) xylylated mgx glycan. Note: mg 
refers to the mammalian terminal  (1-4)-Gal. 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -78.2 (10.9) -131.1 (15.8) 97.5 
Cluster 2 -79.6 (11.3) 66.6 (11.5) 2.5 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.7 (17.1) -123.7 (14.7) 91.3 
Cluster 2 -68.1 (12.6) 72.1 (11.9) 8.7 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -81.7 (19.1) 133.6 (20.1) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 72.2 (9.4) 103.5 (11.3) 56.9 
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Cluster 2 69.9 (8.3) -173.8 (15.7) 39.8 
Cluster 3 162.2 (9.1) 131.2 (9.3) 1.7 
Cluster 4 58.5 (3.2) 59.98 (4.3) 1.6 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -78.1 (14.3) 161.9 (12.9) 84.7 
Cluster 2 -76.1 (7.6) 111.6 (7.2) 10.5 
Cluster 3 -147.1 (10.9) 99.5 (10.1) 3.2 
Cluster 4 67.4 (7.4) 152.4 (8.4) 1.6 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -72.9 (15.8) -119.9 (16.0) 98.9 
Cluster 2 -73.5 (12.6) -73.24 (12.5) 0.6 
Cluster 3 63.6 (10.7) -117.8 (6.8) 0.8 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.9 (9.7) 114.5 (16.7) 1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -79.0 (13.8) 162.5 (12.2) 87.5 
Cluster 2 -80.9 (9.12) 109.4 (9.0) 12.5 
Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 






Table S .9 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 4.5 s MD sampling of the  (1-2) xylylated and  (1-6) core 
fucosylated mgmfx glycan. Note: mg refers to the mammalian terminal  (1-4)-Gal and mf to the mammalian core  (1-
6)-Fuc. 
Fuc(1-6) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -74.5 (9.6) 172.4 (14.5) 92.1 
Cluster 2 -95.9 (4.5) 71.78 (6.1) 6.9 
Cluster 3 -75.6 (2.5) 1113.8 (2.17) 1.0 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -77.2 (9.5) -126.0 (14.3) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -74.3 (15.0) -122.7 (14.2) 97.1 
Cluster 2 -67.4 (10.1) 73.6 (10.7) 2.9 
Man(1-6) Man Phi Psi Pop(% ) 
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Cluster 1 71.8 (9.4) 103.3 (10.98) 70.0 
Cluster 2 70.4 (9.0) -177.0 (11.2) 26.9 
Cluster 3 67.5 (5.24) -62.5 (5.7) 3.1 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -83.9 (10.5) 132.8 (14.0) 100 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -91.5 (12.5) 159.9 (10.3) 96.3 
Cluster 2 -75.5 (3.9) 113.6 (3.8) 2.9 
Cluster 3 66.0 (6.8) 154.3 (5.8) 0.8 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -74.9 (13.56) -122.1 (15.5) 97.5 
Cluster 2 -83.6 (18.6) 65.3 (13.5) 2.5 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.7 (9.9) 115.6 (16.9) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -79.1 (13.2) 162.3 (11.4) 90.9 
Cluster 2 -77.9 (6.8) 110.4 (7.6) 9.1 
Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -72.7 (15.4) -118.6 (15.7) 97.3 
Cluster 2 -74.0 (12.4) 70.12 (13.1) 2.7 
 
 
Table S .10 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 4.5 s MD sampling of the  (1-2) xylylated and  (1-3) core 
fucosylated nmgmfx glycan. Note: nmg refers to the absence of mammalian terminal  (1-4)-Gal and mf to the 
mammalian core  (1-6)-Fuc. 
Fuc(1-6) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -73.0 (9.6) 177.0 (14.8) 93.1 
Cluster 2 -95.6 (4.0) 75.0 (5.4) 6.9 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -77.2 3(9.7) -126.0 (14.4) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -76.6 (18.5) -124.8 (16.9) 91.1 
Cluster 2 -66.2 (12.5) 73.0 (11.9) 8.2 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 70.1 (9.2) -173.6 (14.6) 71.5 
Cluster 2 72.1 (8.3) 104.25 (9.7) 28.5 
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Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -80.6 (16.5) 135.8 (14.0) 100 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -82.8 (14.94) 161.1 (11.9) 90.6 
Cluster 2 -77.8 (7.3) 111.3 (6.8) 7.4 
Cluster 3 66.0 (7.3) 152.9 (8.7) 2.0 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.9 (9.4) 114.4 (16.9) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.4 (13.4) 162.6 (11.4) 88.8 
Cluster 2 -78.9 (7.2) 110.4 (7.0) 9.0 
Cluster 2 66.45 (10.9) 152.6 (10.7) 2.2 
 
 
Table S .11 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the  (1-2) xylylated and  (1-3) core 
fucosylated mgpfx glycan. Note: mg refers to the mammalian terminal  (1-4)-Gal and pf to the plant core  (1-3)-Fuc. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -70.8 (10.7) 141.3 (8.9) 93.8 
Cluster 2 -156.8 (7.7) 91.3 (9.3) 6.2 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.5 (8.8) -107.3 (9.1) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -76.4 (15.1) -123.6 (17.3) 87.0 
Cluster 2 -68.2 (12.8) 70.9 (11.2) 13.0 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -80.7 (15.3) 134.5 (16.5) 100 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 69.9 (9.0) -175.5 (15.0) 49.1 
Cluster 2 72.4 (9.7) 105.1 (12.5) 46.7 
Cluster 3 158.6 (11.8) 135.8 (13.6) 4.2 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -86.2 (15.0) 160.9 (11.4) 96.4 
Cluster 2 -78.5 (6.1) 113.5 (4.9) 3.6 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -72.9 (15.0) -119.9 (15.6) 97.2 
Cluster 2 -74.1 (13.1) 70.1 (13.8) 2.8 
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Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.8 (9.6) 114.5 (16.7) 1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.8 (13.8) 162.6 (12.6) 88.3 
Cluster 2 -80.7 (8.0) 109.5 (7.6) 9.6 
Cluster 3 65.2 (9.9) 150.8 (10.8) 2.1 
Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -72.5 (11.5) -118.6 (15.5) 100 
 
Table S .12 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 1.5 s MD sampling of the (1-3) core fucosylated mgpf glycan. Note: 
mg refers to the mammalian terminal  (1-4)-Gal and pf to the plant core  (1-3)-Fuc. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -71.1 (10.6) 140.3 (14.8) 98.1 
Cluster 2 -156.5 (6.2) 91.4 (9.3) 1.9 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -73.0 (14.8) -121.5 (15.7) 95.9 
Cluster 2 -80.9 (15.3) 62.5 (13.4) 4.1 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -76.6 (14.1) -124.9 (16.1) 77.9 
Cluster 2 -153.7 (13.3) -139.7 (8.5) 12.8 
Cluster 3 -71.1 (12.5) 69.6 (11.4) 9.3 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 74.2 (13.0) 86.5 (14.7) 74.8 
Cluster 2 70.3 (9.1) -176.5 (14.7) 25.2 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -80.2 (14.6) 163.2 (12.4) 100 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -73.0 (14.88) -121.58 (15.8) 95.9 
Cluster 2 -80.9 (15.3) 62.5 (13.4) 4.1 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 70.95 (9.6) 140.95 (15.2) 73.0 
Cluster 1 70.1(8.21) 101.2 (8.8) 27.0 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.5 (13.3) 162.1 (11.7) 91.2 
Cluster 2 -77.9 (6.4) 110.7 (6.62) 8.8 
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Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 





Table S .13 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 2 s MD sampling of the  (1-3) and  (1-6) core fucosylated mgmfpf 
glycan. Note: mg refers to the mammalian terminal (1-4)-Gal, pf to the plant core  (1-3)-Fuc and mf to the mammalian 
core  (1-6)-Fuc. 
Fuc(1-6) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.0 (9.6) -179.5 (14.8) 74.3 
Cluster 2 -76.2 (4.0) 117.36 (12.1) 12.9 
Cluster 3 -144.4 (7.7) 171.0 (5.5) 12.8 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -70.2 (10.3) 140.1 (9.7) 88.6 
Cluster 2 -157.3 (7.7) 91.4 (8.9) 11.4 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -73.8 (9.5) -106.4 (14.1) 91.7 
Cluster 2 -154.9 (10.6) -147.8 (7.4) 8.3 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.1 (10.9) -120.7 (12.6) 74.8 
Cluster 2 -153.0 (13.0) -139.9 (8.3) 25.2 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 73.5 (11.7) 86.6 (17.32) 85.1 
Cluster 2 69.5 (9.9) -176.3 (15.8) 14.9 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -85.1 (14.9) 161.7 (13.4) 100 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -73.9 (11.5) -123.5 (16.5) 98.7 
Cluster 2 -146.2 (8.5) -142.1 (6.9) 1.3 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 71.1 (9.3) 140.5 (15.6) 72.9 
Cluster 1 69.9 (8.8) 100.63(9.8) 27.1 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.7 (13.8) 161.1 (12.8) 90.4 
Cluster 2 -79.1 (7.7) 110.7 (7.2) 9.6 
Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -72.4 (10.9) -118.6 (15.2) 95.0 
Cluster 1 -143.2 (10.4) -144.4 (5.9) 2.9 






Figure S .2. Conformational analysis N-linked GlcNAc pucker along the 1.5 ms cumulative sampling of the  (1-3) and 
 (1-6) core fucosylated A2G2 (mgmfpf) N-glycan. Representative structures of the fucosylated chitobiose selected from 
MD sampling of the whole N-glycans are shown on the left- and right-hand side of the heat map where the ring pucker 
is also indicated. The monosaccharides colouring follows the SFNG nomenclature. The structure rendering was done 
with VMD and the graphical statistical analysis with RStudio (www.rstudio.com).  
 
Table S .14 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 2 s MD sampling of the  (1-2) xylylated and  (1-3) and  (1-6) core 
fucosylated mgxmfpf glycan. Note: mg refers to the mammalian terminal (1-4)-Gal, pf to the plant core  (1-3)-Fuc 
and mf to the mammalian core  (1-6)-Fuc. 
Fuc(1-6) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.9 (11.25) 175.65 (14.0) 79.3 
Cluster 2 -142.7 (9.8) 171.3(6.2) 16.9 
Cluster 3 -95.48 (4.4) 71.95(4.8) 3.8 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -70.6 (10.3) 141.4 (8.3) 88.8 
Cluster 2 -156.0 (8.1) 89.5 (8.7) 11.2 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.8 (8.9) -106.6 (11.0) 96.7 
Cluster 2 -82.1 (7.1) -154.8 (6.8) 3.3 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -75.5 (11.0) -123.5 (12.6) 94.6 
Cluster 2 -62.42 (7.9) 72.2 (9.5) 4.4 
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Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 73.4 (10.5) 102.8 (10.6) 55.3 
Cluster 2 70.4(9.4) -176.8 (16.7) 26.7 
Cluster 2 102.5 (9.3) 55.9 (7.7) 17.9 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
Cluster 1 -91.8 (13.5) 159.4 (11.1) 100 
Gal (1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -74.2 (11.1) -121.1 (15.3) 99.2 
Cluster 2 -146.6 (7.5) -143.6 (4.9) 0.8 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 68.7 (9.7) 115.4 (16.8) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -79.5 (13.8) 162.3 (12.4) 92.4 
Cluster 2 -79.3 (6.9) 110.3 (6.9) 7.6 
Gal (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -72.6 (11.0) -119.1 (15.2) 93.4 
Cluster 1 -143.2 (10.4) -144.4 (5.9) 4.9 
Cluster 1 -74.2 (11.6) 69.7 (12.1) 1.7 
 
 
Table S .15 Results of the clustering analysis showing the median and standard deviation values (in parenthesis) for the 
torsion angles (°) measured through a cumulative 2 s MD sampling of the  (1-2) xylylated and  (1-3) fucosylated A2 
glycan terminating with LeX on both arms. 
Fuc(1-3) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -70.2 (11.0) 141.9 (8.4) 90.8 
Cluster 2 -156.7 (7.6) 90.2 (8.6) 9.2 
GlcNAc(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -72.2 (8.6) -107.5 (7.7) 100 
Man(1-4) GlcNAc Phi Psi Pop(% ) 
Cluster 1 -76.4 (15.7) -124.6 (16.7) 75.0 
Cluster 2 -68.1 (9.7) 71.0 (10.1) 25.0 
Man(1-6) Man Phi Psi Pop(% ) 
Cluster 1 70.7 (9.2) -173.6 (13.4) 89.7 
Cluster 2 152.4 (12.9) 145.6 (12.3) 10.3 
Xyl(1-2) Man Phi Psi Pop(% ) 
Cluster 1 -77.6 (9.6) 140.1 (18.1) 100 
GlcNAc (1-2) Man (1-6) Phi Psi Pop(% ) 
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Cluster 1 -78.2 (14.3) 162.3 (13.1) 91.8 
Cluster 2 -76.9 (7.4) 111.1 (6.8) 8.2 
Fuc (1-3) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -69.7 (8.9 142.1 (7.0) 100 
Gal(1-4) GlcNAc (1-6) Phi Psi Pop(% ) 
Cluster 1 -67.7 (8.0) -107.9(7.2) 100 
Man (1-3) Man Phi Psi Pop(% ) 
Cluster 1 61.5 (8.5) 111.0 (15.1) 100 
GlcNAc (1-2) Man (1-3) Phi Psi Pop(% ) 
Cluster 1 -78.8 (13.9) 162.6 (11.7) 91.6 
Cluster 2 -79.1 (6.2) 112.5 (6.2) 8.3 
Gal (1-3) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -69.1 (9.45) 142.2 (8.0) 100 
Fuc (1-4) GlcNAc (1-3) Phi Psi Pop(% ) 
Cluster 1 -67.8 (7.9) -108.1 (7.4) 94.8 






Figure S .3. Structural alignment of different plant N-glycoforms from our MD simulations on to the DC-
SIGN/GlcNAc2Man3 complex resolved at 2.5 Å resolution (PDBid 1k9i). Panel a) The water accessible surface of the 
DC-SIGN (chain C) binding site is shown in grey and the Man3 region of the co-crystallized glycan in 1k9i is rendered 
as yellow sticks. Ca2+ ions are shown as red spheres. Panel b) Structural alignment of representative structure from our 
MD simulation of the ngx plant N-glycan shows that the (1-6) xylose sterically hinders binding by clashing with the 
surface of the binding site. Only the Xyl-Man3 glycoblock from the whole N-glycan is represented. Panel c) Structural 
alignment of representative structure from our MD simulation of the ngf plant N-glycan shows that the  (1-3) fucose 
does not hinders recognition or binding by DC-SIGN. Only the Man3 and  (1-3)-Fuc chitobiose glycoblocks from the 
whole N-glycan is represented. The monosaccharides colouring, aside from panel a), follows the SFNG nomenclature. 
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The crystal structure of the human Fc fragment with PDBid 1FC1 was used as a starting point for the 
preparation of all our systems. The N-glycans in this structure were functionalized to match our 
chosen glycoforms, therefore a β(1-4) galactose and α(2-6) sialic acid were added to the (1-3) arm 
using the CHARMM GUI PDB reader tool(Park, S.J., Lee, J., et al. 2019). This structure was edited 
using the academic version of Schrödinger’s Maestro v.10.7.015 to rotate the torsion angles of the 
glycosidic linkages to release any steric clash that may have occurred during the build. The values of 
the glyosidic linkage torsion angles were taken from our earlier work on the unlinked 
glycans(Harbison, A.M., Brosnan, L.P., et al. 2019). Protein residues Cys 239 to Gly 250 from the 
human IgG B12 with PDBid 1HZH were linked to the structurally aligned 1FC1 using Maestro to 
build the disulfide bonds that keep the Fc region stable during the simulation. To ensure by 
construction that a potential folded conformation of the of the (1-6) arm was sampled, all 
simulations were started with both outstretched (open) and folded (closed) conformations of the arm. 
Maestro(Schrodinger, Maestro, 2012) was also used to modify the (1-6) glycosidic linkage to get the 
open and closed conformations for a total of six starting structures. 
 
Each system was prepared through an initial 500k cycles of conjugate gradient minimization with a 
restraint of 5 kcal mol-1Å-2 on all heavy atoms. The cutoff for van der Waals interactions was set to 12 
Å and smoothing functions were applied between 11 and 13.5 Å. Particle Mesh Ewald (PME) was 
used to treat electrostatic interactions with a charge grid of 1 Å and a sixth order spline function for 
mesh interpolation. All non-bonded interactions not directly connected were excluded, namely 1-3 
pair interaction, or scaled by 0.8333, namely 1-4 pair interaction. Following energy minimization, the 
systems were heated from 0 to 300 K over 600 cycles with restraints on all heavy atoms in place. For 
the temperature Replica Exchange Molecular Dynamics (REMD)(Sugita, Y. and Okamoto, Y. 1999), 
90 replicas were generated in the temperature range between 300 and 500 K. The systems were 
equilibrated with restraints on the protein backbone atoms and on the glycans heavy atoms for 500 ps, 
followed by 500 ps of unrestrained equilibrations for each replica. The production steps ranged 
between 13 ns and 11 ns for each replica, with an integrated time step of 2 fs. The SHAKE algorithm 
was used to restrain bonds to hydrogen atoms. Data analysis and structural alignments were done with 
VMD v.1.9.3 beta 1(Humphrey, W., Dalke, A., et al. 1996) and seaborn (https://seaborn.pydata.org) 






Figure S.2 Structure of the  (1-6) arm in a snapshot from the end of the oo IgG1 Fc closed simulation (11 ns x 90 
replicas) shows an extremely compact Fc core where the N-glycans are compressed together. The chitobiose and the 
 (1-6) arm are highlighted with SNFG colouring, while the  protein is showed through a solvent accessible area in gray.   
 
Table S . I Average protein backbone RMSD values (Å) calculated through the REMD simulations of the IgG Fc linked 
to different sets of N-glycans. Sugars o and p are shown in Figure 1. Standard deviation values are shown in parenthesis. 
The “open” and “closed” labels correspond to simulations started from an outstretched (open) or from a folded-over 
(closed) conformation of the  (1-6) arm. 
 Fc CH2 CH3 
N297-glycans open closed open closed open closed 
pp 3.3 (0.9) 3.3 (0.9) 4.4 (1.3) 4.4 (1.2) 1.1 (0.2) 1.0 (0.1) 
oo 2.5 (0.6) 3.9 (1.3) 3.3 (0.8) 5.2 (1.8) 1.0 (0.2) 1.1 (0.2) 
op (nFuc side) 3.1 (0.8) 3.4 (0.8) 4.1 (1.1) 4.6 (1.0) 1.0 (0.2) 1.1 (0.1) 
op (Fuc side) 3.3 (1.2) 4.1 (1.3) 4.4 (1.7) 5.6 (1.8) 1.1 (0.1) 1.1 (0.2) 
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Table S . II Average RMSD values (Å) calculated over all N-glycans heavy atoms. For each N-glycan the alignment was 
dove over all the heavy atoms of the core chitobiose and the arms were considered from the central Man. Standard 
deviation values are shown in parenthesis.    
  (1-6)  (1-3) 
N297-glycans g1 g2 g1 g2 
pp 4.1 (1.8) 4.7 (2.2) 9.5 (3.2) 7.1 (2.0) 
oo 2.4 (1.1) 4.1 (1.3) 8.0 (1.8) 4.4 (1.1) 






Figure S . 3 Heat maps (Ramachandran plots) representing the conformational propensities in terms of torsion angles 
of the  (1-3) arms throughout the simulation of the pp IgG Fc. Only the data on g1 are shown for the S ia-(2-6)-Gal 




Table S . III. Averaged torsion angle values calculated for one of the two  (1-3) arms (g1) during the simulation of the 
pp IgG Fc. Standard deviations are indicated in parenthesis and populations (%) are highlighted in red.  
pp (1-3) phi psi omega 
Man-(1-3)-Man 68 (9) 100 - 96 (15) 55 138 (11) 45 - - 
GlcNAc-(1-2)-
Man 
-77 (12) 82 -116 (14) 18 
178 (44) 
79 
98 (13) 21 - - 
Gal-(1-4)-
GlcNAc 
-72 (13) 95 61 (11) 5 
-118 (15) 
100 
- - - 
Sia-(2-6)-Gal 66 (11) 93 -50 (16) 7 
-178 (27) 
87 






Figure S . 4 The two trimannose cores (highlighted by SNFG colouring) in the symmetrically opposed N-glycans shown 
in a snapshot from the simulation of the oo IgG1 Fc. The interactions between the residues are primarily hydrogen 






Figure S . 5 Alignment of a representative structure from the pp IgG1 Fc REMD simulation represented in grey and 
the structure of the complex between the IgG1 Fc and the FcRIII, shown in green tubes, with PDBid 
1E4K(Sondermann, P., Huber, R., et al. 2000). The IgG1 Fc from PDBid 1E4K is omitted for clarity. The position of 





Figure S . 6 KDE distributions of the distance (Å) between one of the CH2 Glu 252 carboxylic oxygen and the O4 of the 
terminal Gal in the N-glycan (1-6) arm in function of temperature. This distance was used as a parameter to gauge 
the position of the  (1-6) arm relative to CH2 and to identify the bound (values within hydrogen bond distance) from 
the unbound (values above hydrogen bond distance) 
 
Rationale for the selection of the starting structure  
The glycan fragment database(Jo, S. and Im, W. 2013) was used to search the PDB for IgG crystal 
structures with N-glycans that were: di-galactosylated, core-fucosylated and sialylated on the (1-3) 
arm. No IgG was found with these specifications and only one with a di-galactosylated N-glycan, 
namely PDBid 1HZH, which does not fit our requirements as it has an asymmetric glycosylation 
pattern. Based on these results we decided that the essential minimum requirements to be: a) a human 
IgG1 structure, b) with core-fucosylation and c) terminal Gal on the (1-6) arm and d) with 
symmetric glycosylation on both sides of the Fc. The terminal Gal requirement was determined by our 
aim to understand the significance of galactosylation on the conformational propensity of the linked 
N-glycan and directly compare the results to our earlier study of the isolated N-glycans(Harbison, 
A.M., Brosnan, L.P., et al. 2019). Out of all the structures in Table S.IV, only two structures, namely 
1FC1 (2.9 Å resolution) and 3DO3 (2.5 Å resolution), were found to match these minimum criteria 
and between the two which in many aspects were equivalent, we chose 1FC1. As shown in Figure S.6 
some of the structures in Table S.IV were eliminated because of highly speculative ring 








Table S.IV: Results from the Glycan fragment DB search of the PDB for Fc structures with core-
fucosylated, (1-6) galactosylated N-glycans  
PDB id Contents of Crystal Structure Resolution (Å) 
Exact glycan match 
5VGP IgG1 2.12 
5XJE IgG1 Fc receptor complex 2.40 
5YC5 IgG1 Fc receptor complex 2.71 
2RGS IgG2 2.10 
4C55 IgG4 2.35 
4W4O IgG4 receptor complex 1.80 
5VAA mutant IgG 1.55 
4BSV mutant IgG 1.75 
4BSW mutant IgG 2.15 
5XJF mutant IgG 2.50 
5TPS mutant IgG 2.70 
5W5L mutant IgG1 1.90 
5D4Q mutant IgG1 2.39 
5HYI mutant IgG1 2.90 
5VAA mutant IgG4 1.55 
5W5N mutant IgG4 1.85 
5W5M mutant IgG4 1.90 
1-6 branch Galactosylated, core-Fucosylated Fragment 
1HZH IgG1 b12 2.70 
4BYH IgG 1-6 sialylation 2.30 
3WKN IgG complex with artifical protein 2.90 
5D6D IgG1 Fc receptor complex 3.13 
1-6 branch Galactosylated Fragment 
1FC1 IgG1 2.90 
3DO3 IgG1 2.50 
4CDH IgG1 2.30 






1FC2 IgG1 (one chain only) 2.80 
2VUO IgG (rabbit) 1.95 
1FRT IgG Fc receptor complex 4.50 
1E4K IgG1 Fc receptor complex 3.20 
3AY4 IgG1 Fc receptor complex 2.20 
3RY6 IgG1 Fc receptor complex 3.80 
4X4M IgG1 Fc receptor complex 3.49 
5VU0 IgG1 Fc receptor complex 2.26 
6EAQ IgG1 Fc receptor complex 2.22 
6EA7 IgG1 receptor complex 4.25 
2RGS IgG2B mab (mouse) 2.13 
5HVW IgG4 1.95 
2QL1 mutant IgG1 2.53 
3C2S mutant IgG1 2.30 
4BSV mutant IgG1 1.75 
4Q74 mutant IgG1 2.19 
5M3V mutant IgG1 1.97 
5W5L mutant IgG1 1.90 
6F2Z mutant IgG1 2.30 
3WJJ mutant IgG1 and complex 2.60 
3WJL mutant IgG1 and complex 2.86 
3WN5 mutant IgG1 and complex 2.78 
5BW7 mutant IgG1 and complex 3.00 
5XJF mutant IgG1 and complex 2.50 
5IW3 mutant IgG1 mab 2.05 
5W5N mutant IgG4 1.85 
1L6X Riuxmab Fc fragment 2.12 





Figure S .6: 4KU1 (magenta), 5VGP(yellow), 4CDH(orange), 3DO3(light pink), 1HZH(green) and 1FC1(cyan) glycans 
from the crystal structure with  or -L-fucose with the ring conformation distorted in 4KU1 and 4CDH in particular. 
The B factors from each crystal structure are shown in Figure  S.7. 1FC1 has the lowest B factors. 




Figure S.7. Panel A. Fc regions from the selected PDBs, coloured based on their B-factors, with dark blue 
being the lowest B-factors and dark red being the highest B-factors recorded. Those atoms with a B-factor 
of 0.0 were coloured light pink to differentiate them from those who are represented by the rainbow 
spectrum, as B-factors of 0.0 can be from error in refinement calculations. Panel B. A closer view of the Fc 
region and glycans from the 1FC1 crystal structure, coloured using the same colouring scheme for B-factors  




Shown in Table  S.V is a RMSD analysis of based on backbone atoms of the six IgG1 Fc structures 
from Table S.4 that fit the glycosylation pattern requirements on at least one glycan. This analysis 
demonstrates how similar all these structures are. 
 










In addition to the analysis of the protein backbone similarities between different crystal structures, we 
also analysed the Fc N-glycans’ structures, shown in Table  S.VI.  Due to the flexibility of the CH2 
domain, the position of the two glycans vary between each crystal structure, depending on the 
conformation of the C’E loop, see Figure S.8.  
 
In terms of sequences, the crystal structures 5VGP, 4CDH, 1HZH and 4KU1 are asymmetrically 
glycosylated, meaning that the two N-glycans have different sequences. While IgGs can be 
asymmetrically glycosylated, asymmetric glycoforms result in asymmetric protein conformation in 
the Fc region(Masuda, K., Yamaguchi, Y., et al. 2000). Based on these consideration and 
observations, we could only consider crystal structures 3DO3 and 1FC1 as suitable as starting 
structures for our simulations.  
PDB 
id 
4KU1 5VGP 4CDH 3DO3 1HZH 1FC1 
 RMSD (Å) 
4KU1  0.718 0.726 0.771 2.04 0.893 
5VGP   0.258 0.294 0.718 0.486 
4CDH    0.342 1.429 0.496 
3DO3     1.08 0.554 
1HZH      1.284 




Table S.VI: N-glycans sequence on the two CH2 domains from selected crystal structure. The asterisk (*) 
indicates the prescence of -L-fucose instead -L. Note, we replaced -L-fucose with -L-fucose in all our 
starting structures. 
PDB id Glycan sequence, Chain A Glycan sequence, Chain B 
4KU1 GalGlcNAc2Man3GlcNAc2Fuc* Gal2GlcNAc2Man3GlcNAc2Fuc* 
5VGP GalGlcNAc2Man3GlcNAc2Fuc GlcNAc2Man3GlcNAc2Fuc 
4CDH Gal2GlcNAc2Man3GlcNAc2Fuc* GalGlcNAc2Man3GlcNAc2 
3DO3 GalGlcNAc2Man3GlcNAc2Fuc* GalGlcNAc2Man3GlcNAc2Fuc* 
1HZH Gal2GlcNAc2Man3GlcNAc2 GalGlcNAc2Man3GlcNAc2Fuc 
1FC1 GalGlcNAc2Man3GlcNAc2Fuc* GalGlcNAc2Man3GlcNAc2Fuc* 
 
 
Effect of different conformations of the  (1-6) Gal on the arm’s dynamics  
 
A difference between the 1FC1 structure and 3DO3 pre-selected as potential candidates as starting 
structure is the conformation of the Gal-(1-4)-GlcNAc, see Figure S.9. To assess the impact of the 
starting conformation of the Gal on the conformational propensity of the (1-6) arm, we ran a set of 
simulations of our three differently glycosylated starting structures, namely pp, oo and op, with the 
conformation of the galactose modified by rotation of the   and  angles to match the conformation 








Figure S.9. Conformational difference of the bound galactose to the CH2 protein surface in the crystal structure 
of 1FC1(left, cyan) and 3DO3(right, light pink). Values given for the  and  torsion angles of the glycosidic 
linkage from the corresponding crystal structure. 
 
 
Results are presented below in Figure S.10 in terms of RMSF values calculated throughout 
the trajectories at 300 K to measure changes in conformational flexibility of both (1-3) and 
(1-6) arm from different starting conformation of the Gal-(1-4)-GlcNAc linkage. 
 
 
Figure S .10. Root Mean Square Fluctuation (RMSF) values indicating the different dynamics/flexibility of the  (1-3/6) 
arm in function of the different Gal conformation calculated throughout the six trajectories. “Original” indicates the 




The average RMSF values calculated are also shown in Table S.7 below. The data do not show any 
significant change in the dynamics of the arms in function of the starting conformation of the Gal.  
 
Table S.VII: RMSF values calculated for the two arms in simulations started from a conformation of the 
Gal-(1-4)-GlcNAc linkage corresponding to the 1FC1. Standard deviation values are indicated in 
parenthesis.  
1FC1 pp op oo 
(1-3) 8.3 (2.7) 8.4 (4.2) 7.3 (2.5) 
(1-6) 3.7 (1.4) 3.6 (1.2) 2.7 (1.2) 
 
Table S.8: RMSF values calculated for the two arms in simulations started from a conformation of the Gal -
(1-4)-GlcNAc linkage corresponding to the 3DO3. Standard deviation values are indicated in parenthesis .    
3DO3 pp op oo 
a(1-3) 6.1 (2.5) 7.8 (2.1) 6.6 (2.4) 





Harbison AM, Brosnan LP, Fenlon K, Fadda E. 2019. Sequence-to-structure dependence of isolated 
IgG Fc complex biantennary N-glycans: a molecular dynamics study. Glycobiology, 29:94-103. 
Humphrey W, Dalke A, Schulten K. 1996. VMD: visual molecular dynamics. J Mol Graph, 14:33-38, 
27-38. 
Jo S, Im W. 2013. Glycan fragment database: a database of PDB-based glycan 3D structures. Nucleic 
Acids Res, 41:D470-474. 
Masuda K, Yamaguchi Y, Kato K, Takahashi N, Shimada I, Arata Y. 2000. Pairing of 
oligosaccharides in the Fc region of immunoglobulin G. Febs Letters, 473:349-357. 
Park SJ, Lee J, Qi Y, Kern NR, Lee HS, Jo S, Joung I, Joo K, Im W. 2019. CHARMM-GUI Glycan 
Modeler for modeling and simulation of carbohydrates and glycoconjugates. Glycobiology, 29:320-
331. 
Sondermann P, Huber R, Oosthuizen V, Jacob U. 2000. The 3.2-A crystal structure of the human 
IgG1 Fc fragment-Fc gammaRIII complex. Nature, 406:267-273. 
Sugita Y, Okamoto Y. 1999. Replica-exchange molecular dynamics method for protein folding. 







Table of Contents: 
1. Materials and Methods 
1.1. Computational Methods 
1.2. Experimental Methods 
2. Supplementary Simulations: All-Atom MD Simulations of S Protein Head using 
Amber FF14SB/Glycam06 Force Fields 
2.1. Computational Methods 
2.2. Results and Discussion 
2.3. Conclusions 
3. Overview of Neutralizing Antibody Epitope Accessibility 
4. Supplementary Figures (S1 to S16) 
5. Supplementary Tables (S1 to S12) 
6. Supplementary Movies (S1 to S3) 
7. Supplementary References 
 
1. Materials and Methods  
1.1. Computational Methods  
Model systems. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) 
glycoprotein is a large, glycosylated homotrimer, where each of its three identical monomers 
(residues 16–1273) can be divided into three main topological domains: the “head,” comprising S1 
and S2 subunits until residue 1140; the “stalk,” composed of heptad repeat 2 (HR2) and 
transmembrane (TM) domains (residues 1141–1234); and the cytoplasmic tail (CT) (residues 1235–
1273) (Figure 1A main text).1 Experimental structures of SARS-CoV-2 S have been resolved in two 
main conformational states, open and closed, that were used in this study to build two complete, fully 
glycosylated models, referred to in this manuscript as “Open” and “Closed”, respectively. The Closed 
system is based on a cryo-EM structure of the S protein solved at 2.80Å average resolution (PDB ID: 
6VXX),2 where all receptor binding domains (RBDs) are in the “down” conformation. The Open 
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system is instead built upon a cryo-EM structure of the S protein solved at 3.46-Å average resolution 
(PDB ID: 6VSB),1 where only one RBD (chain A) is in the “up” conformation. A third system, called 
“Mutant”, was also generated from the Open system upon mutation of N165 and N234 into alanine 
within all the three monomers, which ablated the respective N-glycan sequons. Although the cryo-
EM structures of the S protein already provide critical information about its structure, they are usually 
incomplete and/or have been modified to increase protein stability.1,3 For example, the introduction of 
two consecutive prolines (S-2P variant) in the central helix and/or of an engineered C-terminal foldon 
trimerization domain4 has been adopted as a common strategy to stabilize the S protein for cryo-
EM.1,3 In addition, highly flexible protein regions (loops) and glycans beyond the first three sugars 
often remain unresolved owing to resolution limits. Therefore, several modeling steps were required 
to produce a full-length model of the wild type protein as described below.  
  
Missing loops modeling. The employed cryo-EM structures of the S protein reveal several missing 
gaps corresponding to flexible loops ranging from 3 to 38 residues. To generate a complete construct, 
missing gaps were modeled as disordered loops using Modeller9.19.5 Keeping the cryoEM 
coordinates fixed, 50 models were independently generated for each monomer, from which the top 
models were selected and reassembled to recreate the full trimeric head. The alignment between the 
cryo-EM structure and the FASTA sequence of SARS-CoV-2 spike (QHD43416.1)6 used by 
Modeller was generated using Clustal Omega.7 The top models were further visually inspected to 
discard those in which loops were entangled in a knot or clashed with the rest of the structure. Finally, 
the stabilizing proline mutations from the cryo-EM structures were mutated back to wild type, and 
modeling artifacts were detected and corrected prior to simulations.  
  
HR2 and TM domain (stalk) modeling. Both cryo-EM structures employed to build our models were 
stabilized using an engineered C-terminal foldon trimerization domain.4 Therefore, the stalk region of 
the S protein from residues 1147–1234, including the HR2 and TM domains, had to be constructed. 
Using the Jpred4 server,8 the secondary structure of the stalk sequence was predicted as three helical 
segments connected by two unstructured loops (Figure S13). Given the amphipathic nature of the 
helical segments, the three chains were assembled into an alpha-helical coiled-coil trimeric bundle 
using Modeller9.19.5 A coiled-coil crystal structure, where the smaller and more hydrophobic 
residues are positioned inside the bundle and the polar residues are solventexposed, served as a 
template (PDB ID: 2WPQ).9 Each alpha-helix was broken into three segments separated by two loops 
according to Jpred4 secondary structure predictions.   
CT modeling. The CT of the S protein (residues 1235–1273) was modeled using the i-TASSER 
software.10–12 i-TASSER generated five models with confidence scores of −1.25, −2.65, −3.15, −4.33, 
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and −1.33 (C-score range [−5, 2]). Out of these, model 3 was selected because it revealed a helical 
domain between residues 1238 and 1245, where two cysteines were shown to be palmitoylated in 
another betacoronavirus, MHV-A59.13,14 The corresponding cysteines in SARSCoV-2 were C1240 
and C1241. The remaining sequence of CT was predicted to be intrinsically disordered. Both 
cysteines (C1240 and C1241) were palmitoylated using lipid-tail functionality available within 
Glycan Reader in CHARMM-GUI.15,16  
  
Glycosylation. SARS-CoV-2 S protein features 22 N-glycan sequons (N-X-S/T) per monomer, which 
have been found to be heterogeneously populated in different glycoanalytic studies.17–19 Interestingly, 
two O-glycans have also been characterized at positions T323 and S325.19 Our modeled constructs 
have been fully N-/O-glycosylated using the Glycan Reader & Modeler tool20 integrated into Glycan 
Reader15 in CHARMM-GUI.16 An asymmetric (i.e., not specular across monomers) site-specific 
glycoprofile has been derived according to glycoanalytic data reported by Watanable et al.17 for N-
glycans and by Shajahan et al.19 for O-glycans. Detailed per-chain descriptions of the site-specific 
glycoprofile of the S protein systems simulated in this work are shown in Tables S1-S3. In the 
Mutant system, N165A and N234A mutations were introduced to remove the respective N-glycans. 
This was performed with PSFGEN during system setup. In summary, 70 glycans (22 × 3monomers N-
glycans and 2chainA + 1chainB + 1chainC O-glycans) have been added in the Open and Closed systems, 
whereas 64 have been added in the Mutant system. Our modeled N-glycans account for oligo-
mannose from Man5GlcNAc2 to Man9GlcNAc2, complex and hybrid types, displaying one to four 
antennas. Additional modifications, such as fucosylation and sialylation, have also been site-
specifically considered, as reported in Watanabe et al.17 We remark that the oligosaccharides 
(GlcNAc-/GlcNAc2-/ManGlcNAc2-) originally solved in the cryo-EM structures have been generally 
retained or used as a basic scaffold, when possible, to build the full glycans. However, owing to steric 
clashes arising at particularly buried sites (for example, N122), a manipulation of glycan dihedrals 
and/or asparagine side chain has been necessary to fit in all the glycans.  
  
Membrane modeling. The lipid composition of the membrane patch was selected based on the 
lipoprofiles21,22 of the endoplasmic reticulum and trans-Golgi network, organelles in which the 
coronavirus membranes are known to be constructed.23,24 A symmetric 225 Å × 225 Å lipid bilayer 
patch was generated using CHARMM-GUI’s input generator.16,25 The lipids were packed to an area 
per lipid of 70 Å2 with the following ratio of phospholipids and cholesterol: POPC (47%), POPE 
(20%), CHL (15%), POPI (11%), and POPS (7%). The IUPAC names corresponding to these 
abbreviations are given in Table S4. The area per lipid value was selected based on the suggested 
CHARMM-GUI areas; the equilibrium values for this system were calculated and can be found in 




System preparation. Upon functionalization (i.e., glycosylation and palmitoylation) of the 
glycoproteins through the Glycan Reader module available within CHARMM-GUI, further 
modifications to the structures were necessary and formatting issues were manually solved. 
Differently from SARS-CoV, where the S1/S2 site is cleaved prior to fusion (i.e., at the host cell 
surface), in SARS-CoV-2 the cleavage occurs when the virus is assembled.2 Therefore, all the three 
constructs were modeled in their cleaved form, i.e. with the furin site cleaved between residues R685 
and S686. However, for convenience, S1 and S2 subunits within each protomer have been assigned to 
the same chain (referred to as A/B/C), following the scheme used in 6VSB,1 where RBD of chain A is 
in the “up” conformation. Glycans were attributed segnames from G1 to G70 (G1–G64 for Mutant), 
as reported in Tables S1-S3. Protonation states were assessed using PROPKA326 at pH 7.4 in the 
presence and absence of glycans, without registering any critical differences. The generated models 
were parametrized using PSFGEN and CHARMM36 all-atom additive force fields for protein, lipids, 
and glycans.27,28 Parameters for palmitoylated cysteine were taken from Jang et al.29 Sodium and 
chloride ions were added to neutralize the charge of the system at 150 mM concentration and they 
were treated using Beglov and Roux force fields.30 The systems were fully solvated with explicit 
water molecules described using the TIP3P model.31 The total number of atoms is 1,693,017 for the 
Open system (size: 225 Å × 225 Å × 367 Å), 1,658,797 for the Closed system (size: 225 Å × 225 Å × 
359 Å), and 1,693,069 for the Mutant system (size:  
225 Å × 225 Å × 367 Å).  
  
Molecular dynamics (MD) simulations. All-atom MD simulations were conducted on the Frontera 
computing system at the Texas Advanced Computing Center (TACC) using NAMD 2.14.32 The 
systems were initially relaxed through a series of minimization, melting (for the membrane), and 
equilibration cycles. During the first cycle, the protein, glycans, lipid heads (P atom for POPC, POPI, 
POPE, and POPS and O3 atom for CHL), solvent, and ions were kept fixed and the systems were 
subjected to an initial minimization of 10000 steps using the conjugate gradient energy approach. 
Subsequently, to allow the lipids tails to equilibrate, the temperature was incrementally changed from 
10 to 310 K for 0.5 ns at 1 fs/step (NVT ensemble). The following simulation cycle was run at 2 
fs/step, 1.01325 bar, and 310 K (NPT ensemble). Next, the systems were simulated with only the 
protein and glycans harmonically restrained at 5 kcal/mol to allow the full environment to relax in 
2500 minimization steps and 0.5-ns simulations. Finally, all the restraints were released, and the 
systems were equilibrated for additional 0.5 ns. From this point, the production run was started, and 
frames were saved every 100 ps. Production MD simulations were run in triplicates for ~1 µs for 
Open and Mutant and ~0.6 µs for Closed (Table S5). To further explore the conformational space of 
the RBD in the “up” conformation, additional adaptive sampling simulations were run for Open and 
S55 
 
Mutant, which were also performed in triplicates for ~0.4 µs. Whereas velocities were randomly 
reinitialized, the initial coordinates were selected after principal component analysis (PCA) of RBD-
A. In detail, the minimum (replica 4), mean (replica 5), and maximum (replica 6) along PC1 were 
identified and the corresponding frames used a starting point for adaptive sampling simulations.  
All simulations were performed using periodic boundary conditions and particle-mesh Ewald33 
electrostatics for long-range electrostatic interactions with maximum grid spacing of 2 Å and 
evaluation every 3 time steps. Non-bonded van der Waals interactions and short-range electrostatic 
interactions were calculated with a cutoff of 12 Å and a switching distance of 10 Å. The SHAKE 
algorithm34 was employed to fix the length of all hydrogen-containing bonds, enabling the use of 2-fs 
integration time steps. All simulations were performed under the NPT ensemble using a Langevin 
thermostat35 (310 K) and a Nosé-Hoover Langevin barostat36,37 (1.01325 bar) to achieve temperature 
and pressure control, respectively.   
  
Accessible surface area (ASA). ASA was calculated using the measure sasa command implemented 
in VMD,38 which is based on the Shrake and Rupley algorithm,39 in combination with in-house Tcl 
scripts. Three separate ASA analyses were conducted by taking into account the S protein head 
(residues 16–1140), stalk (residues 1141–1234), and receptor binding motif (RBM) of the RBD 
(residues 400–508), respectively. The area covered by glycans (i.e., the glycan shield) was obtained 
after the subtraction of the ASA of the considered domain in the absence of glycans with the ASA in 
the presence of glycans. This value was calculated along the trajectory with a stride of 150, 20, and 
20 frames between each assessment for head, stalk, and RBM-A, respectively. For each system (Open 
and Closed), the values were averaged across all the respective replicas and standard deviation was 
computed. Apart from the standard 1.4-Å probe, this analysis was repeated for 14 different (1-Å-
interspersed) values of probe radius (from 2 to 15 Å). Note that additional ASA analyses on the whole 
RBD-A (residues 330–530) and on its noninteracting region (residues 330–399 and 509–530) were 
also analogously performed (see SI). Similarly, epitope-specific ASA analyses were conducted on the 
chain A of Open and Closed systems using only 7.2 and 18.6 Å as probe radii. ASA evaluations were 
conducted with a stride of 20 frames. The residues considered for each epitope are listed in Table 
S11.  
  
Principal Component Analysis (PCA). PCA was performed using the sklearn.decomposition.PCA 
function in the Scikit-learn library using python3.6.9.40 First, all simulations were aligned with 
mdtraj41 onto the same initial coordinates using Cα atoms of chainA central scaffold (residues 747–
783 and 920–1032). Next, simulation coordinates of RBD-A (residues 330–530) from all systems 
(Open, Mutant, and Closed) and replicas were concatenated and used to fit the transformation 
function. Subsequently, the fitted transformation function was applied to reduce the dimensionality of 
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each system simulation RBD-A Cα coordinates. Subsequently, the fitted transformation function was 
applied to reduce the dimensionality of RBD-A coordinates from each system into the PC space. Note 
that it is important that the comparative PCA across systems have consistent eigen-basis of the 
principal components. This was ensured by transforming all systems coordinates into the same PC 
space. The same procedure was performed for PCA of RBD-B and RBD-C.  
  
Angles calculation. The lateral angle and axial angle were calculated using in-house Tcl scripts along 
with VMD.38 The axial angle is defined by three points corresponding to (i) the center of mass 
(COM) of RBD-A β-sheets (residues 394–403, 507–517, and 432–437), (ii - vertex) the COM of the 
central helices (residues 987–1032), and (iii) the COM of the top section of the central helices 
(residues 987–993). The lateral angle is described by three points corresponding to the (i) COM of 
RBD-A at frame 0, (ii - vertex) COM of the top section of the central helices, and (iii) COM of RBD-
A β-sheets at frame n. We note that when calculating the COM of RBD-A we only considered the 
core residues defining the β-sheets of the domain, i.e. the most stable part of the RBD, discarding 
instead the highly flexible, solvent exposed loops (like the receptor binding motif) or the hinges that 
would have altered the position of the COM, thus biasing the angle calculation. In this way it was 
possible to keep track of the actual core motions of RBD-A. The other COMs were calculated on the 
central helices (CH). The CH are three alpha-helices (one for each monomer) located around the 
central axis of the spike trimer, representing the most rigid backbone of the spike’s head as shown in 
Figure 1 of the main text.  
Both angles were evaluated at each frame along the trajectories as a variation (positive or negative) 
with respect to their initial value. The trajectories were aligned by the S protein central scaffold 
(residues 747–783 and 920–1032) including the central helices using the coordinates at frame 0 as a 
reference. Importantly, whereas the axial angle was calculated in a three-dimensional space defined 
by xyz coordinates, the lateral angle was assessed by considering the projection of the COMs onto a 
two-dimensional space defined only by xy coordinates. In this way, the lateral angle only accounts for 
lateral tilt/shift of the RBD, discarding any other motion along z.  
  
Hydrogen bonds calculation. Hydrogen bonds were calculated using the measure hbonds command 
implemented in VMD38 in combination with in-house Tcl scripts. Hydrogen bonds criteria were set as 
3.5 Å for distance between heavy atoms and as 45° for angle between AccDon-Hyd. All frames 
across all replicas were considered for this analysis. Occupancy (%) was determined by counting the 





Root-mean-square-deviation (RMSD). RMSD of protein Cα atoms was computed using the measure 
rmsd command implemented in VMD38 in combination with in-house Tcl scripts. Different 
alignments were done before RMSD calculations using the initial coordinates of Cα atoms as  a 
reference. In particular, for RBD-A RMSDs, Cα atoms of the S protein central scaffold (residues 
747–783 and 920–1032) were used as a reference for alignment, whereas for the head, stalk, and CT 
RMSDs, the trajectories were aligned onto the Cα atoms of the residues of the respective regions.  
Root-mean-square-fluctuations (RMSF). RMSF was calculated using in-house python scripts along 
with mdtraj.41 RMSF was computed for each glycan of every chain across all replicas in Closed, 
Open, and Mutant. The trajectories were aligned onto the initial coordinates using the Cα atoms of the 
entire protein as a reference.   
  
1.2 Experimental Methods  
Protein expression and purification. The spike S2P variant was expressed using a previously 
described mammalian expression vector containing proline substitutions at residues 986 and 987 and 
C-terminal 8xHis and TwinStrep tags.1 Alanine substitutions were introduced into S2P to yield the 
N165A and N234A spike variants. To generate the disulfide-locked spike with all RBDs down, we 
introduced S383C, D985C substitutions into a previously described stabilized spike construct 
(HexaPro) containing proline substitutions at positions 817, 892, 899 942, 966 and 987.42 ACE2 was 
expressed using a mammalian expression vector encoding residues 1-615 of human ACE2, a C-
terminal HRV 3C cleavage site, a mono-Fc tag, and 8xHis. Plasmids were transiently transfected into 
FreeStyle 293-F cells using polyethyleneimine and cultured for 4 days (for spike variants) or 6 days 
(for ACE2). Spike variants were purified by passing filtered cell supernatant over StrepTactin resin, 
and ACE2 was purified using Protein A agarose. ACE2 was subsequently cleaved with 3C protease 
passed over Protein A to remove the Fc-8xHis fragment.  
  
Biolayer interferometry. Anti-foldon IgG was immobilized to an anti-human Fc (AHC) Octet 
biosensor (FortéBio), which was subsequently dipped into the specified spike ectodomain variant for 
loading. The biosensor was then dipped into 200 nM ACE2 to measure the RBD-spike association 
signal before being transferred to a well containing buffer only (10 mM HEPES pH 7.5, 150 mM 
NaCl, 3 mM EDTA, 0.05% Tween 20 and 1 mg/mL bovine serum albumin) to measure the 
dissociation signal. The total response at the end of the association phase was recorded for each 
variant and used to quantify the relative proportions of accessible RBDs. The total response at the end 
of the association phase, where nearly all the RBDs should be saturated, was recorded for each 
variant and used to quantify the relative proportions of accessible RBDs. Three independent 
experiments were run for each of the S2P, N165A, and N234A spike variants. Collected data shown 
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in Figure 4B are reported as mean ± standard deviation, with the following values: 0.2563 nm ± 
0.0070 nm (S2P); 0.2284 nm ± 0.0051 nm (N165A); 0.1623 nm ± 0.0097 nm (N234A). The 
experiment with the (HexaPro) variant with all the three RBDs locked in the closed conformation was 
used as control. Raw data are made available as supporting information.  
  
  
2. Supplementary Simulations: All-Atom MD Simulations of S Protein Head using Amber 
FF14SB/Glycam06 Force Fields  
  
2.1. Computational Methods  
The model of the SARS CoV2 S protein head was built in the open conformation by homology with 
SWISS MODEL43 using the cryo-EM structure of the spike trimer in the open state as a template 
(PDB ID: 6VYB,44 3.2 Å resolution) and NCBI YP_009724390.1 as reference sequence. We note that 
this structure (6VYB) differs from to the one used as template for building the fulllength, Open and 
Mutant models described in the main text (6VSB). In 6VYB, the RBD “up” belongs to chain B 
(corresponding to chain A in 6VSB), whereas chains C and A corresponds to chains B and C of 
6VSB, respectively. The missing loops in the 6VYB cryo-EM structure were built automatically by 
SWISS MODEL based on structural libraries of backbone fragments from the PDB with similar 
sequences. The resulting protein structure exhibits 18 glycosylation sites per protomer, for a total of 
54 sites per trimer that can be occupied. Glycosylation on these sites was built by aligning 
equilibrated structures of complex fucosylated (FA2B) and non-fucosylated (A2B) and of 
oligomannose (Man5 and Man9) from our in-house database45 to the resolved GlcNAc residues in the 
cryo-EM structure. Because not all the GlcNAc residues were resolved in the cryo-EM and because 
two glycosylation sites per protomer are located in loops also not resolved in the cryo-EM structure, 
we have built the final 54-glycans model in two phases. In the first phase we built models with 46 
glycosylation sites and run a 20 ns equilibration to obtain conformations of the rebuilt loops that 
allowed for the linking of our glycans. The chosen structures were then completed with glycosylation 
in all 54 sites, leading to the 54-glycans model.   
In this additional set of simulations of the SARS-CoV-2 S protein head, we have considered three 
slightly different glycosylation profiles, shown in Table S13, resulting into three models that differs 
specifically at position N234, occupied either by a Man9 (Man9-N234) or where N234 is mutated 
into Ala (N234A) leading to glycan depletion, or where N234 is non-glycosylated. We ran two 
independent trajectories for the 46-glycans model (i.e., Man9-N234) and one for the related N234A 
mutant. Moreover, we performed one run each for the 54(53)-glycans models (i.e., Man9-N234, the 
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N234A mutant, and non-glycosylated N234) for a total of 6 independent MD runs (see Table S14). 
We remark that the N234 N-linked site monitored in this set of simulation belongs to the NTD of 
chain C (NTD-C), corresponding to NTD-B of the full-length model described in the main text. In 
these setups of the spike head based on 6VYB and in the respective MD simulations, the protein was 
described using AMBER ff14SB parameters,46 whereas the glycans by the GLYCAM06j-1 version of 
GLYCAM06.47 An atmosphere of 200 mM NaCl was also included in all simulations, with ions 
represented by parameters in the AMBER ff14SB set. Water molecules were represented by the 
TIP3P model.31 All simulations were run with v18 of the AMBER software package.48  
The same system preparation and running protocol was used for all MD simulations. The energy of 
the system built as described above was minimized in two steps of 50,000 cycles of the steepest 
descent algorithm. During the first minimization all the heavy atoms were kept harmonically 
restrained using a potential weight of 5 kcal mol−1Å2, while the solvent, counterions and hydrogen 
atoms were left unrestrained. During the second minimization step only the protein heavy atoms were 
kept restrained, while the glycans, solvent, counterions and hydrogens were left unrestrained. After 
energy minimization the system was equilibrated in the NVT ensemble with the same restraint 
scheme, where heating was performed in two stages over a total time of 1 ns, from 0 to 100 K (stage 
1) and then 100 to 300 K (stage 2). During equilibration the SHAKE algorithm was used to constrain 
all bonds to hydrogen atoms. The Van der Waals and direct electrostatic interactions were truncated 
at 11 Å and Particle Mesh Ewald (PME) was used to treat long range electrostatics with B-spline 
interpolation of order 4. Langevin dynamics with collision frequency of 1.0 ps -1 was used to control 
temperature, which a pseudo-random variable seed to ensure there are no synchronization artefacts. 
Once the system was brought to 300 K an equilibration phase in the NPT ensemble of 1 ns was used 
to set the pressure to 1 atm. The pressure was held constant with isotropic pressure scaling and a 
pressure relaxation time of 2.0 ps. At this point all restraints on the protein heavy atoms were 
removed, allowing the system to evolve for 15 ns of conformational equilibration before production. 
The total simulation times, including equilibration, are shown in Table S14.  
  
2.2 Results and Discussion  
As remarked in the main text, to further assess possible impact of the force fields and/or to the 
starting cryo-EM structure on the simulations described in the main text, we performed an additional 
set of simulations of the open SARS-CoV-2 S protein’s head (presented here) using AMBER 
ff14SB/GLYCAM06j-1 force fields46,47 and an alternative initial cryo-EM structure (PDB ID: 
6VYB),44 which presents the N234 GlcNAc in a slightly different orientation. The results of this set 
of simulations are described below.  
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Man9-N234 model. We analyzed the relative stability of the RBD domains in chains A, B and C 
during the MD production by calculating the backbone RMSD values relative to the starting 
homology model based on the 6VYB template. RMSD values were calculated using different 
alignments, namely residues 770 to 1255 of chain A, B and C, respectively, to evaluate potential 
biases. The differences in average RMSD values calculated from different alignments are within the 
standard deviation values used as error bars, therefore only results from the alignment to chain A 
(residues 770 to 1255) are shown in Table S15. Data were collected after 20 ns of equilibration. 
Unless otherwise stated, results are shown for the 54(53)-glycans model systems. All simulations of 
the Man9-N234 model show that the glycan gradually inserts itself in the space left empty by the 
lifting-up of RBD-B (chain B in this model, corresponding to chain A in the full-length model) 
(Movie S2). This insertion progresses gradually through the formation of hydrogen bonding 
interactions between Man9 glycan at N234 and Y369 and N370 of RBD-C that evolve to reach the 
core of the spike’s trimer defined by the location of D405, R408 and E409 of RBD-A, located  in the 
diametrically opposite side across the spike apical center (see Figure S14). Similar interactions have 
been registered also in the simulations of the full-length model of the spike described in the main text, 
where Man9 at N234 is found to establish persisent h-bonds with residues of RBD-C (RBD-A here).  
The insertion of Man9 into the open pocket and its stable interactions with the trimer core’s charged 
residues D405, R409 and E409 results in a stabilization of the whole structure, which is evident from 
the backbone RMSD analysis of the three RBD domains, shown in Figure S15. As an interesting 
note, position N357 in SARS-CoV S, corresponding to position N370 in SARSCoV2 S, is part of an 
NST sequon and it is glycosylated.49 The sequon is lost in SARS-CoV2 S with a mutation of the Thr 
to Ala. Because of the important and stable interactions of the Man9 at N234 with N370 along the 
reaction coordinate that allows it to reach the core of the trimer, it is reasonable to infer that 
glycosylation at position N370 in SARS-CoV would interfere with this process, potentially affecting 
or preventing the insertion of the Man9. To understand the significance of the presence of a large 
glycan such as Man9 at position N234 of NTD-C and its role in filling the empty space left by the 
opening of the RBD-B, we decided to remove it and to observe the conformational changes through 
another set of conventional MD simulations.  
N234A mutant and N234-nogly models. To understand the role of the Man9 at N234 within NTD-
C, we designed two models: a model with an N234A mutation in chain C (N234A) and a model 
where the N234 position also in chain C is non-glycosylated (N234-nogly). For those we analyzed 
four independent MD trajectories (see Table S14), two from the 46(45)-glycans model, one from the 
54(53)-glycans model sites in the N234A mutant form, and one from the 54(53)glycans model with 
N234-nogly. In agreement with the full-length model of SARS-CoV2 S protein described in the main 
text, we observed a higher degree of dynamics of the open RBD relative to Man9-N234 when the 
glycan at N234 is missing. As an important note, here the N234A mutant and N234-nogly are missing 
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Man9 only in one site of the trimer, i.e. chain C (chain B in the full-length model), which is a subtler 
modification relative to the full system in which the mutant is missing the glycans at N234 and N165 
in each protomer. As indicated by the average backbone RMSD values shown in Table S15, except 
for the case of the 54(53)-glycans N234A model, for which the open RBD remains in a stable 
conformation for the length of the trajectory considered here, in the two simulations of the 46(45)-
glycans  N234A models and in the simulation of the 54(53)-glycans N234-nogly model, the open 
RBD domain is largely displaced relative to the original homology model, used as reference structure. 
In agreement with the full model discussed in the main text, the dynamics of the open RBD in the 
mutants is quite complex and within this simulation framework cannot (and should not) be defined as 
part of any specific reaction coordinate, such as a domain closing or unfolding. Nevertheless, in the 
simulations of the 46(45)-glycans N234A model, the open RBD (chain B) can be described as 
shifting towards the RBD of chain C, with the flexible loop interacting with the Man5 at N343 within 
chain C. Meanwhile, the conformational change we observed for the open RBD in the simulations of 
the 54(53)-glycans N234-nogly model corresponds more to a shift away from the RBD of chain C 
(Figure S16).  
  
2.3. Conclusions  
The simulations described in this section of the Supporting Information are presented here as 
supplementary material in support of the results discussed in the main manuscript based on much 
larger and complete 3D models of the SARS-CoV2 S glycoprotein. Indeed, despite the differences in 
the systems sizes, setups, original cryo-EM structure (6VYB vs. 6VSB), force field parameter sets 
(AMBER vs. CHARMM), MD software packages (Amber vs. NAMD), in the running protocols and 
details in the models’ glycosylation, these two sets of simulations converge in showing that the 
absence of glycosylation at position N234 and at both positions N234 and N165, causes the open 
RBD to explore a larger conformational freedom, which may indicate a degree of instability. 
Therefore, all the simulations combined support the conclusion that the strangely “patchy” glycan 
shield of the SARS-CoV2 S glycoprotein may very well be engineered to play a structural role in 
supporting the active structure of the protein, by stabilizing the open or “up” conformation of the 
RBD. Also, as an important note, a mutation found in SARS-CoV2 S relative to the SARS-CoV S 
causes the loss of glycosylation at N370. Because of the dynamic process that Man9 follows in 
accessing the trimer core, which involves stable interactions with N370, a glycan at that location may 
interfere with insertion of the glycan at N234 into the pocket, which would remain empty, potentially 





3. Overview of Neutralizing Antibody Epitope Accessibility  
  
Several SARS-CoV-2 antibodies targeting the S protein have been identified (Table S11).50– 61 The 
majority of these antibodies recognize epitopes on the RBD, while only a few have been shown to 
address the antigenic regions within the NTD and CD (Figure S12). Among the RBD antibodies, B38 
interacts with the RBM at the RBD/ACE2 interface,52 whereas S309 and CR3022 target the 
side/bottom part of the RBD.50,51,53 In addition, 4A8 and 1A9 have been found to engage with the 
NTD and CD, respectively.55,56  To quantify the effects of glycan shielding on these epitopes, we 
calculated each epitope’s ASA at two probe radii, 7.2 and 18.6 Å, which approximate the size of 
antibody hypervariable loop and variable fragments domains, respectively (Figures S12A and S12B, 
full data provided in Table S12).62 In Open (RBD “up”), B38 epitope on the RBD/ACE-2 interface 
shows large ASA that is minimally shielded by glycans (10%/11%, for 7.2 and 18.6 Å probes, 
respectively ) (Figure S12A). Antibodies in this region exploit the vulnerability of the S protein when 
RBD is in the “up” conformation. Conversely, in Closed, the shielding of B38 epitope remarkably 
increases to 47%/62% (Figure S12B). When the RBD is in the “down” conformation, the RBM is 
buried by the other two neighboring RBDs, which already reduce its overall accessibility by ~40%. 
These values are in agreement with the RBM ASA trends shown in Figure 7 in the main text.   
The S309 epitope, located on the side of the RBD and near the N-glycan at N343, shows an 
interesting behavior. When including glycan N343 as a shielding factor, the epitope is covered up to 
45%/56% of its total area. However, this glycan has been shown to be incorporated into the 
recognized epitope, which would considerably increase the antigenic region targeted by S309.53 
Interestingly, no substantial differences in shielding are observed between Open and Closed because 
this epitope is mostly located on the RBD side, which remains exposed even in the “down” 
conformation. Considering the bottom part of the RBD, the epitope recognized by the CR3022 
antibody is found to be almost completely shielded in Open (69%/94%) and not accessible at all in 
Closed. This is in agreement with structural data showing that the cryptic epitope engaged by CR3022 
is only available when the RBD is both “up” and rotated.50,51 Remarkably, this epitope partially 
overlaps with VHH72, an antibody found to neutralize SARS-CoV-2 S pseudotyped viruses.60 
Finally, the 4A8 and 1A9 epitopes located within the NTD and CD, respectively, are not affected by 
the conformational changes of the RBD.55,56  Whereas the epitope recognized by 4A8 is about 
36%/51% shielded by glycans, the one targeted by 1A9 is almost completely covered at 86%/99%. 




4. Supplementary Figures   
 
Figure S1. Molecular representation of S protein ectodomain in the Closed (A) and Open (B) systems. Protein 
is shown with cartoons, where chains A-B-C are colored in cyan, red and silver, respectively. Glycans are 
omitted for clarity.  
  
  
Figure S2. RMSD [Å] vs. time [ns] plots of the receptor binding domain of chain A (A-C) (RBD-A; residues 
330530) and the head (D-F) (residues 16-1140) of the S protein Cα atoms in the Closed, Open, and Mutant 
systems along each replica. For the RBD-A RMSDs, Cα atoms of the S protein central scaffold (residue 920 to 
1032, 747 to 783) was used for alignment, while for head RMSDs the S protein was  aligned onto all the head 





Figure S3.  RMSD [Å] vs. time [ns] plots of the stalk (A-C) (residues 1141-1234) and cytoplasmic tail (D-F) 
(residues 1235-1273) Cα atoms of the S protein in the Closed, Open, and Mutant systems along each replica. 
For the stalk RMSDs, the stalk Cα atoms were used for alignment. Similarly, the cytoplasmic tail was aligned 





Figure S4. RMSF [Å] of each glycan for all chains across all simulations in the Closed (A), Open (B), and 
Mutant (C) systems. Glycans are colored based on their structure and composition: complex glycans in 
magenta, oligomannose glycans in green, hybrid glycans in orange, and O-glycans in yellow. Glycans in each 
chain are decomposed by domain: head (N17 to N1134), and stalk (N1158 to N1194), highlighted with 





Figure S5. Plots of equilibrium area per lipid (top row) and P-P distance indicating membrane thickness 
(bottom row) of the membranes for the Closed (left), Open (center), and Mutant (right) systems along with each 






Figure S6. PCA plot showing PC1 vs PC2 of RBD-A (residues 330-530) in Open and Mutant in teal and 




Figure S7. (A-C) PCA plots showing PC1 vs PC2 of RBD-A, RBD-B, and RBD-C (residues 330-530) in 
Closed, Open, and Mutant in blue, teal, and magenta, respectively. (D-N) PCA plots showing each system’s 
time evolution for each replica. The time scale is reported as a color bar for each system. We remark that for 
Open and Mutant, replicas 4, 5, and 6 were simulated for ~400 ns. The RBD state is annotated within each 




Figure S8.  The main hydrogen bond interactions of N-glycans at N165 within the Open system are shown as 






Figure S9. Main hydrogen bond interactions of glycan N165 (A) and N234 (B) within each replica of the Open 




Figure S10. The accessible surface area of the RBD-ARBM (residues 400 to 509), RBD-ANON-INTERACTING 
(residues 330 to 399 and 509 to 530), RBD-AWHOLE (residues 330 to 530) and the area shielded by neighboring 
glycans in the Closed (A-C, respectively) and Open (D-F, respectively) systems is plotted at multiple probe 
radii from 1.4 Å (water molecule) to 15 Å. The values have been averaged across replicates and are reported 
with standard deviation. In blue is the area covered by the glycans (rounded % are reported), while the grey line 
is the accessible area in the absence of glycans. Highlighted in cyan is the area that remains accessible in the 




Figure S11. Molecular representation of the Closed system from top view. Glycans (blue lines) are represented 
at several frames equally interspersed along the trajectories (300 frames along 0.55 ns for Closed and 1.0 us for 
Open), while RBD-A is depicted with cyan cartoons and transparent surface. Chain B and Chain C are shown in 
red and grey cartoons, respectively, and transparent surface. Glycans at N165, N234, N331 and N343 are 




Figure S12. Accessibility of neutralizing antibody epitopes. The accessible surface area of antibody epitopes 
and the area shielded by neighboring glycans are plotted at probe radii 7.2 and 18.6 Å for chain A in Open (A) 
and Closed (B) systems. The area of the protein covered by the glycans is depicted in blue (rounded % values 
are reported), whereas highlighted in cyan is the epitope area that remains accessible in the presence of glycans. 
The values have been averaged across replicas and are reported with standard deviation. (C) Side view of the 
top region of S protein in the Open system, where the antibody epitopes are highlighted following the color 






Figure S13. Secondary structure of stalk and cytosolic tail regions of the S protein as predicted with Jpred4 
server. The secondary structure of the stalk sequence was predicted as three helical segments (“H”, red) 





Figure S14. (A-B) Hydrogen bonding distances (Å) calculated through the 210 ns trajectories of the 46-glycans 
Man9N234 spike chosen here for the higher sampling time. (A) Interactions with Y369, N370, F374 belonging 
to RBD-C. (B) Interactions with R408, D405, E409, L517 belonging to RBD-A. Interactions with F374 and 
L517 involve backbone atoms and double colors indicates distances between different atoms on the same 
residues. Similar hydrogen bonding pattern and behavior have been observed in all other simulations of the 




Figure S15 Left panel: Backbone RMSD values calculated for the 54-glycans Man9-N234 system over 120 ns 
of production. A structural alignment of the protein backbone atoms was done on the stalk residues (resid 770 
to 1255) of chain A, see text for more details. Right panel: Snapshot of the MD simulation (at 44 ns) showing 
the insertion of the Man9 at N234 deep into the trimer core highlighted by the residues in red (D405) and white 
(R408) with labels indicating other important glycans in framing the open conformation of the “u p” RBD, 
highlighted within the yellow circle. All glycans are rendered as Quick Surface (green C atoms) and protein as 
New Cartoon (all grey). Rendering done with VMD and graphs with seaborn.pydata.org.       
  




Figure S16. Left panel: Backbone RMSD values calculated for the 54-glycans N234-nogly system over 225 ns 
of production. A structural alignment of the protein backbone atoms was done on the stalk residues (resid 770 
to 1255) of chain A, see text for more details. Right panel: Snapshot from the MD simulation showing a static 
representation of the protein (red New Cartoon) and the change in the relative position of the open RBD domain 
(resid 437 to 508) along the trajectory. The coloring indicates the trajectory progression as indicated in the bar 
on the right-hand side. The yellow circle highlights the position of the open RBD domain. All glycans are 
shown with Quick Surface (with C atoms in cyan). Rendering done with VMD and graphs with 
seaborn.pydata.org.      
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5. Supplementary Tables  




















































































G23 T323 O-glycan aDNeu5Ac(2→3)bDGal(1→3)aDGalNAc(1→)PROA-323 
G24 S325 O-glycan aDNeu5Ac(2→3)bDGal(1→3)aDGalNAc(1→)PROA-325
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Table S4. Membrane lipids, their percentages in the membrane patch, and corresponding IUPAC 
names.  
 
Lipid Percentage IUPAC Name 
POPC 47% 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine 
POPE 20% 1-palmitoyl-2-oleoyl-sn-glycero-3-
phosphoethanolamine 
CHL 15% (3β)-cholest-5-en-3-ol 





Table S5. Summary of the full-length S protein all-atom MD simulations. 
Replica # Closed Open Mutant 
Rep 1 543.60 ns 1000.50 ns 1001.30 ns 
Rep 2 573.80 ns 1000.30 ns 1036.20 ns 
Rep 3 614.10 ns 1006.30 ns 1018.40 ns 
Rep 4 - 404.30 ns 411.70 ns 
Rep 5 - 404.30 ns 407.00 ns 
Rep 6 - 406.50 ns 416.60 ns 





Table S6. Accessible Surface Area (ASA) values for protein S’ head in Open (A) and Closed (B). 
Glycan shielded area is the area covered by glycans. Glycosylated P ASA is the area effectively 
accessible in the presence of glycans. Non-Glycosylated P ASA is the accessible area in the absence of 
glycans (i.e. of the nude protein). AVG is average, ST.DEV is standard deviation. A full description is 




Table S7. Accessible Surface Area values for protein S’ stalk in Open (A) and Closed (B). Same 




Table S8. Accessible Surface Area values for protein S’ RBDRBM in Open (A) and Closed (B). Same 







Table S9. Accessible Surface Area values for protein S’ RBDNON-INTERACTING. in Open (A) and Closed 





Table S10. Accessible Surface Area values for protein S’ RBDWHOLE in Open (A) and Closed (B). Same 





Table S11. Summary of principal antibody epitopes reported in the literature. Antibodies denoted by * 










 141-156, 246-260 51 








403-409, 415-421, 455-459, 473-479, 
486-505 
54 
47D11 RBD core (338-437, 507-527) 57 
S309 
337-344, 356-361, 440-444, glycan at 
N343 
53 
CR3022 369-392, 427-430, 515-517 49,55 
VHH-72 partial overlap with CR3022 59 
COV2-
2196* 
F486, N487 52 
COV2-
2165* 
F486, N487 52 
COV2-
2130* 
K444, G447 52 
MAb362* Y449, F456, Y489 60 
18F3* D405, V407 58 
7B11* L441, S443, L452 58 
n3021* T500, N501, G502  62 
n3113* N354  62 







Table S12. Accessible Surface Area values for protein S’ epitopes in Open (A) and Closed (B). Same 











Glycosylated full-length model of SARS-CoV-2 spike protein. The movie shows, in the first part, 
the structure of the glycosylated full-length model of SARS-CoV-2 S protein in the open state (i.e. 
with 1 RBD in the “up” conformation, namely RBD-A) referred to as “Open” in the main text. The 
different domains and the color code used for lipids and glycans are indicated in the movie. In the 
second part, the movie shows the MD dynamics (with CHARMM36 force fields) of the same Open 
system. Only one MD replica was selected for illustrative purposes.   
  
Movie S2.  
https://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c01056/suppl_file/oc0c01056_si_003.mp4 
N-glycan at N234 progressively inserts itself into the cavity left empty upon the lifting-up of the 
open RBD. The movie shows the MD dynamics of the glycosylated head-only model of SARS-CoV-
2 S protein described in Section 2 of the Supporting Information. These simulations were conducted 
with AMBER and GLYCAM force fields. N-glycan at N234 (highlighted with a magenta surface) 
progressively inserts in the space left empty by the lifting-up of the open RBD. We remark that in this 
system, based on a different cryo-EM structure (PDB ID: 6VYB), the open RBD is within chain B, 
here highlighted with an orange transparent surface. Nglycans at N165 and N343 are depicted with 
steel blue and cornflower blue surfaces, respectively. All the remaining glycans are shown with an 
admiral blue surface, whereas the protein is represented with gray cartoons.  
  
Movie S3.  
https://pubs.acs.org/doi/suppl/10.1021/acscentsci.0c01056/suppl_file/oc0c01056_si_004.mp4 
N-glycans at N165 and N234 “lock-and-load” the open RBD for infection. The movie illustrates 
the structural role of the N-glycans at N165 and N234 in modulating the RBD conformational 
plasticity. By means of a closed-up view, the movie shows the MD dynamics of the open RBD (i.e., 
RBD-A) within the glycosylated full-length model of the SARS-CoV-2 S protein (wild-type, referred 
to as “Open” in the main text). Only one MD replica was selected for illustrative purpose. N-glycans 
at N165 and N234, and the RBD, are indicated with respective labels in the movie. All the remaining 
glycans are depicted with a per-residue colored licorice representation (GlcNAc in blue, Fucose in 
red, Galactose in yellow, Sialic Acid in purple, Mannose in green). Chain A, B and C of the spike 
trimer are depicted with cyan, red and gray cartoons, respectively.  
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